<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004523.pub3" GROUP_ID="MUSKEL" ID="228701082413473489" MERGED_FROM="" MODIFIED="2010-05-25 16:24:52 -0400" MODIFIED_BY="Michelle Foote" REVIEW_NO="C072-R" REVMAN_SUB_VERSION="5.0.24" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.0">
<COVER_SHEET MODIFIED="2010-05-25 16:24:52 -0400" MODIFIED_BY="Michelle Foote">
<TITLE>Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women</TITLE>
<CONTACT>
<PERSON ID="12662" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>George</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Wells</LAST_NAME>
<SUFFIX>PhD, MSc</SUFFIX>
<POSITION>Director</POSITION>
<EMAIL_1>gawells@ottawaheart.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cardiovascular Research Reference Centre</DEPARTMENT>
<ORGANISATION>University of Ottawa Heart Institute</ORGANISATION>
<ADDRESS_1>Room H1-1</ADDRESS_1>
<ADDRESS_2>40 Ruskin Street</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1Y 4W7</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 798 5555 x18640</PHONE_1>
<PHONE_2>+1 613 798 5555 x18642</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2010-05-25 16:24:52 -0400" MODIFIED_BY="Michelle Foote">
<PERSON ID="12662" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>George</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Wells</LAST_NAME>
<SUFFIX>PhD, MSc</SUFFIX>
<POSITION>Director</POSITION>
<EMAIL_1>gawells@ottawaheart.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cardiovascular Research Reference Centre</DEPARTMENT>
<ORGANISATION>University of Ottawa Heart Institute</ORGANISATION>
<ADDRESS_1>Room H1-1</ADDRESS_1>
<ADDRESS_2>40 Ruskin Street</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1Y 4W7</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 798 5555 x18640</PHONE_1>
<PHONE_2>+1 613 798 5555 x18642</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14918" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Ann</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Cranney</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>ancranney@ohri.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Division of Rheumatology</DEPARTMENT>
<ORGANISATION>Ottawa Hospital</ORGANISATION>
<ADDRESS_1>1053 Carling Ave</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1Y 4E9</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-798-5555 ext: 16804</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5409" ROLE="AUTHOR">
<PREFIX>Miss</PREFIX>
<FIRST_NAME>Joan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Peterson</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>jpeterson@ohri.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Clinical Epidemiology Unit</DEPARTMENT>
<ORGANISATION>Ottawa Civic Hospital / Loeb Research Institute</ORGANISATION>
<ADDRESS_1>1053 Carling Avenue</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1Y 4E9</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 798 5555 ext: 8279</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613 761 5351</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="13F0E8D782E26AA201A9DC553296B984" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Michel</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Boucher</LAST_NAME>
<SUFFIX/>
<POSITION>Research Officer/ Interim Manager</POSITION>
<EMAIL_1>MichelB@CCOHTA.CA</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>HTA Development Canadian Agency for Drugs and Technologies in Health (CADTH)</ORGANISATION>
<ADDRESS_1>865 Carling Ave</ADDRESS_1>
<ADDRESS_2>Suite 600</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1S 5S8</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-226-2553 X 232</PHONE_1>
<PHONE_2/>
<FAX_1>613-226-5392</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5440" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Beverley</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Shea</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>bevshea@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Institute of Population Health</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>1 Stewart St.</ADDRESS_1>
<ADDRESS_2>Room 312</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1N 6N5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 562 5800 ext: 8571</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="13312" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Vivian</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Welch</LAST_NAME>
<SUFFIX/>
<POSITION>Research Associate</POSITION>
<EMAIL_1>vivian.welch@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Centre for Global Health, Institute of Population Health</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>1 Stewart Street, Room 206</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1N 6N5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 562-5800 ext: 2921</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613 562-5659</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="84E856DE82E26AA20104C58EF03F20CE" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Doug</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Coyle</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Scientist</POSITION>
<EMAIL_1>dcoyle@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Epidemiology and Community Medicine</DEPARTMENT>
<ORGANISATION>Ottawa Health Research Institute</ORGANISATION>
<ADDRESS_1>451 Smyth Rd.</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 X 8690</PHONE_1>
<PHONE_2/>
<FAX_1>613-562-5465</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5474" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Tugwell</LAST_NAME>
<SUFFIX/>
<POSITION>Director</POSITION>
<EMAIL_1>elacasse@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Centre for Global Health, Institute of Population Health, Department of Medicine</DEPARTMENT>
<ORGANISATION>Ottawa Hospital</ORGANISATION>
<ADDRESS_1>1 Stewart Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1N 6N5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 ext: 1945</PHONE_1>
<PHONE_2/>
<FAX_1>613-562-5659</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-05-27 23:29:43 -0400" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="14" MONTH="11" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="14" MONTH="11" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="14" MONTH="11" YEAR="2009"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="" YEAR=""/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2003"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2008-08-13 12:57:21 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-08-13 12:57:21 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Absolute event rates included in the Plain language summary</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-05-27 23:28:30 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format. CMSG ID C072-R</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-05-27 23:31:00 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2008-05-27 23:31:00 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="11" YEAR="2007"/>
<DESCRIPTION>
<P>See published notes for details on update.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Ottawa Health Research Institute</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Canadian Agency for Drugs and Technologies in Health</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-08-13 12:55:10 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-08-13 12:55:10 -0400" MODIFIED_BY="[Empty name]">
<TITLE>Risedronate for preventing fractures caused by osteoporosis in postmenopausal women</TITLE>
<SUMMARY_BODY MODIFIED="2008-08-13 12:55:10 -0400" MODIFIED_BY="[Empty name]">
<P>This summary of a Cochrane review, presents what we know from research about the effect of Risedronate for preventing fractures (broken bones) caused by osteoporosis.<BR/>
<BR/>
<B>In women who have already been diagnosed with low bone density putting them at risk for fracture or have already had a fracture in the bones of their spine, risedronate:</B>
</P>
<P>- probably prevents fractures in the bones of the spine and in bones other than in the spine;</P>
<P>- may prevent hip fractures;</P>
<P>- may not lead to any difference in wrist fractures.</P>
<P> </P>
<P>
<B>In women whose bone density is closer to normal or who may not yet have had a fracture in the bones of their spine, risedronate:</B>
</P>
<P> may not lead to any difference in fractures in the bones of the spine, hip fractures or wrist fractures;</P>
<P> there is not enough information to tell if Risedronate prevents fractures in bones other than in the spine.</P>
<P>We do not have precise information about side effects and complications. This is particularly true for rare but serious side effects. Possible side effects may include digestive problems such as damage to the throat, esophagus and stomach and, less commonly, reduced blood supply to the jaw bone, which causes the bone tissue to breakdown .<BR/>
<BR/>
<B>What is osteoporosis and what is risedronate? </B>
<BR/>Bone is a living, growing part of your body. Throughout your lifetime, new bone cells grow and old bone cells break down to make room for the new, stronger bone. When you have osteoporosis, the old bone breaks down faster than the new bone can replace it. As this happens, the bones lose minerals (such as calcium). This makes bones weaker and more likely to break even after a minor injury, like a little bump or fall. Women who have gone through menopause are more likely to get osteoporosis than other people.<BR/>
<BR/>Risedronate belongs to the class of drugs called bisphosphonates. It is a type of medication that slows down the cells that break down the old bone.<BR/>
<BR/>
<B>Best estimate of what happens to women that have already been diagnosed with low bone density putting them at risk for fracture or have already had a fracture in the bones of their spine, who take Risedronate: </B>
</P>
<P>
<B> </B>
</P>
<P>Fracture of the spine</P>
<P>                 - 14 out of 100 women had a fracture when taking a placebo</P>
<P>                 - 9 out of 100 women had a fracture when taking Risedronate</P>
<P> </P>
<P>Fracture in the hip</P>
<P>              - 3 out of 100 women had a fracture when taking a placebo</P>
<P>                 - 2 out of 100 women had a fracture when taking Risedronate</P>
<P> </P>
<P>Fracture in the wrist</P>
<P>                 - 4 out of 100 women had a fracture when taking a placebo</P>
<P>                 - 3 out of 100 women had a fracture when taking Risedronate.</P>
<P> </P>
<P>Fractures in bones other than the spine</P>
<P>                 - 10 out of 100 women had a fracture when taking a placebo</P>
<P>                 - 8 out of 100 women had a fracture when taking Risedronate</P>
<P>
<B> </B>
</P>
<P>
<B>Best estimate of what happens to women whose bone density is closer to normal or who may not yet have had a fracture in the bones of their spine who take risedronate:</B>
</P>
<P>                 - there is no difference in the number of women out of 100 who will have a spine fracture. This may be the result of chance.</P>
<P>                 - for hip and wrist fractures, it is not possible to calculate the effect because no one had fractures of the hip or wrist in the studies.</P>
<P>                 - there is not enough information to tell if Risedronate prevents fractures in bones other than in the spine.</P>
<P> </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Osteoporosis is an abnormal reduction in bone mass and bone deterioration leading to increased fracture risk. Risedronate belongs to the bisphosphonate class of drugs which act to inhibit bone resorption by interfering with the activity of osteoclasts. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the efficacy of residronate in the primary and secondary prevention of osteoporotic fractures in postmenopausal women. </P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We searched CENTRAL, MEDLINE and EMBASE. Relevant randomized controlled trials published between 1966 to 2007 were identified.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Women receiving at least one year of risedronate for postmenopausal osteoporosis were compared to those receiving placebo or concurrent calcium/vitamin D or both. The outcome was fracture incidence.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>We carried out study selection and data abstraction in duplicate. Study quality was assessed through the reporting of allocation concealment, blinding and withdrawals. Meta-analysis was preformed using relative risks and a &gt;15% relative change was considered clinically important. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Seven trials were included in the review representing 14,049 women. </P>
<P>Relative (RRR) and absolute (ARR) risk reductions for the 5 mg dose were as follows. Risk estimates for primary prevention were available only for vertebral and non vertebral fractures and showed no statistically significant effect of risedronate on fractures. For secondary prevention, a significant 39% RRR in vertebral fractures (RR 0.61, 95% CI 0.50 to 0.76) with 5% ARR was found. For non-vertebral fractures, a significant 20% RRR (RR 0.80, 95% CI 0.72 to 0.90) with 2% ARR and for hip fractures there was a significant 26% RRR (RR: 0.74, 95% CI 0.59 to 0.94) with a 1% ARR. When primary and secondary prevention studies were combined, the reduction in fractures remained statistically significant for both vertebral (RR 0.63, 0.51 to 0.77) and non vertebral fractures (RR 0.80, 0.72 to 0.90)</P>
<P>For adverse events, no statistically significant differences were found in any of the included studies. However, observational data has led to concerns regarding the potential risk for upper gastrointestinal injury and, less commonly, osteonecrosis of the jaw. </P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>At 5 mg/day a statistically significant and clinically important benefit in the secondary prevention of vertebral, non-vertebral and hip fractures was observed, but not for wrist. The level of evidence for secondary prevention is Gold (www.cochranemsk.org) for vertebral and non-vertebral and Silver for hip and wrist. There were no statistically significant reductions in the primary prevention of vertebral and non-vertebral fractures. The level of evidence is Silver.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY>
<BACKGROUND>
<P>Osteoporosis is in part a natural consequence of aging in postmenopausal women (<LINK REF="REF-Hodsman-2002" TYPE="REFERENCE">Hodsman 2002</LINK>). It is a skeletal disorder characterized by decreased bone mass and deterioration of microarchitecture of bone resulting in an increased risk of fracture (<LINK REF="REF-NIH-Consensus-2001" TYPE="REFERENCE">NIH Consensus 2001</LINK>).</P>
<P>The most common consequences of osteoporosis are fractures of the hip, wrist and vertebrae (<LINK REF="REF-Hodsman-2002" TYPE="REFERENCE">Hodsman 2002</LINK>). "Bone strength reflects the integration of two main features: bone density and bone quality" (<LINK REF="REF-Brown-2002b" TYPE="REFERENCE">Brown 2002b</LINK>). The clinical indicator of bone quality is a patient's history of a fragility fracture. A fragility fracture is a fracture caused by an injury that would be insufficient to fracture normal bone (for example, a fall from a standing height or less)(<LINK REF="REF-Brown-2002b" TYPE="REFERENCE">Brown 2002b</LINK>). The preferred method of evaluating bone density is the measurement of bone mineral density (BMD) of the lumbar spine and hip by Dual Energy X-ray Absorptiometry (DXA), which can be used to assess response to therapy (<LINK REF="REF-Hanley-2003" TYPE="REFERENCE">Hanley 2003</LINK>).</P>
<P>The interpretation of BMD results is based on comparison of a patient's BMD with the mean value for a young adult population. The "T-score" is the number of standard deviations (SDs) above or below the mean BMD for normal young adults (<LINK REF="REF-Brown-2002b" TYPE="REFERENCE">Brown 2002b</LINK>). The World Health Organization (WHO) Study Group on Osteoporosis defined osteoporosis as "a hip BMD level of more than 2.5 SDs below the mean BMD for young, white, adult women" (<LINK REF="REF-WHO-1994" TYPE="REFERENCE">WHO 1994</LINK>). Using the WHO definition, approximately 30% of postmenopausal women have osteoporosis (<LINK REF="REF-Kanis-1994" TYPE="REFERENCE">Kanis 1994</LINK>; <LINK REF="REF-WHO-1994" TYPE="REFERENCE">WHO 1994</LINK>). It should be noted that there are limitations associated with the WHO definition. The predictive value of BMD measurement for fracture varies depending on the site selected, database used for comparison and the technology used. Furthermore, T-scores do not provide a good basis to establish comparable diagnostic thresholds between different regions of interest and different bone mass measurement techniques (<LINK REF="REF-Black-2001" TYPE="REFERENCE">Black 2001</LINK>). As a result, between-site and technique variability introduces potential for misclassification and inappropriate treatment of some individuals.</P>
<P>Osteoporosis can be detected by BMD measurement or diagnosed by presence of osteoporosis-related fractures. The presence of pre-existing osteoporotic fractures is an important risk factor for future fractures (<LINK REF="REF-Hodsman-2002" TYPE="REFERENCE">Hodsman 2002</LINK>). It is reported that 25% of women aged 80 have had at least one vertebral fracture (<LINK REF="REF-Melton-1989" TYPE="REFERENCE">Melton 1989</LINK>) and Cauley et al., (<LINK REF="REF-Cauley-2000" TYPE="REFERENCE">Cauley 2000</LINK>) demonstrated excess mortality in women who have experienced a clinical vertebral fracture. The cumulative lifetime fracture risk for a 50-year-old woman with osteoporosis is stated to be as high as 60% (<LINK REF="REF-Cummings-1989" TYPE="REFERENCE">Cummings 1989</LINK>). As a result, effective fracture prevention would have a major impact on morbidity and a smaller but important impact on mortality in these women.</P>
<P>Osteoporosis-related morbidity is associated with significant medical and social consequences (<LINK REF="REF-Brown-2002b" TYPE="REFERENCE">Brown 2002b</LINK>). The major source of morbidity and mortality from osteoporosis is attributed to hip fractures. Hip fractures are not only associated with an increase mortality risk but also influence long-term function and independence. Fifty per cent of women who sustain a hip fracture do not return to their previous functional state and become dependent on others for their daily activities (<LINK REF="REF-Brown-2002b" TYPE="REFERENCE">Brown 2002b</LINK>). The mortality associated with hip fractures in older women may be as high as 20% in the first year (<LINK REF="REF-Cauley-2000" TYPE="REFERENCE">Cauley 2000</LINK>). This excess mortality may not be directly attributable to the hip fracture, but to comorbid conditions (<LINK REF="REF-Browner-1996" TYPE="REFERENCE">Browner 1996</LINK>; <LINK REF="REF-Cooper-1993" TYPE="REFERENCE">Cooper 1993</LINK>). </P>
<P>Prevention and treatment of osteoporosis can be complex, due to the multifactorial etiology of the disorder. New anabolic therapies directed at increasing bone formation, such as teriparatide (recombinant human parathyroid hormone (1-34)), (<LINK REF="REF-Shukla-2003" TYPE="REFERENCE">Shukla 2003</LINK>) are available, however most currently available osteoporosis drugs are anti-resorptive agents that act to decrease bone turnover. One class of anti resorptive drugs includes the bisphosphonates: etidronate, alendronate and risedronate. They are recommended as first-line preventive agents in postmenopausal women with low BMD and as first-line agents for the treatment of postmenopausal women with osteoporosis (<LINK REF="REF-Brown-2002b" TYPE="REFERENCE">Brown 2002b</LINK>). </P>
<P>Bisphosphonates are stable analogues of naturally occurring pyrophosphates. The mechanism of action of these drugs is to inhibit bone resorption through their effects on osteoclasts (<LINK REF="REF-Brown-2002b" TYPE="REFERENCE">Brown 2002b</LINK>). Bisphosphonates are poorly absorbed and avidly taken up by bone on active sites of resorption. Risedronate is a nitrogen containing pyridinyl third generation bisphosphonate which is administered daily or once weekly (depending on formulation). The recommended dose for the prevention and treatment of osteoporosis in postmenopausal women is 5 mg/day (35 mg / week) . Risedronate at 5 mg, relative to control, has been shown to increase bone mineral density after 1.5 to three years of treatment by 4.54% (95% CI 4.12 to 4.97) in the lumbar spine, and 2.75% (95% CI 2.32 to 3.17) in the femoral neck (<LINK REF="REF-Cranney-2002" TYPE="REFERENCE">Cranney 2002</LINK>). At a dose of 2.5 mg increases at the lumbar spine and femoral neck were 2.94% (95% CI 1.55 to 4.34) and 1.71%, (95% CI 1.17 to 2.25) (<LINK REF="REF-Cranney-2002" TYPE="REFERENCE">Cranney 2002</LINK>).</P>
</BACKGROUND>
<OBJECTIVES>
<P>The aim of this systematic review was to assess the clinical efficacy of risedronate in the primary and secondary prevention of osteoporotic fractures in postmenopausal women receiving these agents compared with untreated women over a follow-up period of at least one year.</P>
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>Randomized controlled trials (RCTs) with a duration of at least one year were included in this review.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>The population group of interest was post menopausal women. Both primary and secondary prevention trials were accepted. A hierarchy was used to define primary versus secondary prevention according to the information available. We selected a definition of primary and secondary prevention that gave more weight to study inclusion criteria than baseline statistics. That is, if the inclusion criteria restricted the population to women whose bone density was at least 2 SD values below the peak bone mass or the inclusion criteria restricted the population to women that had experienced previous vertebral compression fractures, then the trial was considered a secondary prevention study. If such inclusion criteria were not provided then the baseline statistics were considered as follows: (a) we considered the trial as primary prevention if the average T-score (and SD) was such that it included women whose bone density was within 2 SD of the mean or if the prevalence of vertebral fracture at baseline was less than 20%; and (b) when these data were not available, we considered a trial as secondary prevention if the average age was above 62 years.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Treatment: Risedronate at any dose. <BR/>Comparators: No treatment (including placebo or calcium or vitamin D or both). If the study used calcium or vitamin D controls or both, these same treatments would have to be given concurrently in the risedronate treatment group.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>Incidence of fractures, including vertebral, non-vertebral, hip and wrist fractures.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<P>The Cochrane Collaborative approach for identifying randomized controlled trials (RCTs) as described by Dickersin et al., (<LINK REF="REF-Dickersin-1994" TYPE="REFERENCE">Dickersin 1994</LINK>) and modified for the Cochrane Musculoskeletal Group, guided our literature search. We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE from 1966 to November 2004, Current Contents, and citations of relevant articles. No language restrictions were applied to the search strategy. The actual literature search was conducted in three stages. The first stage was the basis for our systematic review published in 2002 (<LINK REF="REF-Cranney-2002" TYPE="REFERENCE">Cranney 2002</LINK>) and the second and third stages involved updating the search. The first search, for the time period 1966 to December 2000, included Cochrane Controlled Trials Register, MEDLINE, EMBASE, Current Contents, and handsearching of conference abstracts and FDA proceedings. This was followed by a MEDLINE search for the time period 2000 to November 2004. This MEDLINE search was confirmed by a parallel literature search that was conducted for a companion bisphosphonate economic report <LINK REF="REF-CADTH-2006" TYPE="REFERENCE">CADTH 2006</LINK>. For the final update (2004 to February 2007), we searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and EMBASE. </P>
<P>
<B>Search Strategy MEDLINE Using OVID Interface<BR/>
</B>1. osteoporosis, postmenopausal/<BR/>2. osteoporosis/<BR/>3. osteoporosis.tw.<BR/>4. exp bone density/<BR/>5. bone loss$.tw.<BR/>6. (bone adj2 densit$).tw.<BR/>7. or/2-6<BR/>8. menopause/<BR/>9. post-menopaus$.tw.<BR/>10. postmenopaus$.tw.<BR/>11. or/8-10<BR/>12. 7 and 11<BR/>13. 1 or 12<BR/>14. risedronate.tw.<BR/>15. 13 and 14<BR/>16. meta-analysis.pt,sh.<BR/>17. (meta-anal: or metaanal:).tw.<BR/>18. (quantitativ: review: or quantitativ: overview:).tw.<BR/>19. (methodologic: review: or methodologic: overview:).tw.<BR/>20. (systematic: review: or systematic: overview).tw.<BR/>21. review.pt. and medline.tw.<BR/>22. or/16-21<BR/>23. 15 and 22<BR/>24. clinical trial.pt.<BR/>25. randomized controlled trial.pt.<BR/>26. tu.fs.<BR/>27. dt.fs.<BR/>28. random$.tw.<BR/>29. (double adj blind$).tw.<BR/>30. placebo$.tw.<BR/>31. or/24-30<BR/>32. 15 and 31</P>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>
<B>Selection of studies<BR/>
</B>Two review authors examined each title generated from the search and identified potentially eligible articles, for which we obtained the abstracts. We obtained the full article text for abstracts consistent with study eligibility. Overall, we only considered published studies for inclusion, either as the full article or abstract.</P>
<P>
<B>Data abstraction strategy<BR/>
</B>Two independent review authors abstracted all information and data using standardized data abstraction forms with a third review author verifying the data. Abstraction included information on pertinent methodological aspects of the study design, characteristics of the participants, the specific dose of the study drug used and the outcomes assessed (e.g. number of vertebral, non-vertebral, hip and wrist fractures). For fracture data, we considered all reported fractures (whether clinical or radiographic). </P>
<P>For the yearly data, our unit of analysis was number of patients sustaining a fracture. If an article reported yearly data, we used the time points available. For baseline denominators we used the same baseline denominator for each time point. For follow-up denominators we used any yearly follow-up number of patients reported in the article, if available. If these were not available, we assumed a uniform drop-out rate for each year and calculated the denominators by determining the proportion of participants that would have remained at the end of the year in question based on the number of withdrawals over the course of the study. If an article reported only end of study outcomes, these were used for our analysis with the exception of outcomes for which the numerator was zero for both treatment groups. In these instances, we included the outcome (with any necessary adjustments for follow-up denominators) for the earlier years in the duration of the study. For example, if a trial reported zero hip fractures for both treatment arms at the end of year three, we would also include in our analysis zero hip fractures for that trial at years one and two. <BR/> <BR/>For person year data, the unit of analysis, if available, was number of fractures. When these data were not available (that is, in the majority of cases), we used the number of women sustaining a fracture. For denominators, we multiplied the number of women followed by the length of the study. For radiographic vertebral fractures we used the number of women with available radiographs, if the number was reported in the article. For clinical fractures, we estimated the number of women followed over the duration of the study by taking the mean of the baseline and follow-up denominators.</P>
<P>
<B>Strategy for quality assessment<BR/>
</B>Two review authors assessed each eligible RCT for quality based on allocation concealment. Research has shown that lack of adequate allocation concealment is associated with bias, (<LINK REF="REF-Higgins-2005" TYPE="REFERENCE">Higgins 2005</LINK>) and studies can be judged on the method of allocation concealment. The method for assigning participants to interventions should be robust against patient and clinician bias and its description should be clear. The review authors were required to indicate whether allocation concealment was adequate (A), unclear (B), or inadequate (C) as per the Cochrane Collaboration criteria as follows:</P>
<P>
<B>
<I>Adequate: </I>
</B>The following are some approaches that can be used to ensure adequate concealment schemes: centralized or pharmacy-controlled randomization, pre-numbered or coded identical containers which are administered serially to participants, on-site computer system combined with allocations kept in a locked unreadable computer file that can be accessed only after the characteristics of an enrolled participant have been entered or sequentially numbered or sealed, opaque envelopes. Other approaches may include those similar to ones listed previously, along with reassurance that the person who generated the allocation scheme did not administer it.</P>
<P>
<B>
<I>Inadequate:</I>
</B> Approaches to allocation concealment that are considered inadequate include: alternation, use of case record numbers, dates of birth or day of the week and any procedure that is entirely transparent before allocation, such as an open list of random numbers.</P>
<P>
<B>
<I>Unclear: </I>
</B>When studies do not report any concealment approach, adequacy should be considered unclear. Examples include merely stating that a list or table were used, only specifying that sealed envelopes were used and reporting an apparently adequate concealment scheme in combination with other information that leads the review author to be suspicious.</P>
<P>In addition, blinding and loss to follow up were assessed.</P>
<P>
<B>Data analysis<BR/>
</B>For the analysis of fractures (i.e. vertebral, non-vertebral, hip and wrist), we calculated the relative risk (RR) of fracture using a fixed-effect model. The methods we used for pooling the results are described elsewhere by Fleiss, (<LINK REF="REF-Fleiss-1993" TYPE="REFERENCE">Fleiss 1993</LINK>). We calculated the pooled or weighted RRs using the general inverse variance method for the weights. For the pooled results, we calculated site-specific 95% confidence intervals (CIs) for vertebral, non-vertebral, hip and wrist fractures and we tested for association using a chi-squared test procedure taking P value &lt; 0.05 for presence of statistical association. Statistically significant risk reductions were considered to be clinically important if a 15% or greater relative benefit was shown. We also tested for homogeneity using a chi-squared test procedure taking the specific cut-off for presence of statistical heterogeneity as P = 0.10 ( <LINK REF="REF-Fleiss-1993" TYPE="REFERENCE">Fleiss 1993</LINK>). In the event of significant heterogeneity, a random-effects model was used. </P>
<P>If the relative risk reduction (RRR) was significant (P &lt; 0.05), then the absolute risk reduction (ARR) and number needed to treat to benefit (NNTB) were calculated. For these calculations, the five year risk of fracture in the untreated population was based on the FRACTURE Index (FI) of Black et al., (<LINK REF="REF-Black-2001" TYPE="REFERENCE">Black 2001</LINK>) and the lifetime and five year age-specific risks in the untreated population were based on the model by Doherty et al., (<LINK REF="REF-Doherty-2001" TYPE="REFERENCE">Doherty 2001</LINK>) for predicting osteoporotic fractures in postmenopausal women (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>; <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>.)</P>
<P>Trials varied as to the length of treatment (for example, one to four years) and the number of patients available for study at the start of treatment (that is, baseline denominator) compared to those available at different time points during the trial (that is, follow-up denominators). The base case taken for the review of fractures considered the data available for the longest period of time for the treatment in the trial (that is, "all years") and used the baseline denominators for the number of patients in the trial. </P>
<P>Data was initially pooled broadly across primary and secondary trials. The overall analysis was also considered using person years of observation. In addition, we conducted subgroup analysis for: 1) primary versus secondary, 2) treatment duration and 3) treatment dose. Furthermore, we conducted sensitivity analysis for: 1) baseline denominators versus follow-up denominators, 2) fixed versus random-effects model, and 3) baseline vertebral fracture rate. For the last sensitivity analysis, recall that the vertebral fracture criteria for a trial to be considered secondary was a prevalence of vertebral fracture at baseline of greater than 20%. A sensitivity analysis using different vertebral fracture rates (i.e. 100%, &gt; 80%, &gt; 60%, &gt; 40%, &gt; 20%) without the BMD and age criteria was conducted. Such sensitivity analysis allowed evaluating whether the effect of bisphosphonates on the secondary prevention of osteoporotic fractures varied, depending on how strictly secondary prevention was defined.</P>
<P>
<B>Grading of evidence</B>
<BR/>Results from the primary analyses were graded according to the system described in the 2004 book Evidence-based Rheumatology (<LINK REF="REF-Tugwell-2004" TYPE="REFERENCE">Tugwell 2004</LINK>) and recommended by the Cochrane Musculoskeletal Group:</P>
<P>
<B>
<I>Platinum</I>
</B>
<BR/>To achieve the platinum level of evidence, a published systematic review that has at least two randomized controlled trials each satisfying the following is required.<BR/>
</P>
<UL>
<LI>Sample sizes of at least 50 per group - if these do not find a statistically significant difference, they are adequately powered for a 20% relative difference in the relevant outcome. </LI>
<LI>Blinding of patients and assessors for outcomes. </LI>
<LI>Handling of withdrawals &gt; 80% follow up (imputations based on methods such as Last Observation Carried Forward (LOCF) are acceptable). </LI>
<LI>Concealment of treatment allocation. </LI>
</UL>
<P>
<BR/>
<B>
<I>Gold</I>
</B>
<BR/>The gold level of evidence requires at least one randomized clinical trial meeting all of the following criteria for the major outcome(s) as reported: <BR/>
</P>
<UL>
<LI>Sample sizes of at least 50 per group - if these do not find a statistically significant difference, they are adequately powered for a 20% relative difference in the relevant outcome. </LI>
<LI>Blinding of patients and assessors for outcomes. </LI>
<LI>Handling of withdrawals &gt; 80% follow up (imputations based on methods such as LOCF are acceptable). </LI>
<LI>Concealment of treatment allocation. </LI>
</UL>
<P>
<BR/>
<B>
<I>Silver</I>
</B>
<BR/>The silver level of evidence requires a randomized trial that does not meet the above criteria for gold or platinum ranking or evidence from at least one study of non-randomized cohorts that did and did not receive the therapy, or evidence from at least one high quality case-control study. A randomized trial with a 'head-to-head' comparison of agents would be considered silver level ranking unless a reference were provided to a comparison of one of the agents to placebo showing at least a 20% relative difference. </P>
<P>
<B>
<I>Bronze</I>
</B>
<BR/>The bronze level of evidence requires at least one high quality case series without controls (including simple before/after studies in which patients act as their own control) or a conclusion derived from expert opinion based on clinical experience without reference</P>
<P>
<B>
<I>Clinical relevance tables</I>
</B>
<BR/>Clinical relevance tables were compiled under "Additional tables" to improve the readability of the review. Results were presented within the context of both the study population and moderate/high risk women from the population at large. The number needed to treat to benefit (NNTB) was calculated using the relative risk (RR) in combination with either the risk of fracture in the control group, or the five year FRACTURE Index (<LINK REF="REF-Black-2001" TYPE="REFERENCE">Black 2001</LINK>). To do this, the Visual Rx NNT calculator (<LINK REF="REF-Cates-2004" TYPE="REFERENCE">Cates 2004</LINK>) was used. The weighted absolute risk difference was calculated using the risk difference (RD) statistic in RevMan and RR-1 was used to calculate the relative per cent change (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>; <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
<P>In addition, for the outcomes of vertebral and hip fractures we prepared 'Summary of Findings tables using the GRADE criteria from the GRADE working group (<LINK REF="REF-GRADE-2004" TYPE="REFERENCE">GRADE 2004</LINK>), (<LINK REF="FIG-22" TYPE="FIGURE">Figure 22</LINK>; <LINK REF="FIG-23" TYPE="FIGURE">Figure 23</LINK>). </P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>
<B>Quantity of research available<BR/>
</B>The literature search revealed 419 citations as depicted in <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>. Of these, 36 articles were retrieved for further scrutiny. A total of 29 articles were excluded for various reasons including lack of appropriate control group (4), (<LINK REF="REF-Brown-2002b" TYPE="REFERENCE">Brown 2002b</LINK>; <LINK REF="REF-Harris-2001b" TYPE="REFERENCE">Harris 2001b</LINK>; <LINK REF="STD-Harris-1999b" TYPE="STUDY">Harris 1999b</LINK>; <LINK REF="STD-Kushida-2004" TYPE="STUDY">Kushida 2004</LINK>) lack of fracture outcome (8), (<LINK REF="STD-Delmas-1997" TYPE="STUDY">Delmas 1997</LINK>; <LINK REF="STD-Dobnig-2006" TYPE="STUDY">Dobnig 2006</LINK>; <LINK REF="STD-Eriksen-2002" TYPE="STUDY">Eriksen 2002</LINK>; <LINK REF="STD-Hooper-1999" TYPE="STUDY">Hooper 1999</LINK>; <LINK REF="STD-Hu-2005" TYPE="STUDY">Hu 2005</LINK>; <LINK REF="STD-Leung-2005" TYPE="STUDY">Leung 2005</LINK>; <LINK REF="STD-Li-2005" TYPE="STUDY">Li 2005</LINK>; <LINK REF="STD-Yildirim-2005" TYPE="STUDY">Yildirim 2005</LINK>) lack of appropriate fracture data (that is, reported as adverse events and unspecified) (1), (<LINK REF="STD-Hosking-2003" TYPE="STUDY">Hosking 2003</LINK>) lack of randomization (5), (<LINK REF="STD-Goa-1998" TYPE="STUDY">Goa 1998</LINK>; <LINK REF="STD-Licata-1997" TYPE="STUDY">Licata 1997</LINK>; <LINK REF="STD-Reszka-1999" TYPE="STUDY">Reszka 1999</LINK>; <LINK REF="STD-Singer-1995" TYPE="STUDY">Singer 1995</LINK>; <LINK REF="STD-Watts-1998" TYPE="STUDY">Watts 1998</LINK>) extension/discontinuation study (2), (<LINK REF="STD-Sorensen-2003" TYPE="STUDY">Sorensen 2003</LINK>; <LINK REF="STD-Ste_x002d_Marie-2004" TYPE="STUDY">Ste-Marie 2004</LINK>) duplicate report or earlier report of another study (7), (<LINK REF="STD-Eastell-2003" TYPE="STUDY">Eastell 2003</LINK>; <LINK REF="STD-Miller-1999" TYPE="STUDY">Miller 1999</LINK>; <LINK REF="STD-Reginster-2001" TYPE="STUDY">Reginster 2001</LINK>; <LINK REF="STD-Ribot-1999" TYPE="STUDY">Ribot 1999</LINK>; <LINK REF="STD-Roux-2004" TYPE="STUDY">Roux 2004</LINK>; <LINK REF="STD-Watts-1999" TYPE="STUDY">Watts 1999</LINK>; <LINK REF="STD-Watts-2003" TYPE="STUDY">Watts 2003</LINK>) duration of therapy less than one year (1) (<LINK REF="STD-Zegels-2001" TYPE="STUDY">Zegels 2001</LINK>) and no extractable data (1). (<LINK REF="STD-McClung-1998-1" TYPE="STUDY">McClung 1998 1</LINK>) If duplicate reports of the same study were found in preliminary abstracts and articles, the data from the most complete data set was analyzed. In the end, seven trials met the selection criteria (<LINK REF="STD-Clemmesen-1997" TYPE="STUDY">Clemmesen 1997</LINK>; <LINK REF="STD-Fogelman-2000" TYPE="STUDY">Fogelman 2000</LINK>; <LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-Hooper-2005" TYPE="STUDY">Hooper 2005</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>; <LINK REF="STD-Mortensen-1998" TYPE="STUDY">Mortensen 1998</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>). (<I>See </I>
<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>.)</P>
<P>
<B>Trial characteristics<BR/>
</B>The characteristics of the seven selected trials are provided in the 'Characteristics of included studies' table. In total, there were 14,049 women enrolled in these trials, and of these, 4746 received placebo. Two trials were primary prevention (<LINK REF="STD-Hooper-2005" TYPE="STUDY">Hooper 2005</LINK>; <LINK REF="STD-Mortensen-1998" TYPE="STUDY">Mortensen 1998</LINK>) and the other five studied women with low BMD on densitometry or who had experienced previous fractures or both. (<LINK REF="STD-Clemmesen-1997" TYPE="STUDY">Clemmesen 1997</LINK>; <LINK REF="STD-Fogelman-2000" TYPE="STUDY">Fogelman 2000</LINK>; <LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>) All trials had three treatment arms that included two arms involving risedronate at different doses (i.e. 2.5 mg or 5 mg) or different schedules or both and a placebo arm. In our analysis, we did not include data from the two risedronate arms in any single meta-analysis in order to avoid duplication of data in the pooled estimates. In the case of the McClung study, results were not reported separately in the form of raw data for the 2.5 mg and 5 mg doses. We therefore used the combined dose data in our primary 5 mg analysis. Length of follow up ranged from two to three years and mean age was 51 to 78. No trial excluded women with a history of gastrointestinal disease and in three trials fractures were evaluated as the stated primary outcome (<LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>). All trials with the exception of one (<LINK REF="STD-Mortensen-1998" TYPE="STUDY">Mortensen 1998</LINK>) administered 1000 mg of calcium to all patients. Three trials administered up to 500 IU of vitamin D (<LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>).</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>Treatment allocation was concealed in two trials (<LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-Hooper-2005" TYPE="STUDY">Hooper 2005</LINK>) and was unclear for the other five . All seven trials had losses to follow up that exceeded 20%. Two trials (<LINK REF="STD-Clemmesen-1997" TYPE="STUDY">Clemmesen 1997</LINK>; <LINK REF="STD-Hooper-2005" TYPE="STUDY">Hooper 2005</LINK>) had losses to follow up between 20 and 30%, three trials between 30 and 40% (<LINK REF="STD-Fogelman-2000" TYPE="STUDY">Fogelman 2000</LINK>; <LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>) and two trials exceeded 40% (<LINK REF="STD-Mortensen-1998" TYPE="STUDY">Mortensen 1998</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>). All trials were double blind.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>
<B>Effect on fractures<BR/>
</B>A summary of the overall review of fractures with the standard dose of risedronate (5 mg) for the base case (i.e. the longest treatment duration in the trial and using the baseline denominators for the number of patients) is provided in (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). Primary prevention estimates were available only for vertebral and non- vertebral fractures, neither of which were statistically significant. For each of vertebral, non-vertebral, and hip fracture, the pooled estimate of the RR of fracture was significant for secondary prevention. The exception was wrist fracture, which was not significant. </P>
<P>
<B>
<I>Vertebral fractures</I>
</B>
<BR/>For primary prevention, Mortensen (<LINK REF="STD-Mortensen-1998" TYPE="STUDY">Mortensen 1998</LINK>) reported no fractures leaving Hooper (<LINK REF="STD-Hooper-2005" TYPE="STUDY">Hooper 2005</LINK>) as the only primary prevention study reporting vertebral fractures. The estimate of the RR was not statistically significant (RR 0.97, 95% CI 0.42 to 2.25).</P>
<P>Vertebral fractures were reported in four secondary prevention trials (<LINK REF="STD-Clemmesen-1997" TYPE="STUDY">Clemmesen 1997</LINK>; <LINK REF="STD-Fogelman-2000" TYPE="STUDY">Fogelman 2000</LINK>; <LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>). One study was not included in analysis due to the apparent inclusion of an off-drug treatment period in the data (<LINK REF="STD-Clemmesen-1997" TYPE="STUDY">Clemmesen 1997</LINK>). The pooled estimate of the RR of vertebral fractures from the three trials (<LINK REF="STD-Fogelman-2000" TYPE="STUDY">Fogelman 2000</LINK>; <LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>) that could be analyzed demonstrated a significant reduction (39%) in vertebral fractures (RR 0.61, 95% CI 0.50 to 0.76) as detailed in 'Comparison 01, 01'. This demonstrates a fracture risk reduction with risedronate 5 mg daily and results are consistent across studies (P = 0.75).</P>
<P>For both primary and secondary prevention trials combined the pooled estimate (RR 0.63, 95% CI 0.51 to 0.77) was similar to that for that for secondary prevention alone</P>
<P>Corresponding to the significant RRR of 39% for the secondary prevention of vertebral fractures, the absolute measures ARR and NNT of the five year risk of vertebral fracture after treatment with risedronate were calculated for different levels of increasing risk as given by the FI. Results are provided in (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>) as well as for increasing age in (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>). For the illustrative case of the patient with a FI of 6 to 7, the ARR in vertebral fracture was 2.8% (that is, a reduction in risk from 7.1% to 4.3%) and the NNTB was 36 (that is, 36 patients need to be treated to avoid one vertebral fracture). Across the range of increasing FI risk, the ARR for vertebral fracture ranged from 0.5% to 4.4% and the NNT to avoid one vertebral fracture ranged from 214 to 23. For the illustrative patient in the age group 60 to 64 years, the ARR for the first vertebral fracture was 0.4% (that is, a reduction in risk from 1.0% to 0.6%) and the NNT was 256 patients treated to avoid the first fracture. The ARR for a subsequent fracture was 3.8% (that is, a reduction in risk from 9.7% to 5.9%) and the NNT was 26 patients treated to avoid one subsequent fracture. For increasing age, the five-year age-specific ARR for the first vertebral fracture increased from 0.1% for the youngest age group (50 to 54 years) to 1.8% in the highest age group (90+ years) and the NNT decreased from 1282 to 55. For the subsequent fracture, ARR increased from 0.2% to 10.9% and the NNT decreased from 513 to 9.</P>
<P>
<B>
<I>Non-vertebral fractures</I>
</B>
<B>
<BR/>
</B>One primary prevention trial (<LINK REF="STD-Hooper-2005" TYPE="STUDY">Hooper 2005</LINK>) reported non-vertebral fractures. The risk estimate (RR 0.81, 95% CI 0.25 to 2.58) was not statistically significant.</P>
<P>Non-vertebral fractures were reported in five secondary prevention trials (<LINK REF="STD-Clemmesen-1997" TYPE="STUDY">Clemmesen 1997</LINK>; <LINK REF="STD-Fogelman-2000" TYPE="STUDY">Fogelman 2000</LINK>; <LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>). After excluding the study with a possible off drug treatment period, the pooled estimate of the RR of non-vertebral fractures from four trials (<LINK REF="STD-Fogelman-2000" TYPE="STUDY">Fogelman 2000</LINK>; <LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>) that could be analyzed demonstrated a significant 20% reduction in non-vertebral fractures (RR 0.80, 95% CI 0.72 to 0.90). Results are provided in Comparison 02, 01 and they were consistent across studies (P = 0.43).</P>
<P>For both primary and secondary prevention trials combined the pooled estimate (RR 0.80, 95% CI 0.72 to 0.90) was the same that for that for secondary prevention alone as the Hooper trial comprised only 1.04% of the total weight.</P>
<P>Corresponding to the significant RRR of 20% for the secondary prevention of non-vertebral fractures, the absolute measure: ARR and NNT of the five year risk of non-vertebral fracture after treatment with risedronate were calculated for different levels of increasing risk as given by the FI (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>) and for increasing age (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>). For the illustrative case of the patient with a FI of 6 to 7, the ARR in non-vertebral fracture was 4.0% (that is, a reduction in risk from 19.8% to 15.8%) and the NNT was 25 (that is, 25 patients need to be treated to avoid one non-vertebral fracture). Across the range of increasing FI risk, the ARR for non-vertebral fracture ranged from 1.7% to 5.5% and the NNT to avoid one non-vertebral fracture ranged from 58 to 18. For the illustrative patient in the age group 60 to 64 years, the ARR for the first non-vertebral fracture was 0.6% (i.e. a reduction in risk from 3.1% to 2.5%) and the NNT was 161 patients treated to avoid the first fracture. The ARR for a subsequent fracture was 1.2% (that is, a reduction in risk from 6.2% to 5.0%) and the NNT was 81 patients treated to avoid one subsequent fracture. For increasing age, the five year age-specific ARR for the first non-vertebral fracture increased from 0.3% for the youngest age group (50 to 54 years) to 7.0% in the highest age group (90+ years). Accordingly, the NNT decreased from 313 to 14. For the subsequent fracture, ARR increased from 0.5% to 7.5% and NNT decreased from 192 to 13.</P>
<P>
<B>
<I>Hip fractures</I>
</B>
<BR/>Hip fractures were reported in three of the secondary prevention trials (<LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>). The pooled estimate of the RR of hip fractures from the three trials showed a significant 26% reduction in hip fractures (RR 0.74, 95% CI 0.59 to 0.94). Results are provided in Comparison 03, 01 and they were consistent across trials (P = 0.95). </P>
<P>Corresponding to the significant RRR of 26% for the secondary prevention of hip fractures, the absolute measures ARR and NNT of the five year risk of hip fracture after treatment with risedronate were calculated for different levels of increasing risk as given by the FI (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>) and for increasing age (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>). For the illustrative case of the patient with a FI of 6 to 7, the ARR for hip fracture was 1.0% (that is, a reduction in risk from 3.9% to 2.9%) and the NNT was 99 (that is, 99 patients need to be treated to avoid one hip fracture). Across the range of increasing FI risk, the ARR for hip fracture ranged from 0.1% to 2.3% and the NNT to avoid one hip fracture ranged from 962 to 44. For the illustrative patient in the age group 60 to 64 years, the ARR for the first hip fracture was 0.05% (i.e. a reduction in risk from 0.2% to 0.15%) and the NNT was 1923 patients treated to avoid the first fracture. The ARR and NNT for a subsequent fracture were the same. For increasing age, the five year age-specific ARR for the first hip fracture increased from less than 0.05% for the youngest age group (50 to 54 years) to 5.4% in the highest age group (90+ years) and the NNT decreased from more than 1923 to 18. For the subsequent fracture, ARR increased from less than 0.05% to 5.9% and the NNT decreased from more than 962 to 17.</P>
<P>
<B>
<I>Wrist fractures</I>
</B>
<B>
<BR/>
</B>Wrist fractures were reported in two of the secondary trials (<LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>). The pooled estimate of the RR of wrist fractures from the two trials showed a 33% reduction which was not significant (RR 0.67, 95% CI 0.42 to 1.07). Results are given in Comparison 04, 01 and they were consistent across trials (P = 0.81). </P>
<P>
<B>Additional analysis</B>
<BR/>
<B>
<I>Person years</I>
</B>
<B>
<BR/>
</B>Results were similar for vertebral, non-vertebral, hip and wrist fractures when using person years as depicted in (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>). Of note, the pooled estimates of the RR for the secondary prevention trials all showed a significant risk reduction of fracture, with the exception of wrist fractures.<BR/> <BR/>
<B>Subgroup analysis</B>
<BR/>
<B>
<I>Treatment duration</I>
</B>
<B>
<BR/>
</B>No trends over years of treatments were found that deviated from the overall RR estimates. For details, please refer to <LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK> and 'Comparisons 05, 01; 06, 01; 07, 01; 08, 01; 09, 01; 10, 01; 11, 01'.</P>
<P>
<B>
<I>Treatment dose</I>
</B>
<BR/>For risedronate 2.5 mg, fracture data were only available for vertebral and non-vertebral sites. There was no protective effect observed for the primary prevention of vertebral fractures. For the secondary prevention trials, the decrease in risk of vertebral fracture was significant and there was a further, albeit slight, decrease in risk with the 2.5 mg dose, compared with 5 mg (<LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>; <LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>; <LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>; Comparison 12, 01; Comparison 12, 02). For non-vertebral fractures, the decrease in risk was not statistically significant for either primary or secondary prevention but was more pronounced with the 2.5 mg dose compared with 5 mg.</P>
<P>
<B>Sensitivity analysis</B>
<BR/>
<B>
<I>Baseline versus follow-up denominators</I>
</B>
<BR/>By using the data available for the longest treatment duration, standard dose of risedronate (5 mg) and follow-up denominators for the number of patients in the trials, a summary of the overall review of fractures was prepared (<LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>). These data are also provided by years of treatment (<LINK REF="FIG-15" TYPE="FIGURE">Figure 15</LINK>). The pooled estimates of the RR of fracture after risedronate were essentially the same as those obtained using the baseline denominators, with the exception that the pooled estimate of the RR of wrist fractures from two secondary prevention trials (<LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>) demonstrated a significant reduction (39%) in wrist fractures (RR 0.61, 95% CI 0.38 to 0.96) for risedronate 5 mg.</P>
<P>
<B>
<I>Random versus fixed-effect model</I>
</B>
<B>
<BR/>
</B>There were a few instances where heterogeneity of the trial results was such that a random-effects model was needed (that is, only involving the person years analysis). In general, results obtained using the random and fixed-effect models were similar.</P>
<P>
<B>
<I>Baseline vertebral fracture rate</I>
</B>
<B>
<BR/>
</B>Using different baseline vertebral fracture rates (i.e. 100%, &gt; 80%, &gt; 60%, &gt; 40%, &gt; 20%) for defining secondary trials, a summary of the overall review of fractures was prepared (<LINK REF="FIG-16" TYPE="FIGURE">Figure 16</LINK>). For vertebral, non-vertebral and wrist fractures, the pooled estimates of the RR of fracture after risedronate were essentially the same as those obtained using the definition of secondary trials with the &gt; 20% baseline fracture rate. Although the result for hip fractures became non-significant when the criteria increased from &gt; 40% to &gt; 60%, the relative risk of fracture was about the same (0.74 compared to 0.81) but the confidence interval was now wider since the large 2001 trial by McClung et al (<LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>) with over 6000 participants was excluded from the analysis.</P>
<P>
<B>Adverse events<BR/>
</B>A summary of the adverse drug reactions reported in the six randomized placebo-controlled trials of risedronate is provided in <LINK REF="FIG-17" TYPE="FIGURE">Figure 17</LINK>; <LINK REF="FIG-18" TYPE="FIGURE">Figure 18</LINK>; <LINK REF="FIG-19" TYPE="FIGURE">Figure 19</LINK> and <LINK REF="FIG-20" TYPE="FIGURE">Figure 20</LINK>. In general, the reported events were similar between risedronate and placebo. In particular, there were five studies reporting 'any upper gastrointestinal events' resulting in an overall RR 1.01 (95% CI 0.94 to 1.09) and four studies reporting 'esophageal ulcer' resulting in an overall RR 0.75 (95% CI 0.39 to 1.47).</P>
<P>
<B>
<I>Toxicity and withdrawals</I>
</B>
<B>
<BR/>
</B>Discontinuations due to adverse events or dropouts overall were available and analyzed for five (<LINK REF="STD-Fogelman-2000" TYPE="STUDY">Fogelman 2000</LINK>; <LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-Hooper-2005" TYPE="STUDY">Hooper 2005</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>) and six (<LINK REF="STD-Clemmesen-1997" TYPE="STUDY">Clemmesen 1997</LINK>; <LINK REF="STD-Fogelman-2000" TYPE="STUDY">Fogelman 2000</LINK>; <LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-Hooper-2005" TYPE="STUDY">Hooper 2005</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>; <LINK REF="STD-Reginster-2000" TYPE="STUDY">Reginster 2000</LINK>) of the risedronate trials respectively. The pooled estimate demonstrated no statistical difference between risedronate and placebo for the risk of discontinuing medication due to adverse events (RR 0.96, 95% CI 0.88 to 1.05) or for dropouts overall (RR 0.96, 95% CI 0.91 to 1.00) (Comparison 13.01, 13.02). Results were consistent across the trials.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>Based on longest treatment duration and use of baseline denominators for the number of patients in each of the included trials, risedronate at 5 mg per day was associated with a statistically significant and clinically important reduction in the secondary prevention of vertebral, non-vertebral and hip fractures but not wrist. The level of evidence was Gold for vertebral and non-vertebral fractures and Silver for hip and wrist. For primary prevention, one trial reported vertebral and non-vertebral fractures but no statistically significant reductions were found (Silver level evidence). </P>
<P>Secondary analyses showed that a dose of 2.5 mg, for secondary prevention resulted in a statistically significant and clinically important reduction in vertebral fractures that is comparable to that of the 5 mg dose (Gold level evidence). Only one primary prevention trial reported vertebral fractures for the 2.5 mg dose and no reduction was found (Silver level evidence). For non-vertebral fractures, no statistically significant reductions were shown for either primary or secondary prevention (Silver level evidence). In the case of hip fractures, McClung et al (2001), randomized women to receive placebo, 2.5 mg risedronate or 5.0 mg risedronate. This was done separately for younger (70 to 79 years) and older (80 + years) women. Although the results were not generally reported separately by dose and age groups, the authors did note that the effects of dose (2.5 mg versus 5.0 mg) for the younger age group were similar (for 2.5 mg RR 0.5 (95% CI 0.3 to 0.9); for 5 mg RR 0.7 (95% CI 0.4 to 1.1). There were no trials available to assess the efficacy of the 2.5 mg dose for wrist fractures.</P>
<P>There were no substantive differences in the results whether baseline, end of study, or person year denominators were used. Sensitivity analyses indicated that there were no major differences based on the percentage of baseline vertebral fractures. Further, no trends were found for years of treatment. </P>
<P>Adverse drug events observed with risedronate were similar to the ones observed with placebo. The use of risedronate was not associated with any statistically significant difference in withdrawals due to adverse events (RR 0.96; 95% CI 0.88 to 1.05) or overall withdrawals (RR 0.96; 95% CI 0.91 to 1.00), when compared to placebo. In keeping with this, it was concluded that study participants tolerated their risedronate treatment. Although no increased incidence of adverse effects were detected with risedronate, external to the randomized controlled trials, concerns exist regarding the potential risk of upper gastrointestinal events and osteonecrosis of the jaw.</P>
<P>
<B>Study limitations<BR/>
</B>The results of this systematic review are believed to be robust, as we performed a comprehensive literature search, inclusion and exclusion criteria were specified and we conducted a rigorous data analysis. A potential limitation of our approach may be that the update search (that is, 2000 to 2004) did not include non-MEDLINE indexed journals. Recent empirical evidence indicates that this approach may have introduced a slight risk of bias into our meta-analysis. On average, such bias is estimated to result in a 6% variation in the pooled results (<LINK REF="REF-Egger-2003" TYPE="REFERENCE">Egger 2003</LINK>; <LINK REF="REF-Sampson-2003" TYPE="REFERENCE">Sampson 2003</LINK>). Accordingly, given that the initial literature search (that is, 1966 to 2000) was very extensive, the impact of only using MEDLINE for the search update is expected to be minimal, if any. This was confirmed by a parallel literature search update (that is, 1999 to July 2004) that was conducted for an economic report for the Canadian Agency for Drugs and Technologies in Health. The search update included etidronate, alendronate and risedronate (daily dose regimen only) in addition to teriparatide. We searched a number of databases (i.e. <I>The Cochrane Library</I>, MEDLINE, EMBASE, BIOSIS Previews, Toxfile, PubMed) and no additional articles meeting the inclusion criteria were identified (<LINK REF="REF-CADTH-2006" TYPE="REFERENCE">CADTH 2006</LINK>).</P>
<P>While our methodology was robust, the results of our meta-analysis, however, are only as strong as the primary studies included. In keeping with this, the main limitations with regard to study quality were fracture assessment and classification, the lack of clarity of the concealment of allocation and large numbers of withdrawals.</P>
<P>A potential source of heterogeneity is the lack of uniform definition of non-vertebral fracture. While some researchers may use a rather liberal definition (any fracture other than vertebral fracture), others may use a more conservative definition which includes only fractures of the hip, clavicle, humerus, wrist, pelvis or leg (<LINK REF="REF-Mayo-Clin-Proc-2005" TYPE="REFERENCE">Mayo Clin Proc 2005</LINK>). Also, the statistical power to detect heterogeneity was extremely limited for some tests due to the low number of fractures in some categories. Another consideration is the fact that fracture data was not the primary outcome for some of the trials. In particular, four of the seven risedronate trials had fractures as the primary outcome. There is another source of heterogeneity, and possible bias, related to some of the secondary prevention studies. It concerns the inclusion of participants with a low BMD but no proven fractures and the difficulty in discriminating between fracture types (traumatic versus pathological). Also, at times, our criteria for categorizing a study as a secondary prevention trial differed from those used by study investigators. An example is the study by McClung et al (<LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>) which included two age subgroups. In our review, we considered that both subgroups evaluated the effect of risedronate in secondary prevention of osteoporotic fractures, although we acknowledge study investigators may not have intended the same. However both subgroups satisfied two of our secondary prevention criteria, that is, baseline fracture rate and age. Indeed, both age subgroups had a baseline fracture rate &gt; 20% (primary prevention studies were required to have a baseline fracture rate of &lt; 20%). In addition, study participants in both subgroups were over 62 years of age (we considered a trial as secondary prevention if the average age was above 62 years). Finally, the exploration of differences in effect between primary and secondary prevention trials was a particular concern in our review.<BR/> <BR/>Another methodological limitation concerns the approach used for concealment of treatment allocation which was not reported for most trials (that is, classified as 'unclear'). Treatment allocation was concealed in two trials (<LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-Hooper-2005" TYPE="STUDY">Hooper 2005</LINK>) and was unclear for the other five trials.</P>
<P>The length of follow up in the studies (two to three years) is an additional limitation. It is difficult to extrapolate beyond the duration of the follow-up trials in the review with respect to the long-term impact on fractures. Ultimately, data from longer-term trials will help establish if the effect on fractures is maintained, increased or diminished. </P>
<P>In regards to our own methodology, we acknowledge that the approach used to evaluate the effect of bisphosphonates over time may result in some estimates that are not robust. In particular, in order to determine the effect on the five year risk of fracture we based our evaluation on the FRACTURE Index by Black et al. (<LINK REF="REF-Black-2001" TYPE="REFERENCE">Black 2001</LINK>) and for lifetime and five year age-specific risks we used an existing model from Doherty et al. (<LINK REF="REF-Doherty-2001" TYPE="REFERENCE">Doherty 2001</LINK>). Although this latter approach allowed us to estimate the variation in risks between younger and older postmenopausal women, these estimates may be associated with a certain level of uncertainty. Nonetheless, we believe such information may be useful to decision-makers.</P>
<P>Lastly, a limitation of evaluating data on adverse effects from summary meta-analyses is that participants in RCTs tend to be healthier with fewer co-morbid diseases and therefore the results may not be generalizable to clinical practice. None of the six risedronate trials, however, explicitly excluded patients with pre existing GI disorders. Furthermore, RCTs are underpowered for rare effects and meta-analyses of these trials generally cannot provide conclusive information pertaining to drug toxicity. In addition, the heterogeneity of the adverse drug events (ADEs) reported in the RCTs described in this review, including their nature, low occurrence, and way they were assessed by investigators, were obstacles for meta-analysis. As well, the follow up for the included trials, which ranged between one and three years, does not allow for the assessment of long term toxicity associated with risedronate. </P>
<P>Recently, there have been concerns regarding the potential risk of over suppressing bone turnover resulting in osteonecrosis of the jaw (ONJ), (<LINK REF="REF-Khosla-2007" TYPE="REFERENCE">Khosla 2007</LINK>; <LINK REF="REF-Woo-2006" TYPE="REFERENCE">Woo 2006</LINK>). Although the majority of reported cases of ONJ have occurred in cancer patients receiving the intravenous bisphosphonates zolendrate or pamidronate (at higher cumulative doses than used in the treatment of postmenopausal osteoporosis), some osteoporosis patients receiving oral alendronate or risedronate have developed the condition as well. In a systematic review of cases reported in the medical literature, 13 of 368 bisphosphonate treated ONJ patients had received alendronate and one risedronate (<LINK REF="REF-Woo-2006" TYPE="REFERENCE">Woo 2006</LINK>). Since that publication, a review conducted by the American Society for Bone and Mineral Research (ASBMR) Task Force on Bisphosphonate-Associated ONJ has identified studies reporting a total of 67 cases (64 alendronate, 2 risedronate and 1 etidronate) among osteoporosis and Paget's disease patients (<LINK REF="REF-Khosla-2007" TYPE="REFERENCE">Khosla 2007</LINK>). Most notably, an Australian study reported 30 of 114 ONJ cases related to alendronate (22 of whom were under treatment for osteoporosis) and 2 related to risedronate. The median time to onset, for alendronate, was 24 months. The most common triggering factor was dental extraction (<LINK REF="REF-Mavrokokki-2007" TYPE="REFERENCE">Mavrokokki 2007</LINK>). The ASBMR task force has pointed out that the incidence of ONJ in the general population not exposed to bisphosphonates is unknown, information on the incidence of ONJ is rapidly evolving and that, often, the case ascertainment has bee inadequate. They recommend that a hierarchy of evidence quality, based on the completeness of information across seven categories related to diagnosis and history, should be established for all future studies reporting cases of ONJ (<LINK REF="REF-Khosla-2007" TYPE="REFERENCE">Khosla 2007</LINK>). No cases of ONJ were reported in any of the risedronate trials in our review. </P>
<P>Finally, because RCTs are not designed to measure ADEs, particularly rare ones, it is common practice to include sources of information other than RCTs. While some reviewers include ADEs reported in observational studies, we elected to obtain information from the Canadian Adverse Drug Reaction Monitoring Program (CADRMP, <I>see</I> below) (<LINK REF="REF-Health-Canada-2005" TYPE="REFERENCE">Health Canada 2005</LINK>).</P>
<P>
<B>Generalizability of findings<BR/>
</B>Generalizability of our findings is limited by the controlled design of the trials included in our review. Study participants were carefully selected in these trials and so utilization of the drugs in real life may vary substantially from study conditions. Furthermore, study participants were observed for periods of time varying from one to three years. Consequently, while our results provide support for efficacy (that is, can the intervention have an effect on outcome?) they may possibly only provide partial information on the long-term effectiveness (that is, does the intervention have an effect on outcome?) of bisphosphonates in preventing osteoporotic fractures. </P>
<P>From a safety perspective, we could not find any statistically significant difference in either the rates of adverse drug events or withdrawal rates due to adverse drug events between patients receiving a bisphosphonate or patients receiving a placebo. However, outside controlled trials, concerns exist regarding the safe use of these drugs, especially alendronate and, to a lesser extent, risedronate, for which esophageal ulcers and gastritis have been reported (<LINK REF="REF-Kherani-2002" TYPE="REFERENCE">Kherani 2002</LINK>). While such adverse events have mainly been identified through case reports and endoscopic studies, similar concerns are also reflected in the proportions of gastrointestinal adverse drug reactions associated with the use of risedronate reported to the CADRMP (<LINK REF="REF-Health-Canada-2005" TYPE="REFERENCE">Health Canada 2005</LINK>). Indeed, GI adverse drug reactions represented 35% of reports for risedronate (<LINK REF="FIG-21" TYPE="FIGURE">Figure 21</LINK>). These proportions should however be interpreted with caution as adverse drug reactions are reported to CADRMP on a volunteer basis by health professionals, which means that several reactions may be unreported. Indeed, it is estimated that less than 10% of adverse reactions are reported to Health Canada (<LINK REF="REF-Health-Canada-2005c" TYPE="REFERENCE">Health Canada 2005c</LINK>). Also, a definite cause-effect relationship has not been established for these adverse drug reactions.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Risedronate demonstrated a clinically important benefit in the secondary prevention of the majority of osteoporotic fractures. At a dose of 5 mg per day, statistically significant reductions in vertebral, non-vertebral and hip fractures were observed (but not wrist). No statistically significant reduction in the primary prevention of vertebral and non-vertebral fractures and no evidence was available for the primary prevention of hip or wrist fractures. No increased incidence of adverse effects were detected with risedronate, but clinicians should be aware that outside of randomized controlled trials, concerns exist regarding the potential risk of upper gastrointestinal events and, less commonly, osteonecrosis of the jaw. </P>
<P>The prevention of osteoporotic fractures is an important public health intervention. This is particularly true for hip and clinical vertebral fractures (i.e. fractures of the spine that present for medical attention). The RR of death following such fractures is six- to nine-fold greater in postmenopausal women aged 55 to 81 years with low BMD, which represents a typical postmenopausal population (<LINK REF="REF-Cauley-2000" TYPE="REFERENCE">Cauley 2000</LINK>). In most cases, the mortality increase reflects poor underlying health status and comorbidity in addition to the fracture itself (<LINK REF="REF-Cauley-2000" TYPE="REFERENCE">Cauley 2000</LINK>). Osteoporotic fractures are also associated with increase in morbidity, as it is reported that 50% of women who sustain a hip fracture do not return to their usual daily activities (<LINK REF="REF-Brown-2002b" TYPE="REFERENCE">Brown 2002b</LINK>) while 33% will require long-term care. Accordingly, reducing the incidence of such fractures can potentially increase the quality of life of patients with osteoporosis. Such interventions may also potentially decrease mortality.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>It has been suggested from clinical trials with the bisphosphonates (<LINK REF="REF-Black-2000" TYPE="REFERENCE">Black 2000</LINK>; <LINK REF="STD-Harris-1999" TYPE="STUDY">Harris 1999</LINK>; <LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>) that their effect in reducing non-vertebral fractures may be greater in patients with lower BMD who initiate treatment. The existing data have not fully resolved the question of whether important differences in risk reduction across groups of patients with varying degrees of osteoporosis exist. The impact of risedronate on the RR of non-vertebral fractures in populations without osteoporosis also merits further investigation. Additional research is also needed to clarify the role of risedronate in the primary prevention of osteoporotic fractures. There is also a need for additional post marketing safety data. Finally, research into combination therapy with higher doses of vitamin D or anabolic agents would be merited as would research concerning adherence to bisphosphonate therapy. </P>
<P>Given the morbidity consequences associated with osteoporotic fractures, preventing their recurrence can potentially lessen the need for community-based health services (for example, home care). It may also reduce or delay the demand for long-term care beds. However, very little comparative information is currently available to support this (<LINK REF="REF-Hodsman-2002" TYPE="REFERENCE">Hodsman 2002</LINK>). There is also a lack of studies which evaluated the effect of bisphosphonates on hospital admissions (<LINK REF="REF-Hodsman-2002" TYPE="REFERENCE">Hodsman 2002</LINK>).</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>Thank you to Lara Maxwell and Marie Andree Nowlan from the Musculoskeletal Group for their editorial assistance and Tamara Rader for her assistance with the Consumer Summaries. </P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None at present.</P>
<P>The Cochrane Funding Arbitration Panel recommended withdrawal of the original review from The Cochrane Library. The original review was externally supported by Merck and Proctor &amp; Gamble to support research staff. </P>
<P>This current review was updated without the support of any industry sponsor.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>George Wells was involved in the conception, design and implementation of the project and contributed significantly to the writing of the report. </P>
<P>Ann Cranney was involved with the conception of the review, data abstraction, analysis, interpretation and revision of the final report.</P>
<P>Joan Peterson screened the literature, was involved in the data abstraction, quality assessment and analysis of the primary trials and contributed significantly to the writing of the report.</P>
<P>Michel Boucher assisted in the design of the analysis, reporting and interpretation of the findings and was involved in the writing of the report. </P>
<P>Beverley Shea was involved in developing the protocol and conducting the systematic review.</P>
<P>Vivian Robinson was involved in developing the protocol and conducting the systematic review.</P>
<P>Douglas Coyle assisted with the design of the review and reviewed the analysis.</P>
<P>Peter Tugwell provided clinical rheumatology expertise and methodological guidance.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2008-05-27 23:33:47 -0400" MODIFIED_BY="[Empty name]">
<P>This review updated a previously published review (<LINK REF="REF-Cranney-2003" TYPE="REFERENCE">Cranney 2003</LINK>) of risedronate conceived, conducted and completed, in part, by the authors of this report. There were four general differences in the manner in which the two reviews were conducted. First, the current review included articles published after the previous review was completed (updated to Feb 2007). Second, although both published and unpublished data were used in the previous reviews, only published data were used in this review. Third, in the previous review the random-effects model was always used whereas in the present review the base analysis used the fixed-effect model unless the results were heterogeneous. Fourth, although the previous review considered both BMD and fracture data, this review was only concerned with fractures and therefore the definition of primary and secondary prevention put more of an emphasis on the fracture study inclusion criteria.<BR/>
<BR/>Our updated literature search retrieved an additional trial (<LINK REF="STD-Hooper-2005" TYPE="STUDY">Hooper 2005</LINK>) which was published after the previous review. There were two changes in the choice of the included trials. First, the trials by Mortensen (<LINK REF="STD-Mortensen-1998" TYPE="STUDY">Mortensen 1998</LINK>) at 5 mg per day (for non-vertebral fracture data) and Clemmesen (<LINK REF="STD-Clemmesen-1997" TYPE="STUDY">Clemmesen 1997</LINK>) at 2.5 mg per day (for vertebral and non-vertebral fracture data) were included in the previous review but were excluded for the current review since they appeared to include an off drug treatment period. That is, the fractures may have occurred during the follow-up period on no treatment and not during the active treatment phase of the study. Second, in the previous review, additional data were obtained from the authors for the McClung trial (<LINK REF="STD-McClung-2001" TYPE="STUDY">McClung 2001</LINK>) but this additional information was not used in the current review.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-08-13 14:20:15 -0400" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-08-13 14:20:15 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Clemmesen-1997" NAME="Clemmesen 1997" YEAR="">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Clemmesen B, Ravn P, Zegels B, Taquet AN, Christiansen C, Reginster JY</AU>
<TI>A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis</TI>
<SO>Osteoporosis International</SO>
<YR>1997</YR>
<VL>7</VL>
<NO>5</NO>
<PG>488-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fogelman-2000" NAME="Fogelman 2000" YEAR="">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fogelman I, Ribot C, Smith R, Ethgen D, Sod E, Reginster JY</AU>
<TI>Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group</TI>
<SO>Journal of Clinical Endocrinology &amp; Metabolism</SO>
<YR>2000</YR>
<VL>85</VL>
<NO>5</NO>
<PG>1895-900</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harris-1999" NAME="Harris 1999" YEAR="">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al</AU>
<TI>Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group</TI>
<SO>JAMA</SO>
<YR>1999</YR>
<VL>282</VL>
<NO>14</NO>
<PG>1344-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hooper-2005" NAME="Hooper 2005" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hooper MJ, Ebeling PR, Roberts AP, Graham JJ, Nicholson GC, D'Emden M, et al</AU>
<TI>Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial</TI>
<SO>Climacteric</SO>
<YR>2005</YR>
<VL>8</VL>
<PG>251-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McClung-2001" NAME="McClung 2001" YEAR="">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al</AU>
<TI>Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.[see comment]</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>344</VL>
<NO>5</NO>
<PG>333-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mortensen-1998" NAME="Mortensen 1998" YEAR="">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mortensen L, Charles P, Bekker PJ, Digennaro J, Johnston CC Jr</AU>
<TI>Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up</TI>
<SO>Journal of Clinical Endocrinology &amp; Metabolism</SO>
<YR>1998</YR>
<VL>83</VL>
<NO>2</NO>
<PG>396-402</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reginster-2000" NAME="Reginster 2000" YEAR="">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R</AU>
<TI>Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group</TI>
<SO>Osteoporosis International</SO>
<YR>2000</YR>
<VL>11</VL>
<NO>1</NO>
<PG>83-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-08-13 14:20:15 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-2002" NAME="Brown 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown JP, Kendler DL, McClung MR, Emkey RD, Adachi JD, Bolognese MA, et al</AU>
<TI>The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis</TI>
<SO>Calcified Tissue International</SO>
<YR>2002</YR>
<VL>71</VL>
<NO>2</NO>
<PG>103-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Delmas-1997" NAME="Delmas 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Delmas PD, Balena R, Confravreux E, Hardouin C, Hardy P, Bremond A</AU>
<TI>Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1997</YR>
<VL>15</VL>
<NO>3</NO>
<PG>955-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dobnig-2006" NAME="Dobnig 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dobnig H, Hofbauer LC, Viereck V, Obermayer-Pietsch B, Fahrleitner-Pammer A, Dobnig H, et al</AU>
<TI>Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients</TI>
<SO>Osteoporosis International</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>5</NO>
<PG>693-703</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="13"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eastell-2003" NAME="Eastell 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD</AU>
<TI>Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate</TI>
<SO>Journal of Bone &amp; Mineral Research</SO>
<YR>2003</YR>
<VL>18</VL>
<NO>6</NO>
<PG>1051-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eriksen-2002" NAME="Eriksen 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eriksen EF, Melsen F, Sod E, Barton I, Chines A</AU>
<TI>Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis</TI>
<SO>Bone</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>5</NO>
<PG>620-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goa-1998" NAME="Goa 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goa KL, Balfour JA</AU>
<TI>Risedronate. [Review] [36 refs]</TI>
<SO>Drugs &amp; Aging</SO>
<YR>1998</YR>
<VL>13</VL>
<NO>1</NO>
<PG>83-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harris-1999b" NAME="Harris 1999b" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harris ST, Wasnich R, Ettinger M, Davidson M, Bosch L, Chines A</AU>
<TI>The effects of risedronate plus estrogen compared with estrogen alone in postmenopausal women</TI>
<SO>Journal of Bone &amp; Mineral Research</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>Suppl 1</NO>
<PG>S404</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harris-2001" NAME="Harris 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harris ST, Eriksen EF, Davidson M, Ettinger MP, Moffett JA Jr., Baylink DJ, et al</AU>
<TI>Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.[see comment]</TI>
<SO>Journal of Clinical Endocrinology &amp; Metabolism</SO>
<YR>2001</YR>
<VL>86</VL>
<NO>5</NO>
<PG>1890-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hooper-1999" NAME="Hooper 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hooper M, Ebeling P, Roberts A</AU>
<TI>Risedronate prevents bone loss in early postmenopausal women [abstract]</TI>
<SO>Calcified Tissue International</SO>
<YR>1999</YR>
<NO>Suppl 1</NO>
<PG>80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hosking-2003" NAME="Hosking 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hosking D, Adami S, Felsenberg D, Andia JC, Valimaki M, Benhamou L, et al</AU>
<TI>Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study</TI>
<SO>Current Medical Research &amp; Opinion</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>5</NO>
<PG>383-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hu-2005" MODIFIED="2008-08-13 14:20:15 -0400" MODIFIED_BY="[Empty name]" NAME="Hu 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-08-13 14:20:15 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hu YF, Sun ZQ</AU>
<TI>Quality of life in the treatment assessment of postmenopausal osteoporosis. [Chinese]</TI>
<SO>Zhong Nan da Xue Xue Bao Yi Xue Ban = Journal of Central South University Medical Sciences</SO>
<YR>2005</YR>
<VL>30</VL>
<NO>3</NO>
<PG>299-303</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="708"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kushida-2004" NAME="Kushida 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kushida K, Fukunaga M, Kishimoto H, Shiraki M, Itabashi A, Inoue T, et al</AU>
<TI>A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial</TI>
<SO>Journal of Bone &amp; Mineral Metabolism</SO>
<YR>2004</YR>
<VL>22</VL>
<NO>5</NO>
<PG>469-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leung-2005" NAME="Leung 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leung JY, Ho AY, Ip TP, Lee G, Kung AW, Leung JYY, et al</AU>
<TI>The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study</TI>
<SO>Bone</SO>
<YR>2005</YR>
<VL>36</VL>
<NO>2</NO>
<PG>358-64</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="274"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2005" NAME="Li 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li Y, Zhang Z, Deng X, Chen L, Li Y, Zhang Z, et al</AU>
<TI>Efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis</TI>
<SO>Journal of Huazhong University of Science and Technology</SO>
<YR>2005</YR>
<VL>Medical Sciences. 25</VL>
<NO>5</NO>
<PG>527-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="292"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Licata-1997" NAME="Licata 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Licata AA</AU>
<TI>Bisphosphonate therapy.[see comment]. [Review]</TI>
<SO>American Journal of the Medical Sciences</SO>
<YR>1997</YR>
<VL>313</VL>
<NO>1</NO>
<PG>17-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McClung-1998-1" NAME="McClung 1998 1" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McClung M, Bensen WG, Bolognese M, Bonnick S, Ettinger M, Harris ST</AU>
<TI>Risedronate increases bone mineral density at the hip, spine and radius in postmenopausal women with low bone mass</TI>
<SO>Osteoporosis International</SO>
<YR>1998</YR>
<VL>8</VL>
<NO>Suppl 3</NO>
<PG>111</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-1999" NAME="Miller 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller P, Roux C, McClung M, Adami S, Eastell R, Ethgen D</AU>
<TI>Risedronate reduces hip fractures in patients with low femoral neck bone mineral density [abstract]</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>1999</YR>
<VL>42</VL>
<PG>S287</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reginster-2001" NAME="Reginster 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reginster JY</AU>
<TI>Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women.[see comment]</TI>
<SO>Clinical &amp; Experimental Rheumatology</SO>
<YR>2001</YR>
<VL>19</VL>
<NO>2</NO>
<PG>121-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reszka-1999" MODIFIED="2008-08-13 14:18:55 -0400" MODIFIED_BY="[Empty name]" NAME="Reszka 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-08-13 14:18:55 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reszka AA, Halasy-Nagy JM, Masarachia PJ, Rodan GA</AU>
<TI>Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase</TI>
<SO>Journal of Bone and Joint Surgery</SO>
<YR>1999</YR>
<VL>274</VL>
<NO>49</NO>
<PG>34967-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ribot-1999" NAME="Ribot 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ribot C, Smith R, Fogelman I, Pack S, Ethgen D</AU>
<TI>Risedronate increases bone mineral density and is well tolerated in postmenopausal women with low bone mineral density</TI>
<SO>Journal of Bone &amp; Mineral Research</SO>
<YR>1999</YR>
<VL>14</VL>
<PG>S163</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roux-2004" NAME="Roux 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roux C, Seeman E, Eastell R, Adachi J, Jackson RD, Felsenberg D, et al</AU>
<TI>Efficacy of risedronate on clinical vertebral fractures within six months</TI>
<SO>Current Medical Research &amp; Opinion</SO>
<YR>2004</YR>
<VL>20</VL>
<NO>4</NO>
<PG>433-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Singer-1995" MODIFIED="2008-08-13 14:19:54 -0400" MODIFIED_BY="[Empty name]" NAME="Singer 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-08-13 14:19:54 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singer FR, Minoofar PN</AU>
<TI>Bisphosphonates in the treatment of disorders of mineral metabolism</TI>
<SO>Advances in Endocrinology and Metabolism</SO>
<YR>1995</YR>
<VL>6</VL>
<PG>259-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sorensen-2003" NAME="Sorensen 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sorensen OH, Crawford GM, Mulder H, Hosking DJ, Gennari C, Mellstrom D, et al</AU>
<TI>Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience</TI>
<SO>Bone</SO>
<YR>2003</YR>
<VL>32</VL>
<NO>2</NO>
<PG>120-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ste_x002d_Marie-2004" NAME="Ste-Marie 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ste-Marie LG, Sod E, Johnson T, Chines A, Ste-Marie LG, Sod E, et al</AU>
<TI>Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis</TI>
<SO>Calcified Tissue International</SO>
<YR>2004</YR>
<VL>75</VL>
<NO>6</NO>
<PG>469-76</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="275"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watts-1998" NAME="Watts 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Watts NB</AU>
<TI>Treatment of osteoporosis with bisphosphonates. [Review]</TI>
<SO>Rheumatic Diseases Clinics of North America</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>2</NO>
<PG>419-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watts-1999" NAME="Watts 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Watts NB, Roux C, Genant H, Adami S, Hangartner T, Miller P</AU>
<TI>Risedronate reduces vertebral fracture risk after the first year of treatment in postmenopausal women with established osteoporosis</TI>
<SO>Journal of Bone &amp; Mineral Research</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>Suppl 1</NO>
<PG>S136</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watts-2003" NAME="Watts 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Watts NB, Josse RG, Hamdy RC, Hughes RA, Manhart MD, Barton I, et al</AU>
<TI>Risedronate prevents new vertebral fractures in postmenopausal women at high risk.[see comment]</TI>
<SO>Journal of Clinical Endocrinology &amp; Metabolism</SO>
<YR>2003</YR>
<VL>88</VL>
<NO>2</NO>
<PG>542-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yildirim-2005" MODIFIED="2008-08-13 14:18:04 -0400" MODIFIED_BY="[Empty name]" NAME="Yildirim 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-08-13 14:18:04 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yildirim K, Gureser G, Karatay S, Melikoglu MA, Ugur M, Erdal A, et al</AU>
<TI>Comparison of the effects of alendronate, risedronate and calcitonin treatment in postmenopausal osteoporosis</TI>
<SO>Journal of Back &amp; Musculoskeletal Rehabilitation</SO>
<YR>2005</YR>
<VL>18</VL>
<NO>3-4</NO>
<PG>85-95</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="540"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zegels-2001" NAME="Zegels 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zegels B, Eastell R, Russell RG, Ethgen D, Roumagnac I, Collette J, et al</AU>
<TI>Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis</TI>
<SO>Bone</SO>
<YR>2001</YR>
<VL>28</VL>
<NO>1</NO>
<PG>108-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-08-13 14:17:06 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-08-13 14:17:06 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Black-2000" NAME="Black 2000" TYPE="JOURNAL_ARTICLE">
<AU>Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, et al</AU>
<TI>Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group</TI>
<SO>The Journal of Clinical Endocrinology and Metabolism</SO>
<YR>2000</YR>
<VL>85</VL>
<NO>11</NO>
<PG>4118-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Black-2001" NAME="Black 2001" TYPE="JOURNAL_ARTICLE">
<AU>Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, et al</AU>
<TI>An assessment tool for predicting fracture risk in postmenopausal women</TI>
<SO>Osteoporos International</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>7</NO>
<PG>519-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brown-2002b" NAME="Brown 2002b" TYPE="JOURNAL_ARTICLE">
<AU>Brown JP, Josse RG</AU>
<TI>2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada</TI>
<SO>CMAJ</SO>
<YR>2002</YR>
<VL>167</VL>
<NO>10 Suppl</NO>
<PG>S1-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Browner-1996" NAME="Browner 1996" TYPE="JOURNAL_ARTICLE">
<AU>Browner WS, Pressman AR, Nevitt MC, Cummings SR</AU>
<TI>Mortality following fractures in older women. The study of osteoporotic fractures</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1996</YR>
<VL>156</VL>
<NO>14</NO>
<PG>1521-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CADTH-2006" NAME="CADTH 2006" TYPE="OTHER">
<AU>Coyle D, Hadj Tahar A, Murphy G, Perras C, Skidmore B, Boucher M, et al</AU>
<TI>Teriparatide and Bisphosphonates of Treatment of Osteoporosis In Women: A Clinical and Economic analysis</TI>
<SO>Canadian Agency for Drugs and Technologies in Health</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cates-2004" NAME="Cates 2004" TYPE="OTHER">
<AU>Cates C</AU>
<TI>Visual Rx NNT Calculator 2.0</TI>
<SO>http://www.nntonline.net/</SO>
<YR>2004</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cauley-2000" NAME="Cauley 2000" TYPE="JOURNAL_ARTICLE">
<AU>Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D</AU>
<TI>Risk of mortality following clinical fractures</TI>
<SO>Osteoporos Int</SO>
<YR>2000</YR>
<VL>11</VL>
<NO>7</NO>
<PG>556-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cooper-1993" NAME="Cooper 1993" TYPE="JOURNAL_ARTICLE">
<AU>Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ, III</AU>
<TI>Population-based study of survival after osteoporotic fractures</TI>
<SO>Am J Epidemiol</SO>
<YR>1993</YR>
<VL>137</VL>
<NO>9</NO>
<PG>1001-1005</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cranney-2002" NAME="Cranney 2002" TYPE="JOURNAL_ARTICLE">
<AU>Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, Robinson V, Shea B, Wells G, Guyatt G</AU>
<TI>Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis</TI>
<SO>Endocr Rev</SO>
<YR>2002</YR>
<VL>23</VL>
<NO>4</NO>
<PG>517-523</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cranney-2003" MODIFIED="2008-05-27 23:32:55 -0400" MODIFIED_BY="[Empty name]" NAME="Cranney 2003" TYPE="COCHRANE_REVIEW">
<AU>Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G</AU>
<TI>Risedronate for the prevention and treatment of postmenopausal osteoporosis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2008-05-27 23:32:20 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE=""/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cummings-1989" NAME="Cummings 1989" TYPE="JOURNAL_ARTICLE">
<AU>Cummings SR, Black DM, Rubin SM</AU>
<TI>Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women</TI>
<SO>Arch Intern Med</SO>
<YR>1989</YR>
<VL>149</VL>
<NO>11</NO>
<PG>2445-2448</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickersin-1994" NAME="Dickersin 1994" TYPE="JOURNAL_ARTICLE">
<AU>Dickersin K, Scherer R, Lefebvre C</AU>
<TI>Identifying relevant studies for systematic reviews</TI>
<SO>BMJ</SO>
<YR>1994</YR>
<VL>309</VL>
<NO>6964</NO>
<PG>1286-1291</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Doherty-2001" NAME="Doherty 2001" TYPE="JOURNAL_ARTICLE">
<AU>Doherty DA, Sanders KM, Kotowicz MA, Prince RL</AU>
<TI>Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women</TI>
<SO>Osteoporos Int</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>1</NO>
<PG>16-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-2003" NAME="Egger 2003" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Juni P, Bartlett C, Holenstein F, Sterne J</AU>
<TI>How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study</TI>
<SO>Health Technol Assess</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>1</NO>
<PG>1-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fleiss-1993" NAME="Fleiss 1993" TYPE="JOURNAL_ARTICLE">
<AU>Fleiss JL</AU>
<TI>The statistical basis of meta-analysis</TI>
<SO>Stat Methods Med Res</SO>
<YR>1993</YR>
<VL>2</VL>
<NO>2</NO>
<PG>121-145</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADE-2004" NAME="GRADE 2004" TYPE="JOURNAL_ARTICLE">
<AU>Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schünemann HJ, Edejer TT, Varonen H, Vist GE, Williams JW Jr, Zaza S; GRADE Working Group.</AU>
<TI>Grading quality of evidence and strength of recommendations.</TI>
<SO>BMJ Jun 19;(7454):1490</SO>
<YR>2004</YR>
<VL>328</VL>
<PG>1490</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hanley-2003" NAME="Hanley 2003" TYPE="BOOK_SECTION">
<AU>Hanley DA</AU>
<TI>Osteoporosis</TI>
<SO>Therapeutic Choices</SO>
<YR>2003</YR>
<PG>637-46</PG>
<EN>4th</EN>
<ED>Gray J</ED>
<PB>Canadian Pharmaceutical Association</PB>
<CY>Ottawa</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harris-2001b" NAME="Harris 2001b" TYPE="JOURNAL_ARTICLE">
<AU>Harris, S.T., Eriksen, E.F., Davidson, M., Ettinger, M.P., Moffett, A. H., Baylink, D.J.</AU>
<TI>Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>2001</YR>
<VL>86</VL>
<NO>5</NO>
<PG>1890-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Health-Canada-2005" MODIFIED="2008-08-13 14:17:06 -0400" MODIFIED_BY="[Empty name]" NAME="Health Canada 2005" TYPE="BOOK_SECTION">
<TI>Canadian Adverse drug Reaction Monitoring Program. Risedronate</TI>
<SO>Adverse reaction database</SO>
<YR>2005</YR>
<ED>Health Canada</ED>
<CY>Ottawa</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Health-Canada-2005c" NAME="Health Canada 2005c" TYPE="OTHER">
<AU>Health Canada</AU>
<TI>Medeffect [website]</TI>
<SO>Health Canada YR:2005</SO>
<PB>Ottawa</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2005" NAME="Higgins 2005" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]</TI>
<SO>In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley &amp; Sons, Ltd</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hodsman-2002" NAME="Hodsman 2002" TYPE="JOURNAL_ARTICLE">
<AU>Hodsman AB, Hanley DA, Josse R</AU>
<TI>Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date</TI>
<SO>CMAJ</SO>
<YR>2002</YR>
<VL>166</VL>
<NO>11</NO>
<PG>1426-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kanis-1994" NAME="Kanis 1994" TYPE="JOURNAL_ARTICLE">
<AU>Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N</AU>
<TI>The diagnosis of osteoporosis</TI>
<SO>Journal of Bone and Mineral Research</SO>
<YR>1994</YR>
<VL>9</VL>
<NO>8</NO>
<PG>1137-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kherani-2002" NAME="Kherani 2002" TYPE="JOURNAL_ARTICLE">
<AU>Kherani RB, Papaioannou A, Adachi JD</AU>
<TI>Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review</TI>
<SO>Drug Safety</SO>
<YR>2002</YR>
<VL>25</VL>
<NO>11</NO>
<PG>781-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Khosla-2007" NAME="Khosla 2007" TYPE="JOURNAL_ARTICLE">
<AU>Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al</AU>
<TI>Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research</TI>
<SO>Journal of Bone and Minereral Research</SO>
<YR>2007</YR>
<VL>22</VL>
<PG>1479-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mavrokokki-2007" NAME="Mavrokokki 2007" TYPE="JOURNAL_ARTICLE">
<AU>Mavrokokki T, Cheng A, Stein B, Gross A</AU>
<TI>Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia</TI>
<SO>Journal of Oral Maxillofacial Surgery</SO>
<YR>2007</YR>
<VL>65</VL>
<PG>415-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mayo-Clin-Proc-2005" NAME="Mayo Clin Proc 2005" TYPE="JOURNAL_ARTICLE">
<TI>Alendronate and vertebral fracture risk [multiple letters]</TI>
<SO>Mayo Clinic Proceedings</SO>
<YR>2005</YR>
<VL>80</VL>
<PG>1233-41</PG>
<EN>80</EN>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Melton-1989" NAME="Melton 1989" TYPE="JOURNAL_ARTICLE">
<AU>Melton LJ, III, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL</AU>
<TI>Epidemiology of vertebral fractures in women</TI>
<SO>American Journal of Epidemiology</SO>
<YR>1989</YR>
<VL>129</VL>
<NO>5</NO>
<PG>1000-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NIH-Consensus-2001" NAME="NIH Consensus 2001" TYPE="JOURNAL_ARTICLE">
<AU>NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy</AU>
<TI>Osteoporosis prevention, diagnosis, and therapy</TI>
<SO>JAMA</SO>
<YR>2001</YR>
<VL>285</VL>
<NO>6</NO>
<PG>785-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sampson-2003" NAME="Sampson 2003" TYPE="JOURNAL_ARTICLE">
<AU>Sampson M, Barrowman NJ, Moher D, Klassen TP, Pham B, Platt R, et al</AU>
<TI>Should meta-analysts search Embase in addition to Medline?</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2003</YR>
<VL>56</VL>
<NO>10</NO>
<PG>943-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shukla-2003" NAME="Shukla 2003" TYPE="BOOK">
<AU>Shukla V</AU>
<SO>Treating osteoporosis with teriparatide: many unknowns? [Issues in emerging health technologies issue 51]</SO>
<YR>2003</YR>
<PB>Canadian Coordinating Office of health Technology Assessment</PB>
<CY>Ottawa</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tugwell-2004" NAME="Tugwell 2004" TYPE="BOOK">
<AU>Tugwell P, Shea B, Boers M, Simons L, Strand V, Wells G</AU>
<SO>Evidence-based Rheumatology</SO>
<YR>2004</YR>
<PB>BMJ Books</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1994" NAME="WHO 1994" TYPE="JOURNAL_ARTICLE">
<AU>WHO</AU>
<TI>Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Report of a WHO study group</TI>
<SO>World Health Organ Technical Report Series</SO>
<YR>1994</YR>
<VL>843</VL>
<PG>1-129</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woo-2006" NAME="Woo 2006" TYPE="JOURNAL_ARTICLE">
<AU>Woo SB, Hellstein JW, Kalmar JR</AU>
<TI>Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2006</YR>
<VL>144</VL>
<NO>10</NO>
<PG>753-61</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES>
<REFERENCE ID="REF-CADTH-2006b" NAME="CADTH 2006b" TYPE="OTHER">
<AU>Wells GA, Cranney A, Bouchere M, Peterson J, Shea B, Robinson V, et al</AU>
<TI>Bisphosphonates for the primary and secondary prevention of osteoporotic fractures in postmenopausal women: a meta-analysis [Technology report no 69]</TI>
<SO>Ottawa: Canadian Agency for Drugs and Technologies in Health</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Clemmesen-1997">
<CHAR_METHODS>
<P>Randomized controlled trial<BR/>Secondary prevention<BR/>Blinding: double blind unspecified<BR/>Study length: 2 years<BR/>on drug plus 3rd <BR/>year drug free follow up <BR/>Withdrawals:<BR/>Continuous: 15/44 (34.1%)<BR/>Cyclic: 11/44 (25.0%)<BR/>Placebo: 13/44 (29.5%)<BR/>Total: 39/132 (29.5%)</P>
<P>
<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Source: Outpatients attending clinics which specialized in osteoporosis. Study was carried out in two centres one in Denmark and one in Belgium. </P>
<P>Inclusion Criteria: Healthy age 53-81, postmenopausal at least 1 year. Had at least one but no more than 4 vertebral fractures and at least 3 intact lumbar vertebrae. </P>
<P>Exclusion Criteria: Estrogen or calcitonin within 12 mos, any bisphosphonate or fluoride, medications affecting bone metabolism, secondary causes of osteoporosis. <BR/>Treatment N: 44, 44 <BR/>Control N: 44<BR/>Age: 68.3 (5.7); YSM: 20.3 (7.3)<BR/>Calcium: not reported<BR/>BMD: 0.78 (0.14) g/cm2<BR/>T-score: -2.4<BR/>Fractures: 100%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Risedronate 2.5 mg/day or cyclical risedronate 2.5 mg/day for 2 wk followed by placebo for 10 wk vs. placebo.</P>
<P>(Calcium 1000 mg/day)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>This study was not included in the analysis as the assessment period for fractures appeared to include the off drug treatment period. </P>
<P>Vertebral Fractures: Lateral thoracic and lumbar radiographs performed under standardized conditions. At the end of study radiographs were displayed simultaneously in chronological order for masked assessment of vertebrae T4 to L5. Vertebral anterior and posterior heights were measured to the nearest millimetre with a transparent ruler. Belgian site incident fractures were defined as = 15% height reduction in anterior to posterior ratio or in the anterior or posterior wall as compared to adjacent vertebrae. For the Danish site the reduction was 25%.</P>
<P>Non-vertebral Fractures: Subjects reported all adverse events and were questioned about intercurrent symptoms and illnesses at every visit.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Fogelman-2000">
<CHAR_METHODS>
<P>Randomized controlled trial<BR/>Secondary prevention<BR/>Blinding: double blind unspecified<BR/>Study length: 2<BR/>(2.5 mg patients from 9 of 13 centres (N = 76) discontinued prior to the end of the study due to protocol amendment.)</P>
<P>Withdrawals:<BR/>2.5 mg: 111/184 (60.0%)<BR/>5.0 mg: 38/177 (21.5%)<BR/>Placebo: 37/180 (20.6%) <BR/>Total: 186/543 (34.3%) <BR/>[not including protocol amendment: 110/467 (23.6%)]</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Source: 13 centres in France, UK, the Netherlands, Belgium and Germany. </P>
<P>Inclusion Criteria: Women up to 80 years who had been postmenopausal 1 year. Mean lumbar T-score of -2 or less. </P>
<P>Exclusion Criteria: Hyperthyroidism, hyperparathyroidism, or osteomalacia within 1 year, cancer, abnormalities affecting lumbar BMD measurement, drugs within 6 - 12 months affecting bone metabolism including parenteral Vitamin D = 10,000 IU. <BR/>Note: patients with previous or ongoing upper GI disease were not excluded.</P>
<P>Treatment N: 184, 177<BR/>Control N: 180<BR/>Age: 64.7 (7.2); YSM: 17.7 (9.4)<BR/>Calcium: not reported<BR/>BMD: 0.74 (0.08)<BR/>t-score: -2.9<BR/>Fractures: 30%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Risedronate 2.5 mg/day or risedronate 5 mg/day vs. placebo.</P>
<P>(Calcium 1000 mg/day)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Vertebral Fractures: Lateral and anterior-posterior thoracic and lumbar (T4-L4) radiographs were taken at baseline and lateral radiographs taken at end of study. Fractures were identified by quantitative morphometry guidelines of US National Osteoporosis Foundation <BR/>Working Group on Vertebral Fractures and verified by a radiologist. A fracture was defined by any vertebral height ratio falling 3 SD of the study population mean. </P>
<P>Non-Vertebral: Adverse events (including vertebral and non-vertebral fractures) were assessed throughout the study via spontaneous reports and direct questioning<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Harris-1999">
<CHAR_METHODS>
<P>Randomized controlled trial<BR/>Secondary prevention<BR/>Blinding: double blind, identical placebo, investigators and other study personnel remained blinded<BR/>Study length: 3<BR/>(2.5 mg/day dose discontinued at 1 year due to protocol amendment.)<BR/>Withdrawals:2.5 mg: 238/817 (29.1%)<BR/>5.0 mg: 332/821 (40.4%)<BR/>Placebo: 370/820 (45.1%)<BR/>Total: 940/2458 (38.2%)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Source: 110 centres in North America</P>
<P>Inclusion Criteria: Ambulatory women up to 85 years old who had been post menopausal at least 5 years. Minimum two radiographically confirmed vertebral T4-L4 fractures (ratio of anterior or middle vertebral height to the posterior height was = 0.8) or 1 vertebral fracture and lumbar BMD T-score = -2SD of young adult (0.83g/cm² Hologic or 0.94g/cm² Lunar). </P>
<P>Exclusion Criteria: Conditions that could interfere with evaluation of spinal osteoporosis, calcitonin, calcitriol or Vitamin D within one month, anabolic steroids, or HRT within 3 months, bisphosphonates, fluoride within 6 months. <BR/>Note: Patients with previous or ongoing upper GI disease or use of medications associated with GI intolerance (NSAIDS or asprin) were not excluded.<BR/>Treatment N: 817<BR/>Control N: 821, 820<BR/>Age: 69 (7.3); YSM: 24 (9.9)<BR/>Calcium: not reported<BR/>BMD: 0.83 g/cm2 (0.16)<BR/>t-score: -2.4<BR/>Fractures: 81%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Risedronate 2.5 mg/day or risedronate 5 mg/day vs. placebo.</P>
<P>(Calcium 1000 mg/day and if 25-hydroxyvitamin D level was &lt; 40 nmol/L they received up to 500 IU/day cholecalciferol.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Vertebral Fractures: Lateral thoracolumbar T4-L4 spine radiographs were obtained at baseline and annually. Prevalent and incident fractures were diagnosed quantitatively and semi-quantitatively. Quantitative assessment defined an incident fracture as a 15% decrease of anterior, posterior or middle vertebral height in a vertebra that was normal at baseline. In the semiquantitative assessment a new fracture was diagnosed if the grade changed from 0 (normal) to 1(mild) 2 (moderate), or 3 (severe). An independent radiologist adjudicated discrepancies between methods. Radiologists were blinded. </P>
<P>Non-vertebral Fractures: Radiographically confirmed fractures of the clavicle, humerus, wrist, pelvis, hip or leg, regardless of relationship to trauma. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hooper-2005">
<CHAR_METHODS>
<P>Randomized controlled trial<BR/>Primary prevention<BR/>Blinding: double blind, matching placebo<BR/>Study length: 2 years<BR/>Withdrawals:<BR/>Risedronate 2.5 mg: 28/128 (21.9%)<BR/>Risedronate 5 mg: 26/129 (20.2%)<BR/>Placebo: 33/126 (26.2%)<BR/>Total: 87/383 (22.8%)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Source: 11 centres in Australia.</P>
<P>Inclusion Criteria: Healthy women who were post menopausal 6- 36 months age with FSH &gt; 50 MIU/ml, and estradiol &lt; 20 pg/ml. BMD T score &gt; -2.5 (0.76g/cm2 Hologic or 0.8 g/cm2 Lunar). Exclusion Criteria: Hyperparathyroidism, hyperthyroidism, osteomalacia or treatments affecting bone metabolism. Patients not excluded due to GI disease or medications with potential to irritate GI tract. </P>
<P>Treatment N: 2.5 mg 127, 5 mg 129<BR/>Control N: 125<BR/>Age: 52.6 (3.3); YSM 3.9 (5.6)<BR/>Calcium: not reported<BR/>BMD: 1.079 (12)<BR/>t-score: -0.410 (-0.1073)<BR/>Fractures: 18.3%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Risedronate 2.5 mg/day or 5.0 mg/day vs. placebo</P>
<P>(Calcium 1000 mg/day)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Vertebral Fractures: Lumbar and thoracic lateral and anterior-posterior radiographs were taken at baseline and 2 years. Deformity was confirmed by visual inspection and defined as vertebral height ratio below 3 SD of study population mean. Incident fracture was defined as a loss of 14% or more in anterior, posterior or middle vertebral height in a vertebra that was normal at baseline. </P>
<P>Non-vertebral Fractures: Were monitered as adverse events. At each visit patients were questioned regarding medically related changes in well being with particular attention to fractures and GI events. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-McClung-2001">
<CHAR_METHODS>
<P>Randomized controlled trial<BR/>Secondary prevention<BR/>Blinding: double blind, identical placebo<BR/>Study length: 3 years<BR/>Withdrawals:2.5/ 5.0 mg combined: 2197/6197 (35.5%)<BR/>placebo: 1127/3134 (35.9%)<BR/>Total: 3324/9331 (35.6%)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Source: 2 cohorts from 183 centres in North America, Europe, New Zealand and Australia. </P>
<P>Inclusion Criteria: Group 1 - Women age 70-79 with osteoporosis defined as femoral neck BMD T-score &gt; 4 SD below peak bone mass (originally calculated according to densitometer reference data base and later according to Third National Health and Nutrition Examination Survey) or &gt; -3 SD and at least one clinical risk factor i.e. difficulty standing from a sitting position, poor tandem gait, fall-related injury in previous year, psychomotor score = 5 on Clifton Modified Gibson Spiral Maze test, smoking during previous 5 years, maternal history of hip fracture, previous hip fracture, hip axis length = 11.1cm. <BR/>Group 2 - Women age 80 or older with at least one non-skeletal risk factor for hip fracture, a femoral-neck t score &lt; -4 or a femoral-neck t score &lt; -3 plus a hip axis length = 11.1cm.</P>
<P>Exclusion Criteria: Major medical illness, recent history of cancer, another metabolic bone disease within 1 year, important lab test abnormalities, recent drugs affecting bone, allergy to bisphosphonates, bilateral hip fractures.<BR/>Note: Patients with previous or ongoing upper GI or use of medications associated with GI intolerance (NSAIDS, asprin, proton pump inhibitors or antacids) were not excluded.</P>
<P>Treatment N: 3093, 3104<BR/>Control N: 3134<BR/>Age: 78.0 (9.7); YSM: 31.8 (19.3)<BR/>Calcium: not reported<BR/>BMD: not reported<BR/>t-score (femoral): -3.7<BR/>Fractures: 42%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Risedronate 2.5 mg/day or risedronate 5 mg/day vs. placebo</P>
<P>(Calcium 1000 mg/day and if 25-hydroxyvitamin level was &lt; 40 nmol/L, they received vitamin D 500 IU/day)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Hip Fractures: Radiographically confirmed. </P>
<P>Non-vertebral Fractures: Radiographically confirmed osteoporotic fractures of wrist leg, humerus, hip, pelvis or clavicle.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mortensen-1998">
<CHAR_METHODS>
<P>Randomized controlled trial<BR/>Primary prevention<BR/>Blinding: double blind, identical placebo<BR/>Study length: 2<BR/>on drug plus 3rd year drug free follow up. (Patients given option to continue in study after completing 1st year.) <BR/>Withdrawals:<BR/>Continuous: 20/37 (54.1%)<BR/>Cyclic: 14/38 (36.8%)<BR/>Placebo: 15/36 (41.7%)<BR/>Total:49/111 (44%)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Source: Two centres - USA and Denmark</P>
<P>Inclusion Criteria: Ambulatory, active women 6-60 month postmenopausal (as measured by FSH and estradiol) weighing 45-90 kg (within 25% of normal height and weight). Lumbar spine within 2 SD of age matched bone mass.</P>
<P>Exclusion Criteria: Bisphosphonates, thyroid hormone therapy, glucocorticoids = 5 mg/day, anabolic agents, calcitonin, vitamin D &gt; 400 IU/day, calcium &gt; 1500/day, diuretics, anticonvulsants &gt; 1 month in previous 6 months, HRT &gt; 1 month in previous 6 months, fluoride &gt; 1 month ever, any bone disease including hyperparathyroidism, alcohol or drug abuse, psychiatric disease, any evidence of osteoporosis - vertebral deformity or osteoporosis related fracture of hip or wrist, bilateral oophorectomy, or artificial menopause. <BR/>Note: Nothing in criteria to indicate exclusion of those with upper GI disease. <BR/>Treatment N: 37, 38 <BR/>Control N: 36<BR/>Age: 51.2 (3.8); YSM: 2.7 (1.7)<BR/>Calcium: 977 (535)mg/d<BR/>BMD: 0.94 (0.11) g/cm2<BR/>T-score: -1.0<BR/>Fractures: 0% (excluded)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Risedronate 5 mg/day or cyclical risedronate 5 mg/day for 1st 2 wk of every calendar month followed by placebo for remainder vs. placebo.</P>
<P>(Not required to take supplemental calcium.)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Vertebral fractures - Thoracic and lumbar radiographs were taken at baseline, 7, 13 and 25 months and 12 months after treatment cessation. Vertebral deformities were defined as a 25% or more decrease in anterior, mid or posterior, height of a vertebra as compared to baseline and were evaluated for safety purposes. </P>
<P>Non-vertebral fractures- Ascertainment not specified but adverse events were recorded at all patient visits. This endpoint was not included in the meta-analysis as the evaluation period appeared to include the follow up time in which patients were off drug. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Reginster-2000">
<CHAR_METHODS>
<P>Randomized controlled trial<BR/>Secondary prevention<BR/>Blinding: double blind unspecified<BR/>Study length: 3<BR/>(2.5 mg/dose discontinued at 2 years due to protocol amendment)</P>
<P>Withdrawals:<BR/>2.5 mg (at 1 year): 76/408 (18.6%)<BR/>5.0 mg (at 3 years): 156/407 (38.3%)<BR/>Placebo (at 3 years): 186/407 (45.7%) <BR/>Total for 5.0 mg and placebo: 342/814 (40%)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Source: 80 European and Australian centres. VERT study. </P>
<P>Inclusion Criteria: Ambulatory women up to 85 years old who had been post menopausal at least 5 years. Minimum two radiographically confirmed vertebral T4-L4 fractures.</P>
<P>Exclusion Criteria: Conditions that could interfere with evaluation of spinal osteoporosis, calcitonin, calcitriol or Vitamin D within one month, anabolic steroids, or HRT within 3 months, bisphosphonates, fluoride within 6 months. <BR/>Note: Patients with previous or ongoing upper GI disease or use of medications associated with GI intolerance (NSAIDS or asprin) were not excluded.</P>
<P>Treatment N: 408, 407<BR/>Control N: 407<BR/>Age: 71.0 (7.0); YSM: 24.4 (8.5)<BR/>Calcium: not reported<BR/>BMD: 0.79 g/cm2 (0.15)<BR/>T-score: -2.7<BR/>Fractures: 100%<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Risedronate 2.5 mg/day or risedronate 5 mg/day vs. placebo</P>
<P>(Calcium 1000 mg/day and if 25-hydroxyvitamin level was &lt; 40 nmol/l, they received vitamin D 500 IU/day) <BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary Outcome: Vertebral fractures </P>
<P>Vertebral Fractures: Lateral thoracolumbar T4-L4 spine radiographs were obtained at baseline, 1,2 and 3 years and were read in the order they were taken at a single radiology department. Prevalent and incident fractures were diagnosed quantitatively and semi-quantitatively. Quantitative assessment defined incident fracture as a 15% decrease of anterior, posterior or middle vertebral height in a vertebra that was normal at baseline. In the semiquantitative assessment a new fracture was diagnosed if the grade changed from 0 (normal) to 1(mild) 2 (moderate), or 3 (severe). An independent radiologist adjudicated discrepancies between methods. </P>
<P>Non-vertebral Fractures: Radiographically confirmed fractures of the clavicle, humerus, wrist, pelvis, hip or leg, regardless of relationship to trauma. <BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BMD: Lumbar Bone Mineral Density<BR/>Calcium: Baseline calcium intake<BR/>GI: gastointestinal<BR/>HRT: hormone replacement therapy<BR/>NSAID: Non steroidal anti inflammatory drugs<BR/>Participant Characteristics: Unless othewise specified, participant characteristics are presented as mean (SD)<BR/>SD: Standard deviation<BR/>t-score calculated using the lumbar spine BMD [(LS BMD -1.047)/0.110]<BR/>vs: versus<BR/>YSM: Years Since Menopause</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Brown-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of an appropriate control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Delmas-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of fracture outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dobnig-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of fracture outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Eastell-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Duplicate report or earlier report of another study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Eriksen-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of fracture outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Goa-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Harris-1999b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of an appropriate control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Harris-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of an appropriate control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hooper-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of fracture outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hosking-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of appropriate fracture data (i.e. reported as adverse event and unspecified.)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hu-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of fracture outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kushida-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of an appropriate control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Leung-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of fracture outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Li-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of fracture outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Licata-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-McClung-1998-1">
<CHAR_REASON_FOR_EXCLUSION>
<P>No extractable data.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Miller-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Duplicate report or earlier report of another study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Reginster-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Duplicate report or earlier report of another study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Reszka-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ribot-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Duplicate report or earlier report of another study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Roux-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Duplicate report or earlier report of another study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Singer-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sorensen-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Extension / discontinuation study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ste_x002d_Marie-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Extension study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Watts-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Watts-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Duplicate report or earlier report of another study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Watts-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Duplicate report or earlier report of another study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yildirim-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Lack of fracture outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zegels-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Duration of therapy &lt; 1 year.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Clemmesen-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fogelman-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Harris-1999">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Hooper-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-McClung-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mortensen-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Reginster-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES>
<ADDITIONAL_TABLE ID="TBL-01" NO="1">
<TITLE>Clinical Relevance Table for Fracture Primary Prevention Trials</TITLE>
<TABLE COLS="8" ROWS="26">
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P># Patients # Trials</P>
</TH>
<TH>
<P>Control Event Rate</P>
</TH>
<TH>
<P>Wt Absolute RD</P>
</TH>
<TH>
<P>Wt Rel % Change</P>
</TH>
<TH>
<P>NNTB</P>
</TH>
<TH>
<P>Statistical Sig</P>
</TH>
<TH>
<P>Quality of Evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>Vertebral Fractures - (Trial Population) Primary Prevention 5mg/day for 2 yrs</P>
</TD>
<TD>
<P>327 (2)</P>
</TD>
<TD>
<P>6.2% (6 out of 100)</P>
</TD>
<TD>
<P>0% 0 fewer patients out of 100</P>
</TD>
<TD>
<P>-3% (I)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-5, 5)</P>
</TD>
<TD>
<P>(-58, 125)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Vertebral Fractures - (Low Risk Woman) Primary Prevention 5mg/day for 2 years</P>
</TD>
<TD>
<P>327 (2)</P>
</TD>
<TD>
<P>1.2% (1 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-3% (I)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-58, 125)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Vertebral Fractures - (Moderate Risk Woman) Primary Prevention 5mg/day for 2 yrs</P>
</TD>
<TD>
<P>327 (2)</P>
</TD>
<TD>
<P>5.3% (5 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-3% (I)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-58, 125)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Non Vertebral Fractures - (Trial Population) Primary Prevention(5 mg/day for 2 yrs)</P>
</TD>
<TD>
<P>254 (1)</P>
</TD>
<TD>
<P>4.8% (5 out of 100)</P>
</TD>
<TD>
<P>-1% 1 fewer patient out of 100</P>
</TD>
<TD>
<P>-19% (I)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-3, 4)</P>
</TD>
<TD>
<P>(-75, 158)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Non Vertebral Fractures - (Low Risk Woman) Primary Prevention(5 mg/day for 2 yrs)</P>
</TD>
<TD>
<P>254 (1)</P>
</TD>
<TD>
<P>8.9% (9 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-19% (I)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-75, 158)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Non Vertebral Fractures - (Moderate Risk Woman) Primary Prevention(5 mg/day for 2 yrs)</P>
</TD>
<TD>
<P>254 (1)</P>
</TD>
<TD>
<P>16.5% (17 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-19% (I)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-75, 158)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Hip Fractures - (Trial Population) Primary Prevention (5mg/day for 2 yrs)</P>
</TD>
<TD>
<P>73 (1)</P>
</TD>
<TD>
<P>0.0 (0 out of 100)</P>
</TD>
<TD>
<P>0% 0 fewer patients out of 100</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-5, 5)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Hip Fractures - (Low Risk Woman) Primary Prevention (5mg/day for 2 yrs)</P>
</TD>
<TD>
<P>73 (1)</P>
</TD>
<TD>
<P>0.4% (0 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not estimable(I)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Hip Fractures - (Moderate Risk Woman) Primary Prevention (5mg/day for 2 yrs)</P>
</TD>
<TD>
<P>73 (1)</P>
</TD>
<TD>
<P>1.9% (2 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wrist Fractures - (Trial Population) Primary Prevention (5mg/day for 2 yrs)</P>
</TD>
<TD>
<P>73 (1)</P>
</TD>
<TD>
<P>0% (0 out of 100)</P>
</TD>
<TD>
<P>-0% 0 fewer patients out of 100</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-5, 5)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wrist Fractures - (Low Risk Woman) Primary Prevention (5mg/day for 2 yrs)</P>
</TD>
<TD>
<P>73 (1)</P>
</TD>
<TD>
<P>Not available</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wrist Fractures - (Moderate Risk Woman) Primary Prevention (5mg/day for 2 yrs)</P>
</TD>
<TD>
<P>73 (1)</P>
</TD>
<TD>
<P>Not available</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Legend</P>
</TD>
<TD>
<P>Secondary prevention = bone density of at least 2 SD values below peak bone mass and/or one or more vertebral compression fractures.</P>
</TD>
<TD>
<P>For Trial Population rates are based on the event rate in the control group. Low and Moderate Risk, are 5 year community population risks derived from the following variables in the FRACTURE Index: age, fracture after 50 yrs, maternal hip fracture after 50 yrs., weight &lt; 125 lbs, smoking, using arms to assist standing and BMD. Low = FRACTURE Index score 1-2, Moderate = FRACTURE Index score 5 (Black 2001) see Figure 1</P>
</TD>
<TD>
<P>Wt = weighted, RD = risk difference</P>
</TD>
<TD>
<P>Wt Rel = weighted relative percent change, I = improvement</P>
</TD>
<TD>
<P>NNT B = number needed to benefit</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Gold level: At least one randomised clinical trial meets all of the following criteria for the major outcome(s) as reported: Sample sizes of at least 50 per group. If a statistically significant difference is not found they must be powered for 20% relative difference in the relevant outcome. Blinding of patients and assessors for outcomes. Handling of withdrawals &gt; 80% follow up (imputations based on methods such as Last Observation Carried Forward (LOCF) acceptable). Concealment of treatment allocation. Silver level: Randomised trial does not meet the above criteria.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" NO="2">
<TITLE>Clinical Relevance Table for Fracture Secondary Prevention Trials</TITLE>
<TABLE COLS="8" ROWS="26">
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P># Patients # Trials</P>
</TH>
<TH>
<P>Control Event Rate</P>
</TH>
<TH>
<P>Wt Absolute RD</P>
</TH>
<TH>
<P>Wt Rel % Change</P>
</TH>
<TH>
<P>NNTB</P>
</TH>
<TH>
<P>Statistical Sig</P>
</TH>
<TH>
<P>Quality of Evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>Vertebral Fractures - (Trial Population) Secondary Prevention 5 mg/day for 3 yrs</P>
</TD>
<TD>
<P>2,812 (3)</P>
</TD>
<TD>
<P>14.1% (14 out of 100)</P>
</TD>
<TD>
<P>-5% 5 fewer patients out of 100</P>
</TD>
<TD>
<P>-39% (I)</P>
</TD>
<TD>
<P>19</P>
</TD>
<TD>
<P>Statistically significant</P>
</TD>
<TD>
<P>Gold</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-8, -3)</P>
</TD>
<TD>
<P>(-50, -24)</P>
</TD>
<TD>
<P>(15, 30)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Vertebral Fractures - (Moderate Risk Woman) Secondary Prevention 5 mg/day for 3 years</P>
</TD>
<TD>
<P>2,812 (3)</P>
</TD>
<TD>
<P>5.3% (5 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-39% (I)</P>
</TD>
<TD>
<P>49</P>
</TD>
<TD>
<P>Statistically significant</P>
</TD>
<TD>
<P>Gold</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-50, -24)</P>
</TD>
<TD>
<P>(38, 79)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Vertebral Fractures - (High Risk Woman) Secondary Prevention 5 mg/day for 3 yrs</P>
</TD>
<TD>
<P>2,812 (3)</P>
</TD>
<TD>
<P>11.2% (11 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-39% (I)</P>
</TD>
<TD>
<P>23</P>
</TD>
<TD>
<P>Statistically significant</P>
</TD>
<TD>
<P>Gold</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-50, -24)</P>
</TD>
<TD>
<P>(18, 38)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Non Vertebral Fractures - (Trial Population) Secondary Prevention(5 mg/day for 2-3 yrs)</P>
</TD>
<TD>
<P>12,143 (4)</P>
</TD>
<TD>
<P>10.3% (10 out of 100)</P>
</TD>
<TD>
<P>-2% 2 fewer patients out of 100</P>
</TD>
<TD>
<P>-20% (I)</P>
</TD>
<TD>
<P>49</P>
</TD>
<TD>
<P>Statistically significant</P>
</TD>
<TD>
<P>Gold</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-3, -1)</P>
</TD>
<TD>
<P>(-28, -10)</P>
</TD>
<TD>
<P>(35, 98)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Non Vertebral Fractures - (Moderate Risk Woman) Secondary Prevention(5 mg/day for 2-3 yrs)</P>
</TD>
<TD>
<P>12,143 (4)</P>
</TD>
<TD>
<P>16.5% (17 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-20% (I)</P>
</TD>
<TD>
<P>31</P>
</TD>
<TD>
<P>Statistically significant</P>
</TD>
<TD>
<P>Gold</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-28, -10)</P>
</TD>
<TD>
<P>(22, 61)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Non Vertebral Fractures - (High Risk Woman) Secondary Prevention(5 mg/day for 2-3 yrs)</P>
</TD>
<TD>
<P>12,143 (4)</P>
</TD>
<TD>
<P>27.5% (28 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-20% (I)</P>
</TD>
<TD>
<P>19</P>
</TD>
<TD>
<P>Statistically significant</P>
</TD>
<TD>
<P>Gold</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-28, -10)</P>
</TD>
<TD>
<P>(13, 37)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Hip Fractures - (Trial Population) Secondary Prevention (5 mg/day for 3 yrs)</P>
</TD>
<TD>
<P>11,786 (3)</P>
</TD>
<TD>
<P>2.8 (3 out of 100)</P>
</TD>
<TD>
<P>-1% 1 fewer patient out of 100</P>
</TD>
<TD>
<P>-26% (I)</P>
</TD>
<TD>
<P>138</P>
</TD>
<TD>
<P>Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-1, 0)</P>
</TD>
<TD>
<P>(-41, -6)</P>
</TD>
<TD>
<P>(88, 596)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Hip Fractures - (Moderate Risk Woman)Secondary Prevention (5 mg/day for 3 yrs)</P>
</TD>
<TD>
<P>11,786 (3)</P>
</TD>
<TD>
<P>1.9% (2 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-26% (I)</P>
</TD>
<TD>
<P>203</P>
</TD>
<TD>
<P>Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-41, -6)</P>
</TD>
<TD>
<P>(129, 878)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Hip Fractures - (High Risk Woman) Secondary Prevention (5 mg/day for 3 yrs)</P>
</TD>
<TD>
<P>11,786 (3)</P>
</TD>
<TD>
<P>8.7% (9 out of 100)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-26% (I)</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD>
<P>Statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-41, -6)</P>
</TD>
<TD>
<P>(29, 192)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wrist Fractures - (Trial Population) Secondary Prevention (5 mg/day for 3 yrs)</P>
</TD>
<TD>
<P>2,455 (2)</P>
</TD>
<TD>
<P>3.5% (4 out of 100)</P>
</TD>
<TD>
<P>-1% 1 fewer patient out of 100</P>
</TD>
<TD>
<P>-33% (I)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-2, 0)</P>
</TD>
<TD>
<P>(-58, 7)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wrist Fractures - (Moderate Risk Woman) Secondary Prevention (5 mg/day for 3 yrs)</P>
</TD>
<TD>
<P>2,455 (2)</P>
</TD>
<TD>
<P>Not available</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-33% (I)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-58, 7) (I)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wrist Fractures - (High Risk Woman) Secondary Prevention (5 mg/day for 3 yrs)</P>
</TD>
<TD>
<P>2,455 (2)</P>
</TD>
<TD>
<P>Not available</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>-33% (I)</P>
</TD>
<TD>
<P>Not applicable</P>
</TD>
<TD>
<P>Not statistically significant</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>95% confidence interval</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>(-58, 7)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Legend</P>
</TD>
<TD>
<P>Secondary prevention = bone density of at least 2 SD values below peak bone mass and/or one or more vertebral compression fractures.</P>
</TD>
<TD>
<P>For Trial Population rates are based on the event rate in the control group. Moderate and High Risk, are 5 year community population risks derived from the following variables in the FRACTURE Index: age, fracture after 50 yrs, maternal hip fracture after 50 yrs, weight &lt; 125 lbs, smoking, using arms to assist standing and BMD. Moderate = FRACTURE Index score 3-4, High = FRACTURE Index score 8-13 (Black 2001) see Figure 1</P>
</TD>
<TD>
<P>Wt = weighted, RD = risk difference</P>
</TD>
<TD>
<P>Wt Rel = weighted relative percent change, I = improvement</P>
</TD>
<TD>
<P>NNT B = number needed to benefit</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Gold level: At least one randomised clinical trial meets all of the following criteria for the major outcome(s) as reported: Sample sizes of at least 50 per group. If a statistically significant difference is not found they must be powered for 20% relative difference in the relevant outcome. Blinding of patients and assessors for outcomes. Handling of withdrawals &gt; 80% follow up (imputations based on methods such as Last Observation Carried Forward (LOCF) acceptable). Concealment of treatment allocation. Silver level: Randomised trial does not meet the above criteria.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-08-13 12:58:14 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Risedronate 5 mg vs Control - all years baseline denominators</NAME>
<DICH_OUTCOME CHI2="1.631556640323763" CI_END="0.7740734587883817" CI_START="0.513970233907201" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.630754085737715" ESTIMABLE="YES" EVENTS_1="132" EVENTS_2="209" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.11121782325428516" LOG_CI_START="-0.2890620320245255" LOG_EFFECT_SIZE="-0.20013992763940533" METHOD="MH" NO="1" P_CHI2="0.6522559792612803" P_Q="0.0" P_Z="1.0272530773757452E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1571" TOTAL_2="1568" WEIGHT="100.0" Z="4.411355902496244">
<NAME>Vertebral Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.689867730082893E-32" CI_END="2.247455639476776" CI_START="0.41778176187845545" DF="0" EFFECT_SIZE="0.9689922480620153" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" I2="100.0" ID="CMP-001.01.01" LOG_CI_END="0.35169112833826666" LOG_CI_START="-0.37905052292065194" LOG_EFFECT_SIZE="-0.013679697291192623" NO="1" P_CHI2="0.0" P_Z="0.9415019839023121" STUDIES="2" TAU2="0.0" TOTAL_1="166" TOTAL_2="161" WEIGHT="4.858381094186374" Z="0.07338219728944306">
<NAME>Vertebral Primary</NAME>
<DICH_DATA CI_END="2.247455639476776" CI_START="0.4177817618784555" EFFECT_SIZE="0.9689922480620154" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" LOG_CI_END="0.35169112833826666" LOG_CI_START="-0.3790505229206519" LOG_EFFECT_SIZE="-0.013679697291192575" ORDER="17213" O_E="0.0" SE="0.42924126317900035" STUDY_ID="STD-Hooper-2005" TOTAL_1="129" TOTAL_2="125" VAR="0.18424806201550387" WEIGHT="4.858381094186374"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17214" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5669320772545208" CI_END="0.7579221541862451" CI_START="0.49656843750193813" DF="2" EFFECT_SIZE="0.6134820452567188" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="199" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="-0.12037539825118596" LOG_CI_START="-0.3040208881933842" LOG_EFFECT_SIZE="-0.21219814322228508" NO="2" P_CHI2="0.7531687231296812" P_Z="5.9155149847092746E-6" STUDIES="3" TAU2="0.0" TOTAL_1="1405" TOTAL_2="1407" WEIGHT="95.14161890581363" Z="4.529386683363196">
<NAME>Vertebral secondary</NAME>
<DICH_DATA CI_END="1.0804185112454712" CI_START="0.21197692711296298" EFFECT_SIZE="0.4785643070787637" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.03359201652142064" LOG_CI_START="-0.6737114078110825" LOG_EFFECT_SIZE="-0.32005969564483094" ORDER="17215" O_E="0.0" SE="0.4154735326613295" STUDY_ID="STD-Fogelman-2000" TOTAL_1="177" TOTAL_2="180" VAR="0.17261825634208486" WEIGHT="8.062868114892249"/>
<DICH_DATA CI_END="0.8914924508178039" CI_START="0.4814126450782892" EFFECT_SIZE="0.6551150576925595" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="93" LOG_CI_END="-0.049882330090479765" LOG_CI_START="-0.3174825064673046" LOG_EFFECT_SIZE="-0.1836824182788922" ORDER="17216" O_E="0.0" SE="0.15718966824598352" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.024708591803282356" WEIGHT="44.50954031992248"/>
<DICH_DATA CI_END="0.8127982686091101" CI_START="0.436303760402502" EFFECT_SIZE="0.5955056179775281" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="89" LOG_CI_END="-0.09001723017618743" LOG_CI_START="-0.36021104391206005" LOG_EFFECT_SIZE="-0.22511413704412372" ORDER="17217" O_E="0.0" SE="0.15871318366940015" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.025189874670476748" WEIGHT="42.569210470998904"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Risedronate 5 mg vs Control - all years baseline denominators</NAME>
<DICH_OUTCOME CHI2="2.7779967137186006" CI_END="0.9000453315121091" CI_START="0.7171167587812417" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8033913062077234" ESTIMABLE="YES" EVENTS_1="664" EVENTS_2="473" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.04573561641648018" LOG_CI_START="-0.14441012806142406" LOG_EFFECT_SIZE="-0.0950728722389521" METHOD="MH" NO="1" P_CHI2="0.5956370722673383" P_Q="0.0" P_Z="1.5882443507350626E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="7731" TOTAL_2="4666" WEIGHT="100.00000000000001" Z="3.7768498143800477">
<NAME>Non Vertebral Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.578542560375559" CI_START="0.2528737850773441" DF="0" EFFECT_SIZE="0.8074935400516796" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.4113743040901099" LOG_CI_START="-0.5970961907677446" LOG_EFFECT_SIZE="-0.09286094333881736" NO="1" P_CHI2="1.0" P_Z="0.718136244605468" STUDIES="1" TAU2="0.0" TOTAL_1="129" TOTAL_2="125" WEIGHT="1.0360610162756227" Z="0.36095077732571734">
<NAME>Non Vertebral Primary</NAME>
<DICH_DATA CI_END="2.578542560375559" CI_START="0.2528737850773441" EFFECT_SIZE="0.8074935400516796" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4113743040901099" LOG_CI_START="-0.5970961907677446" LOG_EFFECT_SIZE="-0.09286094333881736" ORDER="17218" O_E="0.0" SE="0.5923805606889633" STUDY_ID="STD-Hooper-2005" TOTAL_1="129" TOTAL_2="125" VAR="0.35091472868217055" WEIGHT="1.0360610162756227"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.7780298699560815" CI_END="0.9004866979096673" CI_START="0.7166886400262826" DF="3" EFFECT_SIZE="0.8033483596091034" ESTIMABLE="YES" EVENTS_1="659" EVENTS_2="467" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="-0.0455226982437799" LOG_CI_START="-0.14466947932144608" LOG_EFFECT_SIZE="-0.09509608878261301" NO="2" P_CHI2="0.4271294627988085" P_Z="1.700646697771504E-4" STUDIES="4" TAU2="0.0" TOTAL_1="7602" TOTAL_2="4541" WEIGHT="98.96393898372439" Z="3.7597773131644314">
<NAME>Non vertebral secondary</NAME>
<DICH_DATA CI_END="1.3402867496400903" CI_START="0.2237227395824054" EFFECT_SIZE="0.5475880052151239" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.1271977240839463" LOG_CI_START="-0.6502898711861073" LOG_EFFECT_SIZE="-0.2615460735510805" ORDER="17219" O_E="0.0" SE="0.4567000620872959" STUDY_ID="STD-Fogelman-2000" TOTAL_1="177" TOTAL_2="180" VAR="0.20857494671053992" WEIGHT="2.191424392208806"/>
<DICH_DATA CI_END="0.969853786915257" CI_START="0.41424408622686504" EFFECT_SIZE="0.6338424060713951" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="52" LOG_CI_END="-0.013293734107128948" LOG_CI_START="-0.3827436828781426" LOG_EFFECT_SIZE="-0.19801870849263578" ORDER="17220" O_E="0.0" SE="0.21701672871483446" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.047096260542088056" WEIGHT="8.845370090350372"/>
<DICH_DATA CI_END="0.9520829124189253" CI_START="0.7411107243933358" EFFECT_SIZE="0.8399993195862164" ESTIMABLE="YES" EVENTS_1="583" EVENTS_2="351" LOG_CI_END="-0.02132522930662471" LOG_CI_START="-0.13011690214121027" LOG_EFFECT_SIZE="-0.0757210657239175" ORDER="17221" O_E="0.0" SE="0.06390476715050133" STUDY_ID="STD-McClung-2001" TOTAL_1="6197" TOTAL_2="3134" VAR="0.004083819264559795" WEIGHT="79.25716103550991"/>
<DICH_DATA CI_END="1.0571908864410204" CI_START="0.4713149749816441" EFFECT_SIZE="0.7058823529411765" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="51" LOG_CI_END="0.024153410621765823" LOG_CI_START="-0.32668876128306396" LOG_EFFECT_SIZE="-0.15126767533064908" ORDER="17222" O_E="0.0" SE="0.20608642847365705" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.042471616001027765" WEIGHT="8.669983465655308"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Risedronate 5 mg vs Control - all years baseline denominators</NAME>
<DICH_OUTCOME CHI2="0.1028029764801344" CI_END="0.9394309133706242" CI_START="0.5870279671469282" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7426117554623947" ESTIMABLE="YES" EVENTS_1="158" EVENTS_2="121" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-0.027135152812144403" LOG_CI_START="-0.23134120763100227" LOG_EFFECT_SIZE="-0.12923818022157338" METHOD="MH" NO="1" P_CHI2="0.9498972242650917" P_Q="0.0" P_Z="0.013106993726979882" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="7462" TOTAL_2="4397" WEIGHT="100.00000000000001" Z="2.480848855206313">
<NAME>Hip Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Hip primary</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17223" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.1028029764801344" CI_END="0.9394309133706242" CI_START="0.5870279671469282" DF="2" EFFECT_SIZE="0.7426117554623947" ESTIMABLE="YES" EVENTS_1="158" EVENTS_2="121" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="-0.027135152812144403" LOG_CI_START="-0.23134120763100227" LOG_EFFECT_SIZE="-0.12923818022157338" NO="2" P_CHI2="0.9498972242650917" P_Z="0.013106993726979882" STUDIES="3" TAU2="0.0" TOTAL_1="7425" TOTAL_2="4361" WEIGHT="100.00000000000001" Z="2.480848855206313">
<NAME>Hip secondary</NAME>
<DICH_DATA CI_END="1.6964460312296366" CI_START="0.376340810992225" EFFECT_SIZE="0.7990255785627284" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="15" LOG_CI_END="0.22954004805895553" LOG_CI_START="-0.42441868354651646" LOG_EFFECT_SIZE="-0.09743931774378049" ORDER="17224" O_E="0.0" SE="0.38413859609298373" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.14756246100828851" WEIGHT="9.86185428271224"/>
<DICH_DATA CI_END="0.9441010864115394" CI_START="0.5633916659160395" EFFECT_SIZE="0.7293138445597616" ESTIMABLE="YES" EVENTS_1="137" EVENTS_2="95" LOG_CI_END="-0.024981502608336217" LOG_CI_START="-0.24918958169076075" LOG_EFFECT_SIZE="-0.13708554214954846" ORDER="17225" O_E="0.0" SE="0.131700935500907" STUDY_ID="STD-McClung-2001" TOTAL_1="6197" TOTAL_2="3134" VAR="0.01734513641181407" WEIGHT="82.91052364431827"/>
<DICH_DATA CI_END="1.9532360916190699" CI_START="0.34272430786818564" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.29075474051797856" LOG_CI_START="-0.4650550919557789" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="17226" O_E="0.0" SE="0.44396643691409504" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.19710619710619712" WEIGHT="7.227622072969495"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Risedronate 5 mg vs Control - all years baseline denominators</NAME>
<DICH_OUTCOME CHI2="0.06089897878350427" CI_END="1.0712901084125166" CI_START="0.4240583907090902" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6740100587943614" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="43" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.029907094941666983" LOG_CI_START="-0.37257433912239696" LOG_EFFECT_SIZE="-0.171333622090365" METHOD="MH" NO="1" P_CHI2="0.8050806714282971" P_Q="0.0" P_Z="0.09517946599294441" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1265" TOTAL_2="1263" WEIGHT="100.0" Z="1.6686868025045865">
<NAME>Wrist Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Wrist primary</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17227" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.06089897878350427" CI_END="1.0712901084125166" CI_START="0.4240583907090902" DF="1" EFFECT_SIZE="0.6740100587943614" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="43" I2="0.0" ID="CMP-004.01.02" LOG_CI_END="0.029907094941666983" LOG_CI_START="-0.37257433912239696" LOG_EFFECT_SIZE="-0.171333622090365" NO="2" P_CHI2="0.8050806714282971" P_Z="0.09517946599294441" STUDIES="2" TAU2="0.0" TOTAL_1="1228" TOTAL_2="1227" WEIGHT="100.0" Z="1.6686868025045865">
<NAME>Wrist secondary</NAME>
<DICH_DATA CI_END="1.2334907057845854" CI_START="0.32750370598008016" EFFECT_SIZE="0.6355885284021703" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.09113588147741665" LOG_CI_START="-0.48478378123680127" LOG_EFFECT_SIZE="-0.19682394987969232" ORDER="17228" O_E="0.0" SE="0.33829806072664" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.1144455778914054" WEIGHT="51.17801232556493"/>
<DICH_DATA CI_END="1.3657656303903942" CI_START="0.37356635009684275" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="21" LOG_CI_END="0.13537617946189343" LOG_CI_START="-0.4276322508183694" LOG_EFFECT_SIZE="-0.146128035678238" ORDER="17229" O_E="0.0" SE="0.3307139388833034" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.10937170937170936" WEIGHT="48.82198767443508"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Risedronate 5 mg vs Control - 1 year baseline denominators</NAME>
<DICH_OUTCOME CHI2="0.07048858971655528" CI_END="0.5895914352405329" CI_START="0.2741883051286981" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4020684970835172" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="87" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-0.22944883392578924" LOG_CI_START="-0.5619510729833711" LOG_EFFECT_SIZE="-0.39569995345458014" METHOD="MH" NO="1" P_CHI2="0.7906267236058326" P_Q="0.0" P_Z="3.0865148193411168E-6" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1339" TOTAL_2="1335" WEIGHT="100.0" Z="4.664977051903965">
<NAME>Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Vertebral primary</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17230" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.07048858971655528" CI_END="0.5895914352405329" CI_START="0.2741883051286981" DF="1" EFFECT_SIZE="0.4020684970835172" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="87" I2="0.0" ID="CMP-005.01.02" LOG_CI_END="-0.22944883392578924" LOG_CI_START="-0.5619510729833711" LOG_EFFECT_SIZE="-0.39569995345458014" NO="2" P_CHI2="0.7906267236058326" P_Z="3.0865148193411168E-6" STUDIES="2" TAU2="0.0" TOTAL_1="1228" TOTAL_2="1227" WEIGHT="100.0" Z="4.664977051903965">
<NAME>Vertebral secondary</NAME>
<DICH_DATA CI_END="0.6712046791043955" CI_START="0.21568890202719465" EFFECT_SIZE="0.38048837074415637" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="42" LOG_CI_END="-0.17314502461359915" LOG_CI_START="-0.6661722003418004" LOG_EFFECT_SIZE="-0.41965861247769976" ORDER="17231" O_E="0.0" SE="0.28960660354662554" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.08387198481781233" WEIGHT="48.291074091968994"/>
<DICH_DATA CI_END="0.7090077482496722" CI_START="0.2514381618231547" EFFECT_SIZE="0.4222222222222222" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="45" LOG_CI_END="-0.14934901869043138" LOG_CI_START="-0.599568806954598" LOG_EFFECT_SIZE="-0.3744589128225147" ORDER="17232" O_E="0.0" SE="0.26446133225026625" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.06993979625558572" WEIGHT="51.708925908031006"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Hip primary</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17233" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.01.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Wrist primary</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17234" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Risedronate 5 mg vs Control - 2 years baseline denominators</NAME>
<DICH_OUTCOME CHI2="1.6835845609523787" CI_END="1.0156355226265124" CI_START="0.4157151401976118" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6497807812473029" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="46" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.006737882247847899" LOG_CI_START="-0.3812041583551248" LOG_EFFECT_SIZE="-0.18723313805363845" METHOD="MH" NO="1" P_CHI2="0.6405895497199379" P_Q="0.0" P_Z="0.05850675577370092" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="723" TOTAL_2="718" WEIGHT="400.0" Z="1.8918816157546152">
<NAME>Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.689867730082893E-32" CI_END="2.247455639476776" CI_START="0.41778176187845545" DF="0" EFFECT_SIZE="0.9689922480620153" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" I2="100.0" ID="CMP-006.01.01" LOG_CI_END="0.35169112833826666" LOG_CI_START="-0.37905052292065194" LOG_EFFECT_SIZE="-0.013679697291192623" NO="1" P_CHI2="0.0" P_Z="0.9415019839023121" STUDIES="2" TAU2="0.0" TOTAL_1="166" TOTAL_2="161" WEIGHT="100.0" Z="0.07338219728944306">
<NAME>Vertebral primary</NAME>
<DICH_DATA CI_END="2.247455639476776" CI_START="0.4177817618784555" EFFECT_SIZE="0.9689922480620154" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" LOG_CI_END="0.35169112833826666" LOG_CI_START="-0.3790505229206519" LOG_EFFECT_SIZE="-0.013679697291192575" ORDER="17235" O_E="0.0" SE="0.42924126317900035" STUDY_ID="STD-Hooper-2005" TOTAL_1="129" TOTAL_2="125" VAR="0.18424806201550387" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17236" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0804185112454712" CI_START="0.21197692711296298" DF="0" EFFECT_SIZE="0.4785643070787637" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" I2="0.0" ID="CMP-006.01.02" LOG_CI_END="0.03359201652142064" LOG_CI_START="-0.6737114078110825" LOG_EFFECT_SIZE="-0.32005969564483094" NO="2" P_CHI2="1.0" P_Z="0.0760971414756301" STUDIES="1" TAU2="0.0" TOTAL_1="177" TOTAL_2="180" WEIGHT="100.0" Z="1.7737945407481126">
<NAME>Vertebral secondary</NAME>
<DICH_DATA CI_END="1.0804185112454712" CI_START="0.21197692711296298" EFFECT_SIZE="0.4785643070787637" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.03359201652142064" LOG_CI_START="-0.6737114078110825" LOG_EFFECT_SIZE="-0.32005969564483094" ORDER="17237" O_E="0.0" SE="0.4154735326613295" STUDY_ID="STD-Fogelman-2000" TOTAL_1="177" TOTAL_2="180" VAR="0.17261825634208486" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.578542560375559" CI_START="0.2528737850773441" DF="0" EFFECT_SIZE="0.8074935400516796" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" I2="0.0" ID="CMP-006.01.03" LOG_CI_END="0.4113743040901099" LOG_CI_START="-0.5970961907677446" LOG_EFFECT_SIZE="-0.09286094333881736" NO="3" P_CHI2="1.0" P_Z="0.718136244605468" STUDIES="1" TAU2="0.0" TOTAL_1="129" TOTAL_2="125" WEIGHT="100.0" Z="0.36095077732571734">
<NAME>Non vertebral primary</NAME>
<DICH_DATA CI_END="2.578542560375559" CI_START="0.2528737850773441" EFFECT_SIZE="0.8074935400516796" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4113743040901099" LOG_CI_START="-0.5970961907677446" LOG_EFFECT_SIZE="-0.09286094333881736" ORDER="17238" O_E="0.0" SE="0.5923805606889633" STUDY_ID="STD-Hooper-2005" TOTAL_1="129" TOTAL_2="125" VAR="0.35091472868217055" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3402867496400903" CI_START="0.2237227395824054" DF="0" EFFECT_SIZE="0.5475880052151239" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" I2="0.0" ID="CMP-006.01.04" LOG_CI_END="0.1271977240839463" LOG_CI_START="-0.6502898711861073" LOG_EFFECT_SIZE="-0.2615460735510805" NO="4" P_CHI2="1.0" P_Z="0.187282815129388" STUDIES="1" TAU2="0.0" TOTAL_1="177" TOTAL_2="180" WEIGHT="100.0" Z="1.3186599698222257">
<NAME>Non vertebral secondary</NAME>
<DICH_DATA CI_END="1.3402867496400903" CI_START="0.2237227395824054" EFFECT_SIZE="0.5475880052151239" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.1271977240839463" LOG_CI_START="-0.6502898711861073" LOG_EFFECT_SIZE="-0.2615460735510805" ORDER="17239" O_E="0.0" SE="0.4567000620872959" STUDY_ID="STD-Fogelman-2000" TOTAL_1="177" TOTAL_2="180" VAR="0.20857494671053992" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.01.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Hip primary</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17240" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.01.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Wrist secondary</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17241" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>Risedronate 5 mg vs Control - 2 years baseline denominators</NAME>
<DICH_OUTCOME CHI2="1.6835845609523785" CI_END="1.0156355226265126" CI_START="0.4157151401976117" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6497807812473029" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="46" I2="0.0" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="0.0067378822478479945" LOG_CI_START="-0.3812041583551249" LOG_EFFECT_SIZE="-0.18723313805363845" METHOD="MH" NO="1" P_CHI2="0.6405895497199379" P_Q="0.0" P_Z="0.05850675577370099" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="723" TOTAL_2="718" WEIGHT="200.0" Z="1.8918816157546148">
<NAME>Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3972191376581966" CI_END="1.180231939739514" CI_START="0.3724034450132129" DF="1" EFFECT_SIZE="0.6629648861543285" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="27" I2="28.42926545680974" ID="CMP-007.01.01" LOG_CI_END="0.07196736345069174" LOG_CI_START="-0.4289863101200501" LOG_EFFECT_SIZE="-0.17850947333467918" NO="1" P_CHI2="0.23718994628946544" P_Z="0.16246640532925968" STUDIES="3" TAU2="0.0" TOTAL_1="343" TOTAL_2="341" WEIGHT="100.0" Z="1.3968243256560424">
<NAME>Vertebral</NAME>
<DICH_DATA CI_END="1.0804185112454712" CI_START="0.21197692711296298" EFFECT_SIZE="0.4785643070787637" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.03359201652142064" LOG_CI_START="-0.6737114078110825" LOG_EFFECT_SIZE="-0.32005969564483094" ORDER="17242" O_E="0.0" SE="0.4154735326613295" STUDY_ID="STD-Fogelman-2000" TOTAL_1="177" TOTAL_2="180" VAR="0.17261825634208486" WEIGHT="62.400066622251835"/>
<DICH_DATA CI_END="2.247455639476776" CI_START="0.4177817618784555" EFFECT_SIZE="0.9689922480620154" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" LOG_CI_END="0.35169112833826666" LOG_CI_START="-0.3790505229206519" LOG_EFFECT_SIZE="-0.013679697291192575" ORDER="17243" O_E="0.0" SE="0.42924126317900035" STUDY_ID="STD-Hooper-2005" TOTAL_1="129" TOTAL_2="125" VAR="0.18424806201550387" WEIGHT="37.599933377748165"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17244" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.26971332300523587" CI_END="1.278251528213826" CI_START="0.3115092674462379" DF="1" EFFECT_SIZE="0.6310207581101616" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="19" I2="0.0" ID="CMP-007.01.02" LOG_CI_END="0.10661632061972466" LOG_CI_START="-0.5065290284883023" LOG_EFFECT_SIZE="-0.19995635393428882" NO="2" P_CHI2="0.603524193228825" P_Z="0.20112598641560642" STUDIES="2" TAU2="0.0" TOTAL_1="306" TOTAL_2="305" WEIGHT="100.0" Z="1.2783502403183098">
<NAME>Non vertebral</NAME>
<DICH_DATA CI_END="1.3402867496400903" CI_START="0.2237227395824054" EFFECT_SIZE="0.5475880052151239" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.1271977240839463" LOG_CI_START="-0.6502898711861073" LOG_EFFECT_SIZE="-0.2615460735510805" ORDER="17245" O_E="0.0" SE="0.4567000620872959" STUDY_ID="STD-Fogelman-2000" TOTAL_1="177" TOTAL_2="180" VAR="0.20857494671053992" WEIGHT="67.8988164113145"/>
<DICH_DATA CI_END="2.578542560375559" CI_START="0.2528737850773441" EFFECT_SIZE="0.8074935400516796" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4113743040901099" LOG_CI_START="-0.5970961907677446" LOG_EFFECT_SIZE="-0.09286094333881736" ORDER="17246" O_E="0.0" SE="0.5923805606889633" STUDY_ID="STD-Hooper-2005" TOTAL_1="129" TOTAL_2="125" VAR="0.35091472868217055" WEIGHT="32.10118358868551"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Hip</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17247" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.01.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Wrist</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="17248" O_E="0.0" SE="0.0" STUDY_ID="STD-Mortensen-1998" TOTAL_1="37" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" NO="8">
<NAME>Risedronate 5 mg vs Control - 3 years baseline denominators</NAME>
<DICH_OUTCOME CHI2="6.994467244183123" CI_END="0.8296728678012808" CI_START="0.6908223590173496" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7570710453763044" ESTIMABLE="YES" EVENTS_1="953" EVENTS_2="800" I2="0.0" I2_Q="0.0" ID="CMP-008.01" LOG_CI_END="-0.08109311209843766" LOG_CI_START="-0.16063361458936226" LOG_EFFECT_SIZE="-0.12086336334389995" METHOD="MH" NO="1" P_CHI2="0.6376955576278803" P_Q="0.0" P_Z="2.578422898526958E-9" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="17306" TOTAL_2="11176" WEIGHT="400.0" Z="5.9564079125965">
<NAME>Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.18263614789061375" CI_END="0.7792178922744316" CI_START="0.5028683623754804" DF="1" EFFECT_SIZE="0.6259744606784824" ESTIMABLE="YES" EVENTS_1="114" EVENTS_2="182" I2="0.0" ID="CMP-008.01.01" LOG_CI_END="-0.10834108381573324" LOG_CI_START="-0.2985456868645833" LOG_EFFECT_SIZE="-0.2034433853401583" NO="1" P_CHI2="0.6691175026859284" P_Z="2.755735089540128E-5" STUDIES="2" TAU2="0.0" TOTAL_1="1228" TOTAL_2="1227" WEIGHT="100.0" Z="4.192766124142704">
<NAME>Vertebral secondary</NAME>
<DICH_DATA CI_END="0.8914924508178039" CI_START="0.4814126450782892" EFFECT_SIZE="0.6551150576925595" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="93" LOG_CI_END="-0.049882330090479765" LOG_CI_START="-0.3174825064673046" LOG_EFFECT_SIZE="-0.1836824182788922" ORDER="17249" O_E="0.0" SE="0.15718966824598352" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.024708591803282356" WEIGHT="51.11412361299392"/>
<DICH_DATA CI_END="0.8127982686091101" CI_START="0.436303760402502" EFFECT_SIZE="0.5955056179775281" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="89" LOG_CI_END="-0.09001723017618743" LOG_CI_START="-0.36021104391206005" LOG_EFFECT_SIZE="-0.22511413704412372" ORDER="17250" O_E="0.0" SE="0.15871318366940015" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.025189874670476748" WEIGHT="48.88587638700607"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.047808420695852" CI_END="0.90785424374855" CI_START="0.7211594546119601" DF="2" EFFECT_SIZE="0.8091400813758133" ESTIMABLE="YES" EVENTS_1="652" EVENTS_2="454" I2="2.334613932274306" ID="CMP-008.01.02" LOG_CI_END="-0.041983871982156314" LOG_CI_START="-0.1419686983851375" LOG_EFFECT_SIZE="-0.09197628518364691" NO="2" P_CHI2="0.35918998445947914" P_Z="3.1101148841285994E-4" STUDIES="3" TAU2="0.0" TOTAL_1="7425" TOTAL_2="4361" WEIGHT="100.0" Z="3.6059512803506353">
<NAME>Non vertebral secondary</NAME>
<DICH_DATA CI_END="0.969853786915257" CI_START="0.41424408622686504" EFFECT_SIZE="0.6338424060713951" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="52" LOG_CI_END="-0.013293734107128948" LOG_CI_START="-0.3827436828781426" LOG_EFFECT_SIZE="-0.19801870849263578" ORDER="17251" O_E="0.0" SE="0.21701672871483446" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.047096260542088056" WEIGHT="9.140374338403186"/>
<DICH_DATA CI_END="0.9520829124189253" CI_START="0.7411107243933358" EFFECT_SIZE="0.8399993195862164" ESTIMABLE="YES" EVENTS_1="583" EVENTS_2="351" LOG_CI_END="-0.02132522930662471" LOG_CI_START="-0.13011690214121027" LOG_EFFECT_SIZE="-0.0757210657239175" ORDER="17252" O_E="0.0" SE="0.06390476715050133" STUDY_ID="STD-McClung-2001" TOTAL_1="6197" TOTAL_2="3134" VAR="0.004083819264559795" WEIGHT="81.90048731301509"/>
<DICH_DATA CI_END="1.0571908864410204" CI_START="0.4713149749816441" EFFECT_SIZE="0.7058823529411765" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="51" LOG_CI_END="0.024153410621765823" LOG_CI_START="-0.32668876128306396" LOG_EFFECT_SIZE="-0.15126767533064908" ORDER="17253" O_E="0.0" SE="0.20608642847365705" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.042471616001027765" WEIGHT="8.959138348581714"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.10280297648013441" CI_END="0.9394309133706241" CI_START="0.5870279671469282" DF="2" EFFECT_SIZE="0.7426117554623947" ESTIMABLE="YES" EVENTS_1="158" EVENTS_2="121" I2="0.0" ID="CMP-008.01.03" LOG_CI_END="-0.027135152812144455" LOG_CI_START="-0.23134120763100227" LOG_EFFECT_SIZE="-0.12923818022157338" NO="3" P_CHI2="0.9498972242650917" P_Z="0.013106993726979882" STUDIES="3" TAU2="0.0" TOTAL_1="7425" TOTAL_2="4361" WEIGHT="100.00000000000001" Z="2.480848855206313">
<NAME>Hip secondary</NAME>
<DICH_DATA CI_END="1.6964460312296366" CI_START="0.376340810992225" EFFECT_SIZE="0.7990255785627284" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="15" LOG_CI_END="0.22954004805895553" LOG_CI_START="-0.42441868354651646" LOG_EFFECT_SIZE="-0.09743931774378049" ORDER="17254" O_E="0.0" SE="0.38413859609298373" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.14756246100828851" WEIGHT="9.86185428271224"/>
<DICH_DATA CI_END="0.9441010864115394" CI_START="0.5633916659160395" EFFECT_SIZE="0.7293138445597616" ESTIMABLE="YES" EVENTS_1="137" EVENTS_2="95" LOG_CI_END="-0.024981502608336217" LOG_CI_START="-0.24918958169076075" LOG_EFFECT_SIZE="-0.13708554214954846" ORDER="17255" O_E="0.0" SE="0.131700935500907" STUDY_ID="STD-McClung-2001" TOTAL_1="6197" TOTAL_2="3134" VAR="0.01734513641181407" WEIGHT="82.91052364431827"/>
<DICH_DATA CI_END="1.9532360916190699" CI_START="0.34272430786818564" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.29075474051797856" LOG_CI_START="-0.4650550919557789" LOG_EFFECT_SIZE="-0.08715017571890014" ORDER="17256" O_E="0.0" SE="0.44396643691409504" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.19710619710619712" WEIGHT="7.227622072969495"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.06089897878350427" CI_END="1.0712901084125166" CI_START="0.4240583907090902" DF="1" EFFECT_SIZE="0.6740100587943614" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="43" I2="0.0" ID="CMP-008.01.04" LOG_CI_END="0.029907094941666983" LOG_CI_START="-0.37257433912239696" LOG_EFFECT_SIZE="-0.171333622090365" NO="4" P_CHI2="0.8050806714282971" P_Z="0.09517946599294441" STUDIES="2" TAU2="0.0" TOTAL_1="1228" TOTAL_2="1227" WEIGHT="100.0" Z="1.6686868025045865">
<NAME>Wrist secondary</NAME>
<DICH_DATA CI_END="1.2334907057845854" CI_START="0.32750370598008016" EFFECT_SIZE="0.6355885284021703" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.09113588147741665" LOG_CI_START="-0.48478378123680127" LOG_EFFECT_SIZE="-0.19682394987969232" ORDER="17257" O_E="0.0" SE="0.33829806072664" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.1144455778914054" WEIGHT="51.17801232556493"/>
<DICH_DATA CI_END="1.3657656303903942" CI_START="0.37356635009684275" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="21" LOG_CI_END="0.13537617946189343" LOG_CI_START="-0.4276322508183694" LOG_EFFECT_SIZE="-0.146128035678238" ORDER="17258" O_E="0.0" SE="0.3307139388833034" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.10937170937170936" WEIGHT="48.82198767443508"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" NO="9">
<NAME>Risedronate 2.5 mg vs Control - 1 year baseline denominators</NAME>
<DICH_OUTCOME CHI2="0.008560999324761839" CI_END="0.7628231551792917" CI_START="0.38298810691269786" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.540511050868794" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="87" I2="0.0" I2_Q="0.0" ID="CMP-009.01" LOG_CI_END="-0.1175761325977586" LOG_CI_START="-0.4168147121472632" LOG_EFFECT_SIZE="-0.2671954223725109" METHOD="MH" NO="1" P_CHI2="0.926280398645517" P_Q="0.0" P_Z="4.649562274143675E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="1225" TOTAL_2="1227" WEIGHT="100.00000000000001" Z="3.500173042342971">
<NAME>Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.008560999324761839" CI_END="0.7628231551792917" CI_START="0.38298810691269786" DF="1" EFFECT_SIZE="0.540511050868794" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="87" I2="0.0" ID="CMP-009.01.01" LOG_CI_END="-0.1175761325977586" LOG_CI_START="-0.4168147121472632" LOG_EFFECT_SIZE="-0.2671954223725109" NO="1" P_CHI2="0.926280398645517" P_Z="4.649562274143675E-4" STUDIES="2" TAU2="0.0" TOTAL_1="1225" TOTAL_2="1227" WEIGHT="100.00000000000001" Z="3.500173042342971">
<NAME>Vertebral</NAME>
<DICH_DATA CI_END="0.9053675054220707" CI_START="0.33366893854253665" EFFECT_SIZE="0.5496298886751763" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="42" LOG_CI_END="-0.04317509684003147" LOG_CI_START="-0.4766842202179814" LOG_EFFECT_SIZE="-0.2599296585290064" ORDER="17259" O_E="0.0" SE="0.25464540497697724" STUDY_ID="STD-Harris-1999" TOTAL_1="817" TOTAL_2="820" VAR="0.06484428227588873" WEIGHT="48.19944354850802"/>
<DICH_DATA CI_END="0.8563585772246387" CI_START="0.3305295529289854" EFFECT_SIZE="0.5320261437908497" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="45" LOG_CI_END="-0.06734434805420537" LOG_CI_START="-0.4807897038025898" LOG_EFFECT_SIZE="-0.27406702592839755" ORDER="17260" O_E="0.0" SE="0.2428598485541189" STUDY_ID="STD-Reginster-2000" TOTAL_1="408" TOTAL_2="407" VAR="0.058980906039729566" WEIGHT="51.80055645149199"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2008-08-13 12:58:14 -0400" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Risedronate 2.5 mg vs Control - 2 years baseline denominators</NAME>
<DICH_OUTCOME CHI2="1.6132234474252003" CI_END="1.1990854329616194" CI_START="0.46647669110271356" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7478939798643929" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="46" I2="0.0" I2_Q="0.0" ID="CMP-010.01" LOG_CI_END="0.07885012700377356" LOG_CI_START="-0.33117005219267437" LOG_EFFECT_SIZE="-0.12615996259445042" METHOD="MH" MODIFIED="2008-08-13 12:58:14 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6563952778141617" P_Q="0.0" P_Z="0.22776708355229291" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="470" TOTAL_2="610" WEIGHT="200.0" Z="1.206130798053099">
<NAME>Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.30219867777311793" CI_END="1.6246302550958331" CI_START="0.5165090621756616" DF="1" EFFECT_SIZE="0.9160438032330958" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="27" I2="0.0" ID="CMP-010.01.01" LOG_CI_END="0.21075453673460615" LOG_CI_START="-0.2869220543605115" LOG_EFFECT_SIZE="-0.03808375881295268" NO="1" P_CHI2="0.5825074128875999" P_Z="0.7642038032162235" STUDIES="2" TAU2="0.0" TOTAL_1="235" TOTAL_2="305" WEIGHT="100.0" Z="0.2999650656867289">
<NAME>Vertebral</NAME>
<DICH_DATA CI_END="1.755595537933585" CI_START="0.3503927907656723" EFFECT_SIZE="0.7843137254901961" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.24442446836040174" LOG_CI_START="-0.45544483790034973" LOG_EFFECT_SIZE="-0.10551018476997398" ORDER="17261" O_E="0.0" SE="0.41110669490650464" STUDY_ID="STD-Fogelman-2000" TOTAL_1="108" TOTAL_2="180" VAR="0.1690087145969499" WEIGHT="55.84912219711455"/>
<DICH_DATA CI_END="2.4582033889671147" CI_START="0.47684819313190285" EFFECT_SIZE="1.0826771653543308" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.3906178130711048" LOG_CI_START="-0.3216198586504556" LOG_EFFECT_SIZE="0.03449897721032462" ORDER="17262" O_E="0.0" SE="0.4183719340025803" STUDY_ID="STD-Hooper-2005" TOTAL_1="127" TOTAL_2="125" VAR="0.17503507516105943" WEIGHT="44.150877802885454"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.002132675422964123" CI_END="1.1861555924638902" CI_START="0.2149146885991069" DF="1" EFFECT_SIZE="0.504898266767144" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" I2="0.0" ID="CMP-010.01.02" LOG_CI_END="0.07414166079586718" LOG_CI_START="-0.6677339011230852" LOG_EFFECT_SIZE="-0.296796120163609" NO="2" P_CHI2="0.9631660778659127" P_Z="0.11683127050807647" STUDIES="2" TAU2="0.0" TOTAL_1="235" TOTAL_2="305" WEIGHT="100.0" Z="1.5682136900890282">
<NAME>Non vertebral</NAME>
<DICH_DATA CI_END="1.5328624251267933" CI_START="0.17156456708614304" EFFECT_SIZE="0.5128205128205128" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="0.1855031785403484" LOG_CI_START="-0.7655724012653846" LOG_EFFECT_SIZE="-0.29003461136251807" ORDER="17263" O_E="0.0" SE="0.5586665034779356" STUDY_ID="STD-Fogelman-2000" TOTAL_1="108" TOTAL_2="180" VAR="0.31210826210826215" WEIGHT="61.71816126601357"/>
<DICH_DATA CI_END="1.9245765978586813" CI_START="0.12583961825444176" EFFECT_SIZE="0.4921259842519685" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28433520062954487" LOG_CI_START="-0.9001826078533082" LOG_EFFECT_SIZE="-0.30792370361188165" ORDER="17264" O_E="0.0" SE="0.6957916241605445" STUDY_ID="STD-Hooper-2005" TOTAL_1="127" TOTAL_2="125" VAR="0.4841259842519685" WEIGHT="38.28183873398644"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" NO="11">
<NAME>Risedronate 2.5 mg vs Control - 2 years baseline denominators</NAME>
<DICH_OUTCOME CHI2="1.6132234474252" CI_END="1.1990854329616192" CI_START="0.46647669110271345" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7478939798643928" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="46" I2="0.0" I2_Q="0.0" ID="CMP-011.01" LOG_CI_END="0.07885012700377347" LOG_CI_START="-0.3311700521926745" LOG_EFFECT_SIZE="-0.12615996259445048" METHOD="MH" NO="1" P_CHI2="0.6563952778141618" P_Q="0.0" P_Z="0.2277670835522927" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="470" TOTAL_2="610" WEIGHT="400.0" Z="1.2061307980530995">
<NAME>Fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.4582033889671147" CI_START="0.47684819313190285" DF="0" EFFECT_SIZE="1.0826771653543308" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" I2="0.0" ID="CMP-011.01.01" LOG_CI_END="0.3906178130711048" LOG_CI_START="-0.3216198586504556" LOG_EFFECT_SIZE="0.03449897721032462" NO="1" P_CHI2="1.0" P_Z="0.8494099683793702" STUDIES="1" TAU2="0.0" TOTAL_1="127" TOTAL_2="125" WEIGHT="100.0" Z="0.18987131829819362">
<NAME>Vertebral primary</NAME>
<DICH_DATA CI_END="2.4582033889671147" CI_START="0.47684819313190285" EFFECT_SIZE="1.0826771653543308" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.3906178130711048" LOG_CI_START="-0.3216198586504556" LOG_EFFECT_SIZE="0.03449897721032462" ORDER="17265" O_E="0.0" SE="0.4183719340025803" STUDY_ID="STD-Hooper-2005" TOTAL_1="127" TOTAL_2="125" VAR="0.17503507516105943" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.755595537933585" CI_START="0.3503927907656723" DF="0" EFFECT_SIZE="0.7843137254901961" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" I2="0.0" ID="CMP-011.01.02" LOG_CI_END="0.24442446836040174" LOG_CI_START="-0.45544483790034973" LOG_EFFECT_SIZE="-0.10551018476997398" NO="2" P_CHI2="1.0" P_Z="0.5545495624414409" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="180" WEIGHT="100.0" Z="0.5909565123127979">
<NAME>Vertebral secondary</NAME>
<DICH_DATA CI_END="1.755595537933585" CI_START="0.3503927907656723" EFFECT_SIZE="0.7843137254901961" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.24442446836040174" LOG_CI_START="-0.45544483790034973" LOG_EFFECT_SIZE="-0.10551018476997398" ORDER="17266" O_E="0.0" SE="0.41110669490650464" STUDY_ID="STD-Fogelman-2000" TOTAL_1="108" TOTAL_2="180" VAR="0.1690087145969499" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9245765978586813" CI_START="0.12583961825444176" DF="0" EFFECT_SIZE="0.4921259842519685" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" I2="0.0" ID="CMP-011.01.03" LOG_CI_END="0.28433520062954487" LOG_CI_START="-0.9001826078533082" LOG_EFFECT_SIZE="-0.30792370361188165" NO="3" P_CHI2="1.0" P_Z="0.30819693217121524" STUDIES="1" TAU2="0.0" TOTAL_1="127" TOTAL_2="125" WEIGHT="99.99999999999999" Z="1.019012740447474">
<NAME>Non vertebral primary</NAME>
<DICH_DATA CI_END="1.9245765978586813" CI_START="0.12583961825444176" EFFECT_SIZE="0.4921259842519685" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28433520062954487" LOG_CI_START="-0.9001826078533082" LOG_EFFECT_SIZE="-0.30792370361188165" ORDER="17267" O_E="0.0" SE="0.6957916241605445" STUDY_ID="STD-Hooper-2005" TOTAL_1="127" TOTAL_2="125" VAR="0.4841259842519685" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5328624251267933" CI_START="0.17156456708614304" DF="0" EFFECT_SIZE="0.5128205128205128" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-011.01.04" LOG_CI_END="0.1855031785403484" LOG_CI_START="-0.7655724012653846" LOG_EFFECT_SIZE="-0.29003461136251807" NO="4" P_CHI2="1.0" P_Z="0.23193120270891687" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="180" WEIGHT="100.00000000000001" Z="1.1953989874426603">
<NAME>Non vertebral secondary</NAME>
<DICH_DATA CI_END="1.5328624251267933" CI_START="0.17156456708614304" EFFECT_SIZE="0.5128205128205128" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="0.1855031785403484" LOG_CI_START="-0.7655724012653846" LOG_EFFECT_SIZE="-0.29003461136251807" ORDER="17268" O_E="0.0" SE="0.5586665034779356" STUDY_ID="STD-Fogelman-2000" TOTAL_1="108" TOTAL_2="180" VAR="0.31210826210826215" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" NO="12">
<NAME>Risedronate 2.5 mg vs Control - all years baseline denominators</NAME>
<DICH_OUTCOME CHI2="2.724166795025012" CI_END="0.8295078898243402" CI_START="0.4612952924271661" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6185855515667663" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="114" I2="0.0" I2_Q="0.0" ID="CMP-012.01" LOG_CI_END="-0.08117947884892905" LOG_CI_START="-0.3360209773954986" LOG_EFFECT_SIZE="-0.20860022812221382" METHOD="MH" NO="1" P_CHI2="0.43613608439071994" P_Q="0.0" P_Z="0.0013335846154462058" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1460" TOTAL_2="1532" WEIGHT="99.99999999999999" Z="3.2086527242867056">
<NAME>Vertebral fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.4582033889671147" CI_START="0.47684819313190285" DF="0" EFFECT_SIZE="1.0826771653543308" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" I2="0.0" ID="CMP-012.01.01" LOG_CI_END="0.3906178130711048" LOG_CI_START="-0.3216198586504556" LOG_EFFECT_SIZE="0.03449897721032462" NO="1" P_CHI2="1.0" P_Z="0.8494099683793702" STUDIES="1" TAU2="0.0" TOTAL_1="127" TOTAL_2="125" WEIGHT="9.17911345451302" Z="0.18987131829819362">
<NAME>Primary prevention</NAME>
<DICH_DATA CI_END="2.4582033889671147" CI_START="0.47684819313190285" EFFECT_SIZE="1.0826771653543308" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.3906178130711048" LOG_CI_START="-0.3216198586504556" LOG_EFFECT_SIZE="0.03449897721032462" ORDER="17269" O_E="0.0" SE="0.4183719340025803" STUDY_ID="STD-Hooper-2005" TOTAL_1="127" TOTAL_2="125" VAR="0.17503507516105943" WEIGHT="9.17911345451302"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7031692423475198" CI_END="0.7842094388351296" CI_START="0.4167492618184986" DF="2" EFFECT_SIZE="0.5716805967895353" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="104" I2="0.0" ID="CMP-012.01.02" LOG_CI_END="-0.1055679347859487" LOG_CI_START="-0.3801251607583533" LOG_EFFECT_SIZE="-0.24284654777215103" NO="2" P_CHI2="0.7035724072687557" P_Z="5.259377872558681E-4" STUDIES="3" TAU2="0.0" TOTAL_1="1333" TOTAL_2="1407" WEIGHT="90.82088654548697" Z="3.4671860171776427">
<NAME>Secondary prevention</NAME>
<DICH_DATA CI_END="1.755595537933585" CI_START="0.3503927907656723" EFFECT_SIZE="0.7843137254901961" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.24442446836040174" LOG_CI_START="-0.45544483790034973" LOG_EFFECT_SIZE="-0.10551018476997398" ORDER="17270" O_E="0.0" SE="0.41110669490650464" STUDY_ID="STD-Fogelman-2000" TOTAL_1="108" TOTAL_2="180" VAR="0.1690087145969499" WEIGHT="11.611217137539503"/>
<DICH_DATA CI_END="0.9053675054220707" CI_START="0.33366893854253665" EFFECT_SIZE="0.5496298886751763" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="42" LOG_CI_END="-0.04317509684003147" LOG_CI_START="-0.4766842202179814" LOG_EFFECT_SIZE="-0.2599296585290064" ORDER="17271" O_E="0.0" SE="0.25464540497697724" STUDY_ID="STD-Harris-1999" TOTAL_1="817" TOTAL_2="820" VAR="0.06484428227588873" WEIGHT="38.17861989124347"/>
<DICH_DATA CI_END="0.8563585772246387" CI_START="0.3305295529289854" EFFECT_SIZE="0.5320261437908497" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="45" LOG_CI_END="-0.06734434805420537" LOG_CI_START="-0.4807897038025898" LOG_EFFECT_SIZE="-0.27406702592839755" ORDER="17272" O_E="0.0" SE="0.2428598485541189" STUDY_ID="STD-Reginster-2000" TOTAL_1="408" TOTAL_2="407" VAR="0.058980906039729566" WEIGHT="41.03104951670401"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.002132675422964123" CI_END="1.1861555924638902" CI_START="0.2149146885991069" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.504898266767144" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-012.02" LOG_CI_END="0.07414166079586718" LOG_CI_START="-0.6677339011230852" LOG_EFFECT_SIZE="-0.296796120163609" METHOD="MH" NO="2" P_CHI2="0.9631660778659127" P_Q="0.0" P_Z="0.11683127050807647" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="235" TOTAL_2="305" WEIGHT="100.0" Z="1.5682136900890282">
<NAME>Non-vertebral fractures</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9245765978586813" CI_START="0.12583961825444176" DF="0" EFFECT_SIZE="0.4921259842519685" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" I2="0.0" ID="CMP-012.02.01" LOG_CI_END="0.28433520062954487" LOG_CI_START="-0.9001826078533082" LOG_EFFECT_SIZE="-0.30792370361188165" NO="1" P_CHI2="1.0" P_Z="0.30819693217121524" STUDIES="1" TAU2="0.0" TOTAL_1="127" TOTAL_2="125" WEIGHT="38.28183873398644" Z="1.019012740447474">
<NAME>Primary prevention</NAME>
<DICH_DATA CI_END="1.9245765978586813" CI_START="0.12583961825444176" EFFECT_SIZE="0.4921259842519685" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.28433520062954487" LOG_CI_START="-0.9001826078533082" LOG_EFFECT_SIZE="-0.30792370361188165" ORDER="17273" O_E="0.0" SE="0.6957916241605445" STUDY_ID="STD-Hooper-2005" TOTAL_1="127" TOTAL_2="125" VAR="0.4841259842519685" WEIGHT="38.28183873398644"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5328624251267933" CI_START="0.17156456708614304" DF="0" EFFECT_SIZE="0.5128205128205128" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-012.02.02" LOG_CI_END="0.1855031785403484" LOG_CI_START="-0.7655724012653846" LOG_EFFECT_SIZE="-0.29003461136251807" NO="2" P_CHI2="1.0" P_Z="0.23193120270891687" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="180" WEIGHT="61.71816126601357" Z="1.1953989874426603">
<NAME>Secondary prevention</NAME>
<DICH_DATA CI_END="1.5328624251267933" CI_START="0.17156456708614304" EFFECT_SIZE="0.5128205128205128" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="0.1855031785403484" LOG_CI_START="-0.7655724012653846" LOG_EFFECT_SIZE="-0.29003461136251807" ORDER="17274" O_E="0.0" SE="0.5586665034779356" STUDY_ID="STD-Fogelman-2000" TOTAL_1="108" TOTAL_2="180" VAR="0.31210826210826215" WEIGHT="61.71816126601357"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" NO="13">
<NAME>Risedronate 5 mg vs Control - all years baseline denominators</NAME>
<DICH_OUTCOME CHI2="4.314305919145262" CI_END="1.0482641476583416" CI_START="0.8762838776885319" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9584242130455153" ESTIMABLE="YES" EVENTS_1="777" EVENTS_2="803" I2="7.285202418087486" I2_Q="0.0" ID="CMP-013.01" LOG_CI_END="0.020470732471730032" LOG_CI_START="-0.05735517860156967" LOG_EFFECT_SIZE="-0.018442223064919844" METHOD="MH" NO="1" P_CHI2="0.3651372020114574" P_Q="0.0" P_Z="0.3529429404237381" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4638" TOTAL_2="4566" WEIGHT="100.0" Z="0.9288961093703845">
<NAME>Withdrawals due to side effects</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1607971182169186" CI_START="0.3241367330267473" EFFECT_SIZE="0.6133979015334947" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="14" LOG_CI_END="0.06475632125596836" LOG_CI_START="-0.4892717494465126" LOG_EFFECT_SIZE="-0.21225771409527214" ORDER="17275" O_E="0.0" SE="0.32543883121381745" STUDY_ID="STD-Fogelman-2000" TOTAL_1="177" TOTAL_2="80" VAR="0.10591043286181555" WEIGHT="2.3932133759220364"/>
<DICH_DATA CI_END="1.258003263372136" CI_START="0.8164695244247968" EFFECT_SIZE="1.0134699433975782" ESTIMABLE="YES" EVENTS_1="138" EVENTS_2="136" LOG_CI_END="0.09968176770914904" LOG_CI_START="-0.08806002111855928" LOG_EFFECT_SIZE="0.005810873295294896" ORDER="17276" O_E="0.0" SE="0.11028045609423873" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.012161778996353316" WEIGHT="16.888330803920663"/>
<DICH_DATA CI_END="2.268387912183566" CI_START="0.31691251290383415" EFFECT_SIZE="0.8478682170542635" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.35571732434577086" LOG_CI_START="-0.49906061288352943" LOG_EFFECT_SIZE="-0.07167164426887933" ORDER="17277" O_E="0.0" SE="0.5021007915475205" STUDY_ID="STD-Hooper-2005" TOTAL_1="129" TOTAL_2="125" VAR="0.2521052048726467" WEIGHT="1.0084612692728232"/>
<DICH_DATA CI_END="1.0951984709181009" CI_START="0.8851745142758708" EFFECT_SIZE="0.9846023433501498" ESTIMABLE="YES" EVENTS_1="550" EVENTS_2="564" LOG_CI_END="0.039492828777965394" LOG_CI_START="-0.052971098663321343" LOG_EFFECT_SIZE="-0.006739134942677967" ORDER="17278" O_E="0.0" SE="0.05431376868283445" STUDY_ID="STD-McClung-2001" TOTAL_1="3104" TOTAL_2="3134" VAR="0.0029499854685324477" WEIGHT="69.65762916618532"/>
<DICH_DATA CI_END="1.0490565097665079" CI_START="0.5766498429522938" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="81" LOG_CI_END="0.020798883063676665" LOG_CI_START="-0.23908782191381275" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="17279" O_E="0.0" SE="0.1526587369637147" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.023304689971356637" WEIGHT="10.05236538469916"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.298869426341842" CI_END="1.0033074156828925" CI_START="0.9112489252128445" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9561709074214256" ESTIMABLE="YES" EVENTS_1="2764" EVENTS_2="1766" I2="20.620675528055493" I2_Q="0.0" ID="CMP-013.02" LOG_CI_END="0.0014340222317044374" LOG_CI_START="-0.04036297090925689" LOG_EFFECT_SIZE="-0.0194644743387762" METHOD="MH" NO="2" P_CHI2="0.27821424131182926" P_Q="0.0" P_Z="0.06792948395572986" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="7775" TOTAL_2="4711" WEIGHT="100.0" Z="1.8254743135873328">
<NAME>Withdrawals overall</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1320622536124625" CI_START="0.6244475012349047" EFFECT_SIZE="1.1538461538461537" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.32879988140784244" LOG_CI_START="-0.20450406791015363" LOG_EFFECT_SIZE="0.062147906748844434" ORDER="17280" O_E="0.0" SE="0.31326537972651575" STUDY_ID="STD-Clemmesen-1997" TOTAL_1="44" TOTAL_2="44" VAR="0.09813519813519811" WEIGHT="0.6085422895676977"/>
<DICH_DATA CI_END="1.56174787248936" CI_START="0.6984756967804779" EFFECT_SIZE="1.0444342647732479" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="37" LOG_CI_END="0.19361092299535376" LOG_CI_START="-0.15584870041272456" LOG_EFFECT_SIZE="0.018881111291314614" ORDER="17281" O_E="0.0" SE="0.20527431264293977" STUDY_ID="STD-Fogelman-2000" TOTAL_1="177" TOTAL_2="180" VAR="0.042137543431031384" WEIGHT="1.7174503143196949"/>
<DICH_DATA CI_END="1.002618553113022" CI_START="0.8010845815794931" EFFECT_SIZE="0.8962043651446818" ESTIMABLE="YES" EVENTS_1="332" EVENTS_2="370" LOG_CI_END="0.0011357368220742416" LOG_CI_START="-0.09632162701943987" LOG_EFFECT_SIZE="-0.04759294509868279" ORDER="17282" O_E="0.0" SE="0.0572469379422368" STUDY_ID="STD-Harris-1999" TOTAL_1="821" TOTAL_2="820" VAR="0.003277211903762311" WEIGHT="17.33060435025355"/>
<DICH_DATA CI_END="1.2087659881331465" CI_START="0.48993476156445803" EFFECT_SIZE="0.7695560253699789" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="33" LOG_CI_END="0.08234223146506484" LOG_CI_START="-0.3098617456425759" LOG_EFFECT_SIZE="-0.11375975708875555" ORDER="17283" O_E="0.0" SE="0.230382557594026" STUDY_ID="STD-Hooper-2005" TOTAL_1="129" TOTAL_2="126" VAR="0.05307612284356471" WEIGHT="1.562934857731336"/>
<DICH_DATA CI_END="1.044275725443482" CI_START="0.9307479555213273" EFFECT_SIZE="0.9858790475799106" ESTIMABLE="YES" EVENTS_1="2197" EVENTS_2="1127" LOG_CI_END="0.018815182793307073" LOG_CI_START="-0.03116790907871449" LOG_EFFECT_SIZE="-0.006176363142703729" ORDER="17284" O_E="0.0" SE="0.029360315585920557" STUDY_ID="STD-McClung-2001" TOTAL_1="6197" TOTAL_2="3134" VAR="8.620281313048495E-4" WEIGHT="70.07363235277451"/>
<DICH_DATA CI_END="0.9866820212802802" CI_START="0.7129286921475775" EFFECT_SIZE="0.8387096774193549" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="186" LOG_CI_END="-0.005822785175510412" LOG_CI_START="-0.14695390655139895" LOG_EFFECT_SIZE="-0.07638834586345469" ORDER="17285" O_E="0.0" SE="0.08290111930651481" STUDY_ID="STD-Reginster-2000" TOTAL_1="407" TOTAL_2="407" VAR="0.006872595582273003" WEIGHT="8.706835835353214"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-01" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Models for fracture risk in postmenopausal women: FRACTURE Index</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAnEAAAJYCAIAAACCTCeRAAAhFUlEQVR42u3d25ajOrIFUH/6/nN6nNPd1S4jhUIXbC5zPtTIyjQYBI6FAKPXBgCs8NIEACBTAUCmAoBMBQBk6pO269+OfiMNDlesDM3P7/wH/P1dnlArVMPbfmyOi71DZw6cpz4kP+C117xP/pBaoRre/ANzxN4sRMExd2+m6qdyw0z9OA+zP4osft72kyTnsH+xDQTnzNTM53f/WY7PIdf+FLxXXD2+c0lLptLRTy3+nPll5gNZewuxCmfO1GaJaMZq/HZx0ci/4/nPJCtwMrWRqR9zG8vUk38M4GklonjOKf/57fpcN+MwOWeZysUyNT79IlPhsSVi8nMdn6/qytSTn/5V4HxgGmdl42NMmQoyNageca0Y7qeet3ntYbf/zGTOnxRvz2vGsEwFmRp8/TR5o8ZYpuqn8u2PTeamu8xdf7WDyt45nPyGPXhUZWj+6VWxpe8Yqn3wm18x2HLfRJCp/ODDoykAZCprYlU7AMhU9FYBZCoAyFQAQKYCgEwFAJkKAMhUAJCpACBTAUCmAgAyFQBkKgDIVACQqQCATAUAmQoAMhUAkKkAIFMBQKYCgEwFAGQqAMhUAJCp/3kPADgH/VQA0E8FAJkKAMhUAJCpACBTAUCmAgAyFQBkKgDIVABApgKATAUAmQoAMhUAkKkAIFMBQKYCgEwFAGQqAMhUAJCpv1zi12tsqn9r/nds/vNLSG1j8dsNsd8uNo2PGDfJ1Jn94GPC4n/z87c7HtQUH0Vc855ns9oc99uytql+6nZopubnb1+UqTfedgJVpiJTxzN1/3PtrFfxv/EuW3zlx9nm5nnp4s9Bx3psJvt57ucTvyBYho9fZmbiA3/o5yjegeOPADKVp2fqvjNa7JsWIyTfnd1PXntxc7bBL7tCPTmT/Tzja2nHrZ1P+6/SNNiHbReZikwdzNTgvTKniJOnkSdTJ7MAXW9X/O9HlPYuSXJFgsDm+x+fZs21dWQqMrUapZlzwl1Fv9brbS7PCTN1YCaZrm1XN5fv91NlqkxFph6VqfOR1rxwdb9MbZ5DVrVPm6y2jkxFpg5OnomNIEjiipPMv3ymJr9HOzyTmcOLZHffJ/z8n6bk5Q9kKpfP1GQvZzhTa7fjFq8sNm92zdwqGd8SvI/e5JwHZhLfptv8OViGoBlXbVa+8EFz3++Nty/P7ac+oaPwkJX1kQZkKgJVpgLI1DOlyzPPvXhmLCBTAQCZCgAyFQBkKgDIVOAJn/zR8cZ9b/U2O4BGkKnAIfV0bNhgj+m4xxEVMhX4caDKVP1UZCqopCPnb2sTqtEyFZkKz62kY+ONN4ejV6NlKjIVnltJu8Zxy49CiEyVqYBM/czL5njym4dNylRkKqikS/qpCrRMRaaCStodjcGEqrNMRabCc4vp2HMbahNq0hvsA8hUAJCpACBTAQCZCgAyFQBkKgDIVOCOH/i/7X/fO+Gfv2rbK+4GmkKmAuOVtPjf3ocr7f+rOl90N7DhZCpwYGHNPPlh/1+l+R6HWchUQKYiU2UqcPFMDYZiRabKVOCJlTSfqcNJjECVqcBzM7V4a2ht5FS3KclUZCoopuP9VNVZoCJTQTGNvl2aHEJVgb7HPmDDyVRgfQclc/5Wpt5mB3DGXqYCgEwFAJkKAMhUAJCpACBTAUCmAgAyFch/4FtjkgdPShobzJwz7waaQqYC45W09t+upz3kBzPn5LuBrSZTgV8WVkPT3PgwC5kKLMjU/JlAmSpQkalAu55miqxMvc0OYJPJVODYDsrYhVWZqquKTAWVtPqn5pjkHy9TnWUqMhVU0vF+qtIsU5GpoIwKVGw7mQocUEaTJ29rE2rSy+0ATtfLVACQqQAgUwEAmQoAMhUAZCoAyFTgMZ/5ygOSml+uCF7jWxkX3RM0gkwF1pTRrmFQg9f4puN1D620g0wFTpSp//5Zdb7ibmCryVRgfT1NDi9TLMSqs0xFpoKS2u6D5idUna+49W01mQqcpZ9q8NSrH07ZajIVWF9Sa798v42leA31g+a9xA5gq8lU4NuZ2tW/UZqvvjMgUwGZikyVqcBPK6lnPmCryVQAkKkAIFMBAJkKADIVAGQqAMhUAECmAoBMBb73aU9/xz9+LoRnBdxgT7ApZSqwppjmo9cwJg8/ukKmAlPJ2nwmMAIVmQpkk7U4xqpThXfa7jalTAV+01vVy9FhRaYCI2la7KeqxWIVmQr0pemWuC9JIZapyFRQQF+9L5OpdglkKrCmzu5rriosUJGpwF/f9I+/9b//k5tF77cbaAqZCgAyFQBkKgAgUwFApgKATAUAmQoAyFQAkKkAIFMBAJkKADIVAGQqAMhUAECmAoBMBQCZCgAyFQCQqQAgUwFApgIAMhUAZCoAyNTZxf2v+QmHZ/W1Nf3yhCdcl/PsP8ctSbxPLl/gjxme/FPAEz6VMvUUO8FYrF5lrxoucyesj+dZpI8gOVtF2+/ekzt88q3V1mcGqu0uU2fj8EKZqp96wmOyoxvkJ5mqsOqnIlMPydTgnFjydFl+ktrP+2XbnwksTl6sks0TicW3qK1RZgGClim+UWb+8YuD1qu9OHPStWsx9jMfWLxm1K2tgB9rOtzOyFQenam1qlrLpOQv47I4MJ99bsXxWZxzXLKDFgi6TcVJBtala/5xHy65FfI/x1m4avvmF+mI8rfvBw+0MzKVm2Tq8LXGzHyatTIou2sztdmrCF4T9D/eu5XJJj16XTI5Gix8cqOvnfnMfpKfz3G1L+5A97YzMhWZ2u6gDFzWiif5TqY2876rfznQdzwiU+Pub3PJu2Ye9yx7T3LMZPP3M7WrnZGpXD5TF968MxAVl8jU5ot7c+Wcmdq7XvOZ2uzpDuyl589UJVimcttMnbm6szxT405SPvnGTiPPxFLmWKH3UCDuNS7M1IXXU2vtMLwiMwcEX74dt/feYyVYpnK3TG3eXpSZtvab4I7Q5qwy4V27WbSZzXH65m9XDv7avJO5eJmtq2e2duGbW6G5wMmW6ZrzzG3JcSsd91Ea2+u4QaDarDLVAaC1vsCKq1MgUxEt1lqmAjL1TLX1gadTnETaWt9qBWQqACBTAUCmAoBMBU7/aU9/gac5n+Ic5i8qJyd33XrJnqAZZSowW0znI6r55KnJWG0urTBYtQ9oSZkKrO+qLk/lJQ/lzjzQCpkqU4Ff1tPMOIDzPd3MI5G7hu/dz3k/hM7w47qeczpUpspUYHE9HR72dSBTu8bK7eqn1p6huHyoBpmKTAVS9XRsuKSZTJ3J72RvW6bKVJkKfK+ebuHgMyfP1Hiwga4hp542+rpMlanAIZm6/X0BcmGmzg8hvPWc+5WpMlWmAr/P1HzO5W9cmulBBt3ogRnGw8jvf5apyFQgW0yb36XJ3G1bm+3YsKzNqYJZZQb3Ta61PQGZCpygiPzz+trPIFOBR8Tq0f+CTAX0VvVQkakAgEwFAJkKADIVAGQqACBTAUCmAoBMBQBkKgDIVACQqQAgUwEAmQoAMhUAZCoAyFQAQKYCgEwFAJkKAMhUAJCp2+u/5iccntUlWun7c1g1yZKNe6ddF5Cph0fFkgp+pwL3Z13mC/fAHL4zSXPFf3UI8s2tA8jUU3TFHpKpV++nXqJT/tutA8jUHwdqM1OLp+Zq5+vef//xmuJ/iz/Xei37PzUXbP/f5FT5ZYibaKufyA16ZrV3iV9QnP/7MtQ2TbPp8hsrWK/gKsPH0vZuFECmHhKow5laK23Fmh6fVIwniX+Zr8jFhcy8S3OqZtrtq3zcRM1DluS7xAcKwYbo2qbNXwYbK1ivzMuCn11zBZl6ma5q8txv8vrcZMkOZt6svwPBsD+kGFuG5Jsmt9fYivQm99jhUTBVrcfZO9vejQLI1MtkanBeLp7hfAR+LVPzbdhM5a6eaNApPzRT4wWeydTk6ZCufB3esQGZeq5MHStzj8rUrjfNJ+5xmZpv9oWZOnPuV6aCTL1zpibzL1+RJ8+7Zpa2K/8WZmrtbqD5TM1fT13bdMHGWnI9tdaqMhVk6vdyND6rlpm29pvila3mDSPxLcH7bOi6Ryl/d/FWudm1eY/r2DIU76JqnvsN7r+N7x3L3Pe7JW64bTZdfmNlWi/eCslVAGTqk5pP+dO8ADJVxdfCADL1FLXeOTqNDCBTAUCmAoBMBQCZyq7JEk9C31wO5Nx7r73UnqARZOpJ98XkExLghDuw/fOxh1baQaae9OBOpnLRfdjOaTdApk4dmmXGGOkaHXPzBFcuW08zDwJzflimIlNTx+YDz4Vv5qgTa1zl49B1FcOeLFORqR0H6cGDf8fmY6/lciXVeK4yFZnasQ9lhv/M72oylftlau2Do8VkKjJ1a0bd8EA3MpWHZKqdWaYiU1OZ2jVCdT6k7VXcIFNdT5WpyNTGPlQb2DJ/o2PtT837geGEn4Xmn9z0+7QdAJmaW89/Xvuf/2+fKv3+42cAkKmFWA3+/ROx+38BQKY2eqv/OQPyz9vJLr1VAGQqAMhUAJCpAIBMBQCZCvR/2tNfrW7OpziH+W89Jif3xcole4JmlKnAbDGdj6jmgIaTsdpcWmGwah/QkjIVWN9VXZ7KY8U6mc2SQKbKVOAs9TSIruZZwa4BbYLZvj8fNIj/eM77YemKjwitPW2x9rNMRaYCHfW0OapEVx+xmXzFKG0+oL/5+9pzicdW8yEBI1NlKnBgPc1n6ljQrs3vZG9bpspUmQp8r55u4YBuJ8/UeBioZHzu/5WpyFRgMFO3vy9ALszUZl9wvp868y4yVabKVGB9puZzLn/j0kwPMuhGD8wwyNSPa7HP3AdkqkwFxotp87s0mbtta7MdG+q8OVUwq+JbJ4dVf3K0eOaDTAXOWkQqwyMe8TPIVOARsXr0vyBTAb1VPVRkKgAgUwFApgKATAUAmQoAyFQAkKkAIFMBAJkKADIVAGQqAMhUAECmAoBMBQCZCgAyFQCQqQAgUwFApgIAMhUAZOp/F/r1Gpjkw51WObk6+5cVW+PnrXTQ+07O9qJ7TrwW91gpzvMp43XRojC/D91ml0o2SDE7mz9faPseOtvztM/yYqq2PjNQbXeZ+r/P/5JMvVmsTr7sveNy1yNomXq/dUE/VaaeKFP39aV2+Pb+p/jsWe3n5qyas93P4X3azLFnMlPj+dTeK98O8RzyG6X416Ap4tlmfnObYhQcQuXbAZnKtTN1si8VZ2rz4L34gvwvMx2FOEHj12cap+tPzWOLsXZozqE5/6DpmgEcTBgsz/0qUe3YNNMyyFTukKnzJ6yulanFnujwO8Z/6vr9fDuMzWFgSZp98WLPOLnutyypmZZBpnKTTJ28cXcyU4tH98MJ93HOtjnVMzN1C09oz2RqbQdr/ub2mZppGWQql8/U+b0hc6br/Jm61S8ijmXqzOu/kKkzS9KVqb07yXMyVQmWqcjU9lTJL5bEx+xxWW/e9JTpD2Uuaw1nanyvSrMFkpmavCS8f/HAWvdmau/11OdkquupMpUnZmr+ayTNU8eZs8pdj03IJ9zA7cGZm4fj5Sw2yKr7fmvt0LzVeeu8CTm58Jm7tZs3u97sO80DDcXtdwCemKlPPrj7eZX3OQSQqTeJE5kKIFMvn6bnOVXyw+fxOmUEIFMBQKYCgEwFAJkK3PHT3hrUgUftCTa6TAVmi2nylzxhH7DpZSqwvquqZWQqMhUYqafxszCdFZSpyFSgo57ODHCETEWmAu0BDFRbmYpMBbrr6RYOPqPaylRkKtCRqVtl8D7VVqYiU4HuTNVPlanIVGCkmDa/S+O+3yfvCchUAJCpACBTAQCZCgAyFQBkKgDIVABApgKATAUAmQoAMhUAkKkAIFMBQKYCADIVAGQqAMhUAJCpAIBMBQCZCgAyFQBkKgAgUwFApvYt7puZmdjwJ2yHseWZ3x+ettHfm0vr+fjz9Ey1My1Z97NV0rHleZ9EjRjb/7XbYw+ttMPTM3VhoD52fzpzCMlU+wD6qTL128dWk7tCMVP//PKj3BTf7v338Zm02s/xegU/v/9mv8z7+eRfUFydfMsn3zqeZ9yMwczViJnTFc1t7fywTOWemTq/N2QqeOZYvjaf5C8HZtW8DFYsgvsZDixkfhWCRe1ajPx6KRBrz9YUdzwtLFO5eaZuE/ez5FMzWcEXZmp+/sX/fizwwoXsXYVmOwe/7Fov1WHtJyjT2shUZGojKQfKdJBbv8rU4eDfWpeZm7dbx53mfKZmzujK1EMztblxkanI1EYtlqlBpg70Ymf6qVvPuWjV4QuZqpFlKjfP1PkTv12ZOtM5a34RMD9VPlOb536Ds6wDmdp1QXT+l2rBdzLV9VSZys0zNXluMDntayfzds2Qrt3guiXOrAZTZb6qX7uDd//z1rrLqbaEmYbKLEZ+qi1xZ7LqsOSj1NwuPGEH4In9VAd6VgdApkogqwMgU3mLnzudNnEWCECmAoBMBQCZCgDIVACQqcCST/vQ97C5655go8tUYLaYJn/JE/YBm16mAuu7qlpGpiJTgZF6Gj8s2llBmYpMBTrq6eRIushUZCqop+Oj7CFTkanAVquhwYBuqq1MRaYCHZm6/X3XkmorU5GpwHim6qfKVGQqMFJMm9+lcd/vk/cEZCoAyFQAkKkAgEwFAJkKADIVAGQqACBTAUCmAoBMBQCZCgDIVACQqQAgUwEAmQoAMhUAZCoAyFQAQKYCgEwFAJkKADIVAJCpACBTRxb6/w1M8u4+m/BtXb6/XndqSS0GPC5Th0vSx4T3KG3vxwffP1a42dHJz/cKcQsy9TJFZz/tbWJVP1WmAjJ1pOIM942KU30EUm3m73/6eFnxv0E3LnjB/l1qk9RytPiy2nrV2rP4FsXf1I5UJtsq2NC11f9YnngrBA3SXPHmfJozibe4WAWZ+r1MLRamJZna7O3Vomv5rIL5dL1dvBi1Qp950+bZ5pm2io9s4hfHmR289VgDdm3EYthnFgmQqQf2U2+fqb01fSxTmx3cff+p2Dc9oq0yG7f24kwPfmAfS06Vub7Q9WJApt4zU+PO4nymbqVTwXHmNd+udnp2ONq/01bBxo1XP3+E0dUmwXYMzoonN+tvL4cDMnVZpvZ2So7O1OZ8et/uZpmaefHYydvJyVd1T2UqyNSrZmqyFhe7JskqH98ctO1uUWnOZyDCe/tkA9dT41t4Btrq0EzNXE/NnOIeu5665a65KkwgU78Uq2OnyzLPfMjceJm5WXQLb4utvSA5n1dFMIdmS8Z3+myd9/1OtlXyVtvi1qytVP722rH7foOZJ5eweQAEyNQ7ttfrZYHv2lYAMlVICFQAmXqpcLrWebkfLrBnFwAyFQCQqQAgUwFAppJo3PSj28+whL9djPNcgs1/O+v869JcPBe/VSdk6mV22eGH2X7ng3GSYnqqpwhNtsklHjR4y4GEueJnX6Zyugo7OdtTZeoNjt8vl6kKq+qETB0/Lls7qGd+pMzm85tqbzGzIltrhNQtfMBeMDJo/Jj45EioxZZJNvKWGKe2NnnzBcVlbj4bMv8Eq1PV0/lBZJGpPLSfunZQz+HhTmsnYeLhVppvmhlbtJj0ycUYGBggs0Zb+HTG5ICpQTz0LnPtmKCWuCe8Rp7/LGRazPP9ZSoydX2mbomrUAPjjM7kVlf0bj3jrR40KGzv8GrbxBjsyQqyZNSgiw6D2hy9zgP9ZSoytfvwfGYAsubT/Jdn6pYYjLM5tOqjMjV51j3ZeW324G+Qqc1dDpmKTD0kU7tq66pMzfSWjsjULTFIy9kydaDfv/UPW3v7TFWCZSoyNdqTlgzquep66lhfML5BJpmpXZdOm5/AYDizS2Tq8FDwF61NvccTSrBMRaam9qSxQT2DqbrG7MyPhLq1RtzMD62aGZa1tgqZwUcH7vvNNOlAC/cOmptc/Xg43vNXq7EG4WZdC5tVpk6s5z9vNeKf1/73X/756scikw8bApCpl4/VP4H6239lKoBMvfJ6vl56qGvaMH3KyPklQKYCADIVAGQqAMhUAECmwqM+7bkvPWfmU5zD/F1pycnd+LZkT9CMMhWYLabzEdV8HOOhY9AKg4X7gJaUqcD6ruryVB4r1slslgQyVaYCZ6mn8XOVm6O4D/wyOfb7Pv6bD74OBrQvzmfgAaIyFZkKbHEaJX85n6nz49U35zw8IMQDA0amylTgwHo6NkruTKbO5Heyty1TZapMBb5XT7dwQLeTZ2o8HFAyPvf/ylRkKjCYqVt9jNvJTM2PUrytOPcrU2WqTAV+n6n5nMvfuDTTgwy60QMzDDJ1P5ywTEWmAh3FtPldmszdtrXZzo/9HvShi7MqvnVyWPUnR4tnPshU4KxFxFCJIFOBtbF69L8gUwG9VT1UZCoAIFMBQKYCgEwFAJkKAMhUAJCpACBTAQCZCgAyFQBkKgDIVABApgKATAUAmQoAMhUAkKkAIFMBQKYCADIVAGTq9nqz//0R7/XoneOmLZBZrzOs+78X4LWTWcg/fwom//MWwHP7qfsq8Kd2fOG9bhyfJ2yB4949M+f5d//Iv1XTNme7j95VSwXcPFMPLQoy9a4t8J1MHZ5bvJP/+W+xn5rpjIpVkKnlglI7G1b8fa2UxIkSnGqOz8UVz7bV5lP76/v61hbsoyk+pgp+v9VPpwersF+woMrXZl5ctWAJMy3c3C7FxmxulGYbZhYm2EbJMzHFn4vxKVNBpi7rpxYrdRyTtTgpFqli0Uy+e1dvI7PAxagIlqG4UnHANBsz2VbNFm5O3ly7ge2VX9/8ysarn98x9mndTFCZCjJ1ZaAGAZMpc5mOVGZWycBOviB+61rHpfn6ruLebMxkW+VbOF6vZNdtOMwy2bwNXfVsHmfkT/x27fAyFWTqeKbWKldXxc8nSlcntasb0VWXk5F/RKbO9NTzHeL89k0ubfzifBvmXxb3lZs7QzNKM3uXTAWZ2pGpXYU1uJQY91rinlPygll84jffKazNuTd0kwcNyUxtXk4ePhQILtM22zmzuYN3mTnfu7W+pfOdTE0uDHDnTE3e8dt19i8fqFvujGtv2c2cvh4I1K3nTObWc6p5oB88MP+uvnUm8scub+fP6jdPTTc3etc2TR4uNL/GLVDhoZka37ibOdlV68Nlujv7Xkum35O5mTZ+TTxJ8ixfXIibzw1o3sc7dudz8zaiTH40z0kUG61ro2TacOu5FzqOsWLrFWdeO94q3hif6dYDz+qnZsqBGsHldtpf7cA+LCBTG+cqlQmutd/+Kud8UkCm/qcWJL+EAOffb3+Sdj4pIFMBQKYCgEwFAGTqlbeKa8MAMpUgJrteI1O/3BQaH5CpMlXTXeldAJl66mq7Hy8sfs5OZszL5nArmUcyJQco/ZhJc4i3zECeQSslh/9sLsmWfkrRwICjW/0RQs0doHaA0lzZ5Mi7+WYHZOoluy/JZ/X1js/1kShbOLT18AClQSd17L2SrdQck653nLt4cPUtN/rpln6SXy2Ae5d/YFfJNDsgUy8ZqFv/sF+9mZrJj7EBSoOlHX6vTCt1xUw+XJP5NxZvvTtA8pH3A7tT5on8gEy9ZKDOdLZ6a3pmdK2uwdTyRwC9A3nOd9OD5/Xnx6DtWp18puZXLflGvZmaWWtApl6yk5oJxfyApl19oMkBSrsydXhEuXzfdGudK37/U37UsPzopwOZGl/zTm53mQrI1NSJ2Uw3K3OpL/PXrgFKi8G/TZ/VTLbSlh4jNpPlXYHa2ylPDkCbX9/gyujYuK0A187U2h2nC2/63XLXI7sGKM1fcRx7r0wrZWbe7GQHC5PvUwbv2DXWabC++e1ebMnkYLHCFbhypv7zuujPiu9xJy0AZOpUrF7xXwQqIFP1Vhf8zNpA9dQFQKYCgEwFAGQqAMhUAJCpACBTAQCZCgAyFQBkKgDIVABApgKATAUAmQoAyFQAkKkAIFMBQKYCADIVAGQqAMhUAJCpAMCDMvX1t1XTBjN8/9Nr5zurvLDF5he72UrFdvvhArNqd7IhbrYn+HA9PVP3QTgzh2Ks1va8hcswsN/PvNd+8ng+zb/WXrD//XcWmJmd6uipOH8ttVkf3U9dVa9r6dj85arkmMmYQ1us+bKjM9VH/bTJaovIVGTq4Zka//KjoxmfIP145X4+tWmHO6AfM4n/O5yp+4XMFPTMJs40S9BWzZWVrDJVpiJT2yU4iIpi5e3N1DjwPmYbvHX+rwMtNvB2caYWr4PGmb2kx5xvouAA5ZklRqbKVJtVpo7vBEGXKyjQM/3UIM5XhdxBmdr7Cezqp67N1PyGqK3mA2+Jcu5XptqsMvXamdqsa/lMHaiJA5lajJkfZmrtTO+STNU3jZta8ZWpyNSRTN3q52a3njtx8vVo4NzvQFN84dzvl/upM53sx6aF79IgU2XqUUUhqPXJGMgkZT6zi9cd9zcrbcdfTx243JjP1J9fT83vCchUmcrjMjX/LZHaZbPgDOfYMx8yd58Gr9lKd9MM35G71W9qjc+m1m44ys9n31bJ+34zlzbzj+/It/zt68urIj+hinmzPUFTPD1T0dcBkKkgUwGZCosC1ekmQKYCADIVAGQqAMhUAJCpwAOrwGE3jrkx7bRb3HaRqcBR5fWIuPW8nvMfQtkuMhX4Xj91Vc1Vuy+36ZGpwMrCmhz1Xe2WqchUoK+fOnPOUO2WqTIVkKkLMlXhFqgyFbhnGe0d1CifqcHIRVpepspUQD91tp+qcAtUmQoor//70/u/XRU5OQQ9v9ritotMBRaX1+BW3pn7fntHPufLW9x2kakAIFMBQKYCADIVAGQqAMhUAJCpwPNKwJHfqWjO3Jc67rfRZSrw3Npa/Dn+5aqZb545cMqNjkwFVpba5TX30JmzdrsgU4H15fXo8VOdgRSoMhV4aD/1uPFTFfefbG7NLlOBr3ZZvjZ+qvquqypTgUv2TvJDnH5t/FTFXabKVODmhfVr46cq7jJVpgL3qarB9dSjx09V2WWqTAXuUFLjpy4sHz91yV3ErNroWkOmAoBMBQCZCgDIVACQqQAgUwFApgIAMhU4qEwYWvymm1UjyFTgZ5XX0OI3O07SDjIV+FlPxdDid9ruNpxMBX7ZTTG0uExFpgKzaZrpkqrRFwpU20umAsvq6UHTKtMX2gFsLJkKHN5PNbT47be++7RlKvDVZB0LSzX6on1WZCrwpapqaHGZikwFlvVoDS0uU5GpACBTAUCmAoBMBQBkKgDIVACQqQCATAUAmQoAMhUAZCoAIFMBQKYCgEwFAJkKAMhUAJCpACBTAQCZCgAyFQBkKgDI1In3AIA5MhUA9FMBAJkKADIVAGQqAMhUTQAAMhUAZCoAyFQAQKYCwIH+BbvmsRUi71isAAAAAElFTkSuQmCC</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-02" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Five year risk of fracture by Quintiles of the FRACTURE Index: Assessment with bone mineral density</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-03" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Five year risk of fracture by Quintiles of the FRACTURE Index: Assessment without bone mineral density</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-04" NO="4" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Estimated five year age-specific risks of first and subsequent osteoporotic fractures (from Doherty et al 2001)</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-05" NO="5" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Summary of literature search for risedronate</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-06" NO="6" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Weighted relative risk of fracture after risedronate (5mg)</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-07" NO="7" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Five year FRACTURE Index specific risk of fracture after risedronate (5mg)</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-08" NO="8" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Five year age-specific risk of first and subsequent fracture after risedronate (5 mg)</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-09" NO="9" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Weighted relative risk (RR) of fracture after risedronate (5 mg): Person years</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-10" NO="10" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Weighted relative risk of fracture after risedronate (5 mg) by years of treatment</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqIAAAIBCAIAAAAd60rkAAA6aUlEQVR42u3dO3qdsPr24T3BzMOD8BAygkwgvfvUadOu0qW7zGB9+kfX1scGJAQIFof7KXzZmOP7vOinE/CfJxEREV1U/xECIiIimCciIiKYJyIiIpgnIiIimCciIiKYJyIiIpgnIiKCeSIiIoJ5IiIignkiIiI6EOb/Q0RERMfWKsyrDYmPyBMRnbE8hHmwEXkiIpgn8RF5IiKYF1wSeSIimAcbEnkiIpgHGxJ5IiKYBxuRJyJSHsI82Ig8ERHMK0zBRuSJiGBecEnkiYhgHmxI5ImIYB5sSOSJiA6O+QUv2QebyjD+/Pnz79+/o+u//9MLYxJO7O3tDeYn9fn5mQz9/v17WPLr16+uy2GF7sLwS25Xk6Y3vPVyu8rd7IVcXXl6TVK98rTLx5p7/l9fX9Hx5G/P3LBC92TSykHh996SqMfj8ePHj9HD/fnzJ5x82CrcmOFA4briqQ6vOuw2HHpBGEO44h4+Pj5uhQCt+WfMp+5OYk43ubBCqXexNmUvjOGmDb9/+/btmJj//ft391aH+YJC0dy7QYLXwdmwpMuYEM+I/DXAKxSvc2+l3K6G93s5VytPL3eqrVK95rQrK1KVjA97DocIv0T6RkaG3xNiEzW7Fb6gAPL4Z/jZg3qubh13Fe7KdHt2TzVde8y3cFbh3CarZaOHCL+EbXtRujwCYH48+5t4HEvDm2B+GMYj14hD6RPoBfOzishUCifMdxtVTXpHCmyeeysV0m/0fq8xq2a17e76xae9YP0AwtgWj5sEsqaKRdpDzvG0Tu9woSKYUqjXjo/ViB4dC4XJ939qlQ+XRwDM9z1uWDTHWjDMH1D73HuXwXxs0Kc2UCiXQxHfLZpjm287zC+4lV6F+e3u+t0wH7kb68G5mzohP+C2B+9RzIfGfQ7MqfU/bGHnzrx7hs0xfz0EwPz/eByLs+7C2GQJhVosxULyxWGn4cBYTNbAj9gbHA0eHe8Z/b13lNQh1qvkngXzqRQYXuDo5ceOuHixqXafwjsa9t6eu8eKHWW5MbZCiQPzhYpR6jWN/fPd2P76p2TWMHuHXsT7ZfTWiMkQO42Ht1LhBknL01yBmhJ/2Pud23+vJ3mYkzV3fcy9tG39/V4+7V6EYwx7C4e/D/marOneZdGI7h56V9qt5I122oc7NNfNHs9zFqRjJWB0mL8XzF5ZMZkSl0QAzD+fg1kYveXB+Dg9JCZrvAF691jK7GBw78bLVRh7v3ePEvP+zz9VjhoeB/PD+UHDCxxefvdi00BguvBc2Ht77nUqxttmeJ5dJsF8pUJip/pTLF5jYReXdIdsc9nbtSZu+/VP3blaXajkti0core8XKYX5rLVXEI5J4d3fZz1mUY6YnduPGjl/T552t1DJ3bGce7hCmHb0S70dGndfppRU+J/w07i+l3o9qbgde+44ey8mj6G0Z6M0bu7xru7IQDms1W5cmakWaaFCuksjws9SCsv8FWd9pWdjaPIz+2tF/bhOpFGsf4bfqZWSK8nbdlM3TtjPkY+FqzdTpe4pFvg1uT5mt+XbZJLv1hq91q0s/ZZzsnun5G4MXohUYdN5IanHVcINB2tB4Tlo7dG7hxi70gk9GjjstA73R3QGW3oL8b8ZGlTX5BeGwEwXxqYGY1vbGimHpXCmis9bvVox+kwP7pVfdjj/RaKktwUod2qxhcblovkCCV+IkRqxg17tofZO4RQrjVfifnyISp5GSsrvYkFNfuvzMnRP3vPc1be75Wn3WuFh2xPldrUwd7th6+/kWMdevR5it5QelfB3LTJ6LB9ZH95oH03zF8SATA/j08x0YfNzeFDGms8rhmsuhXmc2EfPWIalx3tkyw8uQvzZaXHnFIDMYW6W0bnsrcHobhampAx6x6pOUT92HxspHazpWb/lTk5WjMIZUV32Kjyfp887eEl9wa/0mB8mfTdTvukWLEoPIY6Ot+l9+RqbnbeaCdBLjHKnfbrMX89BMB8/6HMsse5wb+QkeFfobALKdvrjAoL4w2QnOttm8ukWBCElVdiaefn5mvCOBfzubDnbs44gWv0PHM9+TBfaXG3LBs+cFzI3h4jRydkTQ5exlspd4iUJ70Hr8uJGjHTbfXWXEI5J9Op9k6jN3Wx/n6vOe3eacQaQG58OpJ+tCrcnYIXT6k7DyNtHnYb32MTK3zDVn74V498uUfqh09shv92J3X2rr0wBW/B2PzlEXB3zBf6RkYXxvwLuRuci/dJqqumqSXprouTXUOVMy5J84d77xEb7ZaJNp9lpv2sMBbeOZX7fTTshR6t8N/cJLvCjF+Yn1RI7157LuTnsAwaZm/O6NSNnF7CM5oAvVspd4Ok+cndBz1qEjXNne411guXkCsKuqc6mqLhX8Obuny/15z2MHrhxMKx0gML5Zn/vR6vboM1XN2wWhbur/R4S4jD6GSX0bdTlF+QF3cY9tybuNA7+e4ZDpk9a6b9HRCgNX993TA+e7Jc5BdoWMx5i8jR6nP7PHS6+PRe+xpNgnmYf41iR+Ln5+dB6r8yM6doU7clp9Q+lOLzfrsNb81SbBPv87AMwTzMH0ux0+84rRCZWWjNp5eHxFl4R+h9oa66n645WlMe42GexEfkiYhgHmxI5ImIYB5sSOSJiGAebEjkiYhgHmxEnohIeXhMzMcXF8QPDnZf5vz+T7eCTS4Uu13akV/4DPNEROfDfPedxr13avYwv8/XTl8Yn0IodiY9zBMRwfwmXInv8xquFt8vcW3YVIYC5omIYP40mI+fH+h9PWm4WuEDzJeBTWUoYJ6ICOZPg/n0Ou4A8u7LmLrjxOkNX90PXXQ/qHAN2ORCUb7e+K66OJw/unLvaxPx3ZbdL1Wk9dMJpOXpYx7D/YQzTB/biIqjKtsN8MM8EdH5MP/8Nw4dwVP43vPoF7KHn0c8e5syF4rc9aYvUQbGp4Xlb0emL2Xl1k8XGCke6D66n8fjEZaHGklvq4h/rXkiIpj//wpsSE32NNWugPmar6SfEfNzQ5G+uNw7w1mfn58MZvoGaG6dOHkwdjNs9wV6mCciOh/mu4eLXce9VmMB84XPHp8R85OhyH1sfjvMx9NIQwCFg8YKx+fn50ZNeZgnIjor5ruNv0rMj7ZiL4D5XChy1xuWD18t0Arz3Qf8JjGfxvW7Yw0wT0QE8/9JX2KOo7xpKtkQLY/HI37MMRIo9mmHrX78+HENzOdCkbve0M4Om4SwhGZ0Wlgemx/+ntbvPayfG7PPdZ98+6czRp6ICOY3PNevr68AsAiJHuMTUeL88Le3tzQFPZLvSjPtc6EoX2+cDN/9aHR5pn08/9HHFhLO0/JQdXh/fw/ViDhdIJ3DKOnDfzd9hRHMExGdD/NXCu7NFSphsUoh8kREMA/zF1Fo6H/79u3z83PrbhWRJyKCeZjfW/HZ/ThnQuSJiGAe5knkiYhgHmxI5ImIYB5sRJ6ISHkI82Aj8kREME/iI/JERDAvuK32OVR6s83L9f5PME9EBPMwv1CB6N1Xy+3/gd2euu+zOw7miYio/ME2mD9um7Lwsd2dFeocL6xhyEx3CnGQtOZhfkPFN9grdIhfHCSYF9xNMN/9ikzU19fX29tb7DzvfZymu3l6IV38pE3v4zSj68fPAqVvzkbG5zqIyt/F6e1KoeNOIQ4SzEv9Z4+7oxB9PB6BnRHzo5+aDSuHekCsEDz/2/Ee91D+NG36ovzoJ2ufma/WVu5KoeNOIQ4SzEv9EbgWlue+/h4/GB/b6x8fH6lJnVu/5vf1myt03CnEQYJ5qT8b86NTLuOfsWU/uT7ME0gQB2GeDof52HM+upM4cP7+/t59Ii63PswTSBAHYZ72iE96bn74SpwhNT8+PsKSCPI/f/78+PEj/evz87N+/TKnH49HnM1XPzYP88QvDhLMS/3xVnWhEz5H7u7M+aS3t7fhwuH6vT13f48T5sN+vr6+equVZ9oPd6XQcacQBwnmpT6JPL+IgwTzUl/kiV/EQe7AvNQXeeIXcRDmWSv1RX6t0gsH0zzH8HOjCQrP/35J6IXvQr7MnbKzcY/HI77AqjtnloPH9yscN75zDObBhu4b+cjdj4+PtCROY9yudID5cxmXHqXJzZzl4KH8So8sdd8gDvNgQ/eNfCzEu68kCi220BrYNBowfyLjfv7T87+vqjxFcA54krv5FbienkA+pl8wD/Miv7fic4bxBcPh59bVf5g/l3Hd5uZGH324iYM732gxDlrzYEMi/4zvGIjtjPCz+5qj0S8ExuVpuHH4EoLuNwlh/jLGxTV12p/Cr7jDbucBzIMN3TrysSgJP3uFeO7VgXGCTyhKRl8p2P0mIcxfxrg46HvAKV0ncnA3v7pj80ezDOYVXiL/AqVpO703Fk++CTi9bbAe4TB/UuMCmbozyDh4cL/iFL/ehACYBxu6b+RHC47Cy4xjH2PqaYT5axsX+FTozOfgAW+051Fn4cG8wkvkD1T65L4QGD80ECcTwfzljYufh04N0OM/PX86zG9xo6U1j1Y/g3mFl8i/QLnPDOa+ENgbSqwvfQrfM+TXYY1LLzWK+v37tzvusH7Fl1DFR/W2fgcGzEt9OkfkCx2Gz8wXBUMhFUqiWJqk937k9lB5IH4d07iwfu8oR66iHdnBffwKK8TKQfgZduUteGBDIk/84iDBvNQnkecXcZBgXuqTyPOLOEgwL/VFnvhFHOQOzEt9kSd+EQdhnrXiI/LEL+IgzAsuiTzxi4ME81KfRJ5fxEGCealPIs8v4iDtgXkiIiI6srTm1XBFnvhFHNSaZ63UF3niF3EQ5kl8RJ74xUGCealPIk/84iDBvNQnkecXcZBgXuqTyPOLOEgwL/VFnvhFHIR51kp9kSd+EQdhnsRH5IlfHCSYF1wSeeIXBwnmpT6JPL+IgwTzUp9Enl/EQdoV879+/Rq+N//z8zMtCSs0v5LyO/p33s/LU//Pnz9vb2/xWt7f38Of++RTil7DSL4k8vUnP1ytctvuOpObjMaz/hsVc09vdJ+jS452p9QHf3TNmkguM240knNvk7l5lTuH5jHf36/66M3yq7DnuQXaxGdj8jnQ1q8NW/OBK2GFb9++Dbf6/fv33BOtqRY0xPPZMf/z589unMMv4c+wcDfSt43k/pGvv7tGy4KabUdhmdukcuVZDCgXQPXbNox2Q+vrg78GorOMS38uNm5xXXBZbu/g4GK/yte42K+5yb/40gpX1NyvbTvtv3//HtZ5PB5d9v/48WPuWf79+3dYXYD5cgWrB/UQ9p4XMF+5+WSJUGDeLGzXFwqLKbVmP4Vt2wZ8a+OaM35NO3tuBBYcZTvjVu6nVVY3vNFW3oBNcqO5X9tiPvKmy/Xw+9fX19yzfH9/r6/twnwM1+fnZ3dhHDFZUMeC+SNgfkFJtPjSCj2WML/GuPWMh/nZGJtfn56b/E0wX3meR8R8UGiFp9VCozwQqNtGj33L3aZnCnGoDby9vb3/Uy/0oxumbT8+Pnpj/8N9xp3Ezoa4k/DnZTCfO//hqHmIQOp0KcR2VgDvg/maHuwFLYMmmJ/Vh9yEahuNHTY3rnsL1CxvZdwyFLVq2q4c6Hkh5id92civyuTf4kZr7tfmmO8OEv/+p14N4M8/dUfxo6OPxyMsj0TpeVzeMKAoLg9A6hGuu884PS3AaTiH4PKYD1cdLz/2rMQxkcjpelNyAbwJ5nNFwA6Yb9i3uWYo+ryYz9XPVpbdNZOtXtKanywWDo75MvPqA7tRR/oWmG/r1+aYj33FCQy5RnOZDaOzEGftpJAKAXX1K58C890elN75JBh3J+V9fHykefj1puQCeAfM1/eqNcf8SlSs7zno9gmdtzW/rBzfohtm7rXfszW/LP/Pgvmt/drjufnY7BtOvss9TlCJ+fKGNeSOPQ2pj/oymI+z7Xpj86Eh3hubj5cZW/YLTMkF8CaYLwRqu9Jn2b+ak6k5LWB+U8xvN9oC81tgvrlfe2A+PUPfe3S70OgsY75mw0lyxyH8eEoXw3zsQenNtI/j6F0LIp7f39+78xjqTckF8FZT8PZszS8e+oV5mId5mN8W86G9OPoAfXeuXLetn8N8aI/GKWPlDYfjyqP77A1CXwnzKUTl5+bT24qWmZIL4N2em3+unp7zXD2jZ9ng7poXrbSN+c7PzS9+QHmBcc3rRlfC/Eq/FrB/0/t62bHmvhLgoJiPTcnRd7NEqIxO6u7uPIAkQOXt7S09jDfcMDZPE3KGc797+wz/DQwLbdlQe4iT+cM+n3PerHRkzD//9dKnhxRyb8ELIR36UmnKaAD/k9HpMP+cM8tswVvwajapf2na3BOoP1blPg/yQF29cZPTVLcwbn3m1LyFcPJtiTv0o+zgV2Xx0tyvWe/Fq7y0gtFN/PJO+6PDhi4Z+R3OcM8gHArzjNv/WId1kF8wD/Mif82TPBcqznWnMO5cDvIL5mFe5J3niy/hdHFg3LkCcnO/YF5uiTzxizh4R3dgXuqLPPGLOAjzJD4iT/ziIMG84JLIE784SDAv9Unk+UUcJJiX+iTy/CIOEsy/KrhERESvFcyr4Yo88Ys4qDXPWqkv8sQv4iDMk/iIPPGLgwTzUp9EnvjFQYJ5qU8izy/iIMG81CeR5xdxkGBe6os88Ys4CPOslfoiT/wiDsI8iY/IE784SDAvuCTyxC8OEsxLfRJ5fhEHCealPok8v4iDBPN3Sf367xZc1cTzXtSoZSu/TnE3v2pyvibIlSdcH/zcEdfkRv06vUtrHvOL3WVXKidh/rKw6ZVEIn/28x+WSncohhbvqlS0DdaZVayP3lmTl9CDx9zbs2b9wjo1GXW3O25WTGCejo75u5l1AcxPgudKhra6lgVsm1usz0Vp91/Ltm1yaVvT66SYr6zebdH/AfMKL5jXmr9y8/3gmJ/blF+A+ZURmNUBsENf9Hlb8/X5APN0GsynlO3lbm/5aG13WFh0t+qN/L1wwPgynfaVULnkIMUBMb+s4rVsHKEh5ssLmwT/1J32k7cSzNMJMD+s1/dAnltevhly1H/55V8JezkAXGb+3c6YH94Om2J+i57zxYzfrlvo7GPzlbM0TnqjwfyVMZ+bUDqrSjua9wX2wPxumNeaXwywwoTzxYBcNp1iZ8bDPMzD/DVb860wn+vqH+7wmNd+0sypH0SE+Vm7XTMwX4n58nN6+zMe5mfdZc9LdJvBPMzXYn5W5Rfm255/DSEuOXZ4asy35WsTxsP8De8ymIf52ZgvdNrn7haYX3/+npuftaua18jMPZNCob/y2fetH6jbmltXfW4e5mH+oPEpdxIOp9oVJslP/n7MN0Zd4C14hYaFt+DVxLDA1zUPti1rAuZOY2hfzTvscvXs8j49ULf4LhvdEObp1vGBebqqXzuc6p7RuPNz8+4vmJf6J75qmSlnTnq2Z2S8Ow7mBfdG13uQS5aZ7hQnvOcluONgXnBJ5IlfHCSYl/ok8vwiDhLMS30SeX4RBwnmpb7IE7+Ig9yBeakv8sQv4iDMs1bqizzxizgI85R9WxkREdFugnk1XJEnfhEHteZZK/VFnvhFHIR5Eh+RJ35xkGBe6pPIE784SDAv9Unk+UUcJJiX+iTy/CIOEsxLfZEnfhEHYZ61Ul/kiV/EQZgn8RF54hcHCeYFl0Se+MVBgnmpTyLPL+IgwbzUJ5HnF3GQYP6aqd/9OMHOjhw2AZqcWPmTD+XDVW7bXWdyk9GvUNR/o2Lu6Y3uc3TJ0RJpsXH1YVxv3OJrrzRu0s3mMd/ar0I2tvWrsOf61KpZv3DztvUL5s9Nwbnp+5LC9IyRr7+7RsuCmm1HYVkDg8LKs+oW5QKoftuG0W5o/VzjciZuYVwN/udWF+oN2oL0i3e14GbZ1K+5yb/40gpX1NwvmD8x5peV8lrzCxp55TUX0GLuJgt2u+bS5p5D24DfyriGrflKPDTvjFm8n1ZZ3dCvlTfg4vU39QvmL4X563VXwPzikmjxpRV6LGG+uXEw37zyurJaNjf5m2C+8jxh/naYfxZ7zstDuZP7SeVgYeWaUdvh4NPcvsrDYn5WB2n9/ptgvrLEbFX6PDcbO9zNuOfMHviNMN8Kac+mAz0vxHyhIFoTkFbJv8WN1twvmL9CY7dc95yk0XCFwuyP3jq5FcpztQ7ezzEX1TtjvmHf5oJ5gjUpd2TMl/Nwcs5Uc+N2aM2XL+34mC8zr74GsFFH+haYb+sXzF8B86PlV+VczZpaZH2uFw53JczXX1pzzK+csL2+AZp7rOMUmK+M/BbY2GGm/YVb88vCeBbM10/Hg/m7Y/45f25nQ8wPS/9cgu78AMJGtMg9DLMp5pf9qy3mt6DFnpg/qXFrML/daAvMb4H55n7B/IkxP6sOuCnmZ7UbLoD5cj/KRqXPssYizF/DOJiHeZi/KeZrRogXjM1Xrjzagp+sahwf88+Zz6qu7Pt97jL5q8mlPbcZ4n3Jc/PrMf9sMRWr7etxFkwLfe0LjmY9yD63IrXArzX39bJjLR5agvkbtebLk+eXzbQvT4zP0T03tX7/nNnoLXizSpMF9/bkmEjl0z7Putdv1Ryrcp8HeaBupXE1b1Vrblzu5ipc2oJZhPWZs7+Dy/K58hV4a/yqPNXFN9pkc6iVXzB/YsyLyXkjf4oujd2OdaI7hXHncpBfMA/z1wzIKSJ/5DcH7Hysc90pjDuXg/yCeZjfKRQnLb+c5w6XcLo4MO5cAbm5XzAvt0Se+EUcvKM7MC/1RZ74RRyEeRIfkSd+cZBgXnBJ5IlfHCSYl/ok8vwiDhLMS30SeX4RB2k7zBMREdGRpTWvhivyxC/ioNY8a6W+yBO/iIMwT+Ij8sQvDhLMS30SeeIXBwnmpT6JPL+IgwTzUp9Enl/EQYJ5qS/yxC/iIMyzVuqLPPGLOAjzJD4iT/ziIMG84JLIE784SDAv9Unk+UUcJJiX+iTy/CIO0q6Y//HjR3pp/vfv39P6NS/Tl/pN9OfPn7e3txjq9/f38Oc+l5zMfaHRJ82u0YiV75pr3Edtr6Iy64YhrS+dhlvVHGh0tbnXXnmsyXNoHvPt/FofwHq/Ch99WVCg1V9azWkftDUfARN+/v79Oy75/PwMf4afarib6ufPn92wh1/Cn2HhbqyaVeDC/OTJ1xQE7pTuriaL1/KSMgnqD1fY7VxsTH9tLEOF3DlsEfbmfq0PYL1fhaxYQNyaOOfWydX4D4r5r6+v8PPbt29///69W/fOq640NNyHUI/9K4/HA+ZP0aavZ/8FbqhWl1BZLM5t/1U2sJbttmFrvhLnrdqI6x2sCeDkOvX1uTV+zd12o0trEuf2mA8/f/361eu6h/lNFXtQel0msR8lwB7mT5E29cUEzDfH/IIW8+Ldtu20h/mt/YL57ArdrvvuVqGJH7uXY+sztvhTf0VolX779i3+AvMrm4Pd5b1pE+Fn+lfPkV4P0tfX19vbW3Azrpk2TN7BfMOTnyyOYX5x2Vo5IDpr/3OHCZqzp4ZwG03v2A7zz/k97U38ei7qbN+hBrMg1Dthvtt1390qUTz2M4c/u3iIdO8uh/kmmA8uxNl5wZf4ZxpVKTvyeDzC8oj5uIew1eiaMN/k5CtL57OTfmfMl6NaXwOYNZy/zxS8MjNaYWNnzL+kWvZsOuhTU4M5Peafna773KTHmt9hvkYR1aPnk2DcnZT38fGR+ksWuBDrcIfyDuZhfnETavG2Lx+brzmK1nzb3peGNZgrYP753677xZg/3cN4rzrPONuuNzYfGuK9sfkYydiyHzY7ho/fDC8ndu+nTn6Y345V5UekYB7m6w/Rav72PphfMzbfHPPLRkyeTedtHB3zvWaf1vxGirPtejPtYz9Kd5ZDxHOoe/369aumJ6C3/OPjozuwAvPbnXzNozXXe4YQ5hfEaqPThvm513gXzI8+Ih/7intQyY0Ew/xiRQaXn5uPBo3CO4I/mJJa/8M1e97B/KYnD/Nzd9Vw/lRN2Bc/pPfaB+pei/lni7lss+bD7/BahQXHWlPXfCXmCz2K6cm659RM+5e/TO3UsHk8HmmUJPcWvLe3t+E7cyLpR2fa956SCJWAsOd0oLRh4U1SMD95w5ffjFF+P5cKcX3nR+Ftgw37Wibf4Fbo4KxcP5c/Nafx2gfqKv0qvwWy/pVBa/rGZo1mzsqNeq+fx3yg7uYSH5Gni/m1w6nuGY0jYJ5fWx8L5hVeIk/8OsrZnpHxB3eQXzCv8BJ54tftEuw4n67h19aXAPNyS+SJX8TBO7oD81Jf5IlfxEGYJ/EReeIXBwnmBZdEnvjFQYJ5qU8izy/iIB0Y8/FDNb0H/NNr19J71tpeSZPXgzR8zYjUV+gQvzhIl23N995f290qvYS1XjXVgoZ4brgfIiKiF2orzD//+7mUx+PRZX/3I2mVih9EPyPmVSS1LYhfHKRrtuZTg77L9fD719fX3LOMr0yHeRJ5fhEH6UCYf/7vh01DozwAu9tG7363ptfRHWoDb29v7//U63wY3TBt2/3GWm6fcSexs6H71RyYV+gQv4iDMD/D2sjjOBj/+596NYDcV2gfj0dYHpHc4255w8DyuDwQvUfu7j7Df8OSQPfhHAKYV+gQv4iDMF9lbZxdn8iaazSXP+1X+FZj5U4K5A7VglnfgpT6Ch3iF3EQ5v+/Yrt5OPmu/gu+hW8nr8F87GlI/f8wr9AhfhEHYX62tekZ+kD67vLusH0B6s9Mp315w0lyxyH8eEowr9AhfhEHYX6htX///h19gL47V67b1s9h/vF4fP/+fXLD4Zj96D57A/wwr9AhfhEHYX6htQHP3SnxPdKPzrTv7jyQOFD57e0tPYw33PD5rxM+Mbs7eX50n+G/oX7w/v4eag9xMn/YZ25lqa/QIX4RB2GexEfkiV8cJJiX+iTyxC8OEsxLfRJ5fhEHCeal/v8ct/K7BVc18aQXNepX2cpr2Nf2KmpyvnBrVL5Xe8Hh5p5J/X4m9zn6+PFt77i73Wgwf1nY9G5ykT/1yeeuCOZzu6qM2CgLF9xZNYcrHLrV7VyTPFuQ/ox5eJ8bDeZvgfm7mXX2e7KyMREXXsDZVpdQk/OT69T3fq083GLMz6VRq3O4HuZvcqPBPMyL/BFPvh4hMH9kzBc6G9Y8uDtrCADmb36jwfztMJ9Stpe7veXP/HuKhsXEcFir1bsHbov5muIY5lc2eeeOzdfjcy6e54Zi1shC+ZJv+yqw+9xoMH8LzA/bED2Ql78OkNthjvovv/zLDKRVls5nvxN3xvyzOG9uO8zPHVNfuXL5leEwf58bDeavjPlZPXj1tC7M14V5pY/W/IJrrI/AsjW15mEe5i/emm+F+VxX/3CHx7z2M6ZNLp71z0zC/Kx1tsD8mob++kb/+rGGy2P+2jcazMN8LeZnVX5hvuHJT3bJPK/7wM8FML94zH5llGDejQbzML8Q85Mv2Xh5tffyz83D/Fy2bYH5JodbxvhlD/fD/D1vNJi/IGwKvUyjU+0Kk+Qnfz/mG6PO/ha8Qqui8h1nd75TauajFFK3HMa5TcDcKynLd+hkbuRq55PXtdFztid9C95NbjSYB5sLXrjMlDDnPdU9o3Hn5+bdXzAv9U981TJTzpz0bM/IeHcczAvuja73IJcsM90pTnjPS3DHwbzgksgTvzhIMC/1SeT5RRwkmJf6JPL8Ig4SzEt9kSd+EQe5A/NSX+SJX8RBmGet1Bd54hdxEOZp5MVVREREOwvm1XBFnvhFHNSaZ63UF3niF3EQ5kl8RJ74xUGCealPIk/84iDBvNQnkecXcZBgXuqTyPOLOEgwL/VFnvhFHIR51kp9kSd+EQdhnsRH5IlfHCSYF1wSeeIXBwnmpT6JPL+IgwTzUp9Enl/EQYL5a6Z+9+MEOzty2AQ4aWaOfmei/AmKa9yDba+i/K2OYVRrlhdOuGblnHc1pzorVpPnn5Y3j/l2fpUvqubQ9X4VPvqywK/FuTF62jB/U9jMKm62YBLM73PyNQWBO6USYyuDOVr4zi2pF5Tg018bG1RZyvfsFmFv7lfhoiq5W+9XoRq9zK/6VMxVN9sGGebPB5uXt+1gfrf6U6FUusBt2OoSKovFNZgvFPc15CgU681jNXqIVuRo4uCaANZ3b8xNjyZ+bXRpTeIM8+fGPJpepjVfX0zA/NyytWF3/ZpawqaYzxEC5hejGubpNfEpj+sUyrLJ/aRCobByuQOtu4feBIKtO/yv0Wk/2U8I88ta862a+1tgfg17avCwURfgdph/zu9pb+XXgs72HWowC0IN81doU5ZHcSaxMVyhR+LcyoUVctS/ST9Hq5OvLJ3Pfie+CvNzSb8RNubO6qopDepvveNjfrI9szPmF+RVTQ0G5mF+Nh6GnZCLxw7rB6gKh4N5mL8z5ltNopzbvb+y0/u2rfmG8zQrazAwD/PzjlifH60wP0zWytFBmK9xpPA41pEfeYD5toxfhvnCQ2LHx/yaakpzzK+c/9jkcDB/L8zPGoHbFPOzGqAwv8DWfdpkML8F5ts+DLlyst7pWvPHwfyasRWYh/nl+5/1VO76FZ6Z8fvJAfsCsWB+PWBgvrKmuxLAcyvWz9c9ULfgEl7i4Pq5bLM6USrTY/Ioax7Gqy8SYR7mn+WJ62tm2pcnxufonptav3/OnP0teIXme/n9XOe98O2qv8/8tJVc8Bv2teQ6zMvLJzNk1qWtxNXWDk52VpXLk1nXu7hvbI1f5dyo9/rpgbobYl5MRF5WXO9Ud36X5bUd5BfMK7yuGRCRlxgnPdszMv7gDvIL5hVeO4XipOUX8euSCXacT9fwa+tLgHm5JfLEL+LgHd2Beakv8sQv4iDMk/iIPPGLgwTzgksiT/ziIMG81CeR5xdxkGBe6pPI84s4SNthnoiIiI4srXk1XJEnfhEHteZZK/VFnvhFHIR5Eh+RJ35xkGBe6pPIE784SDAv9Unk+UUcJJiX+iTy/CIOEsxLfZEnfhEHYZ61Ul/kiV/EQZgn8RF54hcHCeYFl0Se+MVBgnmpTyLPL+IgwbzUJ5HnF3GQdsX86Hvzhwvf/0nqb6E/f/68vb3FUIcghz/3ueRk7uRXExQ65QDm7qa5X6dwpzDuyA5OfFulIlyTR++uUBPz0cMt8Gty/elPy3ToecTW/N+/f3N5H/4V/4T5jfTz589w9N+/f8c/wy/hz7Bwt/Ku/o6CjcrzH95Kl7nky7QF72bc+qsoY2y4cHTJJEpnUTP3r7nEnXWs3OWPnvyBMD9qwGVqr0cuvELDfQj1Hz9+hIWPxwPmz9I0nEULdwrjTufggsiMblLJ7MrDLairLVu/pv7XJHlg/oKF1/v7ezj05+dnd2H4MywMsIf5s2TOHVqBl2zN38e4nTGfq0I1xHxudADmF2I+N3L/69ev2BhNffsKr/VNiu7yFOrv37+HP8PP9K8Q89jh3+0PSOt/fX29vb3FcZawZtqwaxbMNzz/ykLqkoMUjIP5yvUr2+VrDtf20PWJUTNscQjMF+ZQjP4Z2p2x2/nbt28Kry0wH5AcZ+cFbMc/Q6gjp8MvYfmff+paELd9PB5hecR83EPYanRNmG91/rkb/krTuC5JuzsY90LM19SW1ner5Axt0prP7bN8aQfFfGFJ4U+F12JFVI+eT4Jxd1Lex8dHmoefs6BgR6grLNgKNtbTQmuecffB/PpR9iZTASaHCeYeq7fPyQ1hXuH1f4qz7Xpj86Eh3hubT089hHZ5oQOmYEfs3k+d/DC/0fk3HKVzpzDuGphf8KDdesyvqR9Urj95aTCv8Po/xdl2vZn2cRy9+/R8xPP7+/uvX79qegJ6yz8+PtIOYX7r86+520/9toCr0u7axr0K85X/OiPmazLqQJiveW5+FPO/f/82Nr9SkcHl5+ZjbWAU3hH8wYXU+h+u2RvFh/mtz99z84y7noOVD6Mv+2+BkcsYP6tAq7+0WTWYA2G+5i14uRUiacy0X6nH4xGfrCu8Be/t7W34zpwY/9GZ9t0rCu6ESkDYczpQ2vDl7/m6wFvwCq1Ab8Fj3JUcXN/hMReT5dkShRcaLoD05LHa9grs3Zpv4jfMk8jzizh42BPb89phXuqTyPOLOLjfuR2f8cfCvGdJSeT5RRyUYG0vwYdo5ZbIE7+Ig3d0B+alvsgTv4iDME/iI/LELw4SzAsuiTzxi4ME81KfRJ5fxEGCealPIs8v4iDB/KuCS0RE9FrBvBquyBO/iINa86yV+iJP/CIOwjyJj8gTvzhIMC/1SeSJXxwkmJf6JPL8Ig4SzEt9Enl+EQcJ5qW+yBO/iIMwz1qpL/LEL+IgzJP4iDzxi4ME84JLIk/84iDBvNQnkecXcZBgXuqTyPOLOEgwf5fUr/9uwVVNPO9FjVq28usU/GIcB+eadaUUhfnLpn736Hdz6uzXO3r+w1LpDsUQ4zj4QrNgHuZPg/m7mXUBzE+2J65k6JUwfyvjzo75ylZ7XHjqPkKYh3mRP+L536EVeMnW/H2Mu0BrvsYdmKeTYT6lbC93e8tHa7vDgavuVt3/vnbc8TKd9oWRlysNylyv0/4mxl0A8zWOwDydAPM9cg9Bnltevhly1H/55V8Je6Pxf07NGHKnMI6D6826RrUM5q+M+dyE0llV2tG8LxRhML8bLbTmGcdBmId5rfmJ5bMwn+vqH+7wmNd+0sypH0R0pzCOgw3Nel6i9wXmYb4W87MqvzDf9vwne2WeFx07ZBwHmQXzUn9vzBc67XN3i0Jn/fl7bp5xHHytWTBPR4lPoZdpdKpdYZL85O/HfGPUBd6CV2hYeAse4zi4p1mjG8I83To+ME/84iDBvNR31SJP/OIgwbzUP8/1HuSSZaY7hThIMC/1RZ74RRyEedZKfZEnfhEHYZ7ER+SJXxwkmBdcEnniFwcJ5qU+iTy/iIME81KfRJ5fxEGC+b2DS0RE9FrBvBquyBO/iINa86yV+iJP/CIOwjyJj8gTvzhIMC/1SeSJXxwkmJf6JPL8Ig4SzEt9Enl+EQcJ5qW+yBO/iIMwz1qpL/LEL+IgzJP4iDzxi4ME84JLIk/84iDBvNQnkecXcZBgXuqTyPOLOEgwf83U736cYGdHDpsAJ83M0e9MlD9BcY178OxXcVvjmlzOxLdVKr7CMnn07grlww0PWnZ5zaXV7DP9a2WEYf7Ehdfc9G1etMHGPiefuyKYZ9ypHSxjrKZ6VIPSWdSctKzyYmcdK3f5oycP8zcqvF7eRID53epPhULwArfhZTB/N+NWOjjs/1i2SSWzKw9XU+GY1X+wbJ+jl9YkzjB/bswrnS/Tmq8vJmCecTfBfK4W1RDzudEBmKeXxafQYVUeL5zcT0qywsrlgavuHnoTCLbu8L9Gp/1kfx3MM+7OmJ/sFW+I6raHnlynsP8FoYb5KxRe5brnZOkzXKFH4tzKhRVy1L9JP0erk6+82y8whe1i9/tNjHsh5mvCuBLzNUXfykurLE5hXuE1npHD3qdZNcqaMqvcK1BT84ANtIB5mK/ZyfpR9iZTASp7YuqP1dtnTRkL87cuvOZOW22I+eENsGAgDTae1ZOMJp8ycqcw7sKYX/Cg3XrMr6kf1Bfd5UuD+XsVXoWK3s6Yn9WOgfkFtm5Rx4d5xp0U85X/OiPm6wt5mL8L5msGqxaMzVeuPNqCn/UkKGysrI3BPONO7WDlw+jL/ju3IbSg3tbk0mbVYGD+jq358uT5ZTPtyxPjc3TPTa3fP2fO/ha8Qiuw/H6u81742e/0exrXxMH1fR5zMTk5+JgrORdAumags2GvAMwrvO4SE5GXFcTB5+WGCGFe6guIyEsM4uB+53Z8xsO8wmu/UJzifiB3Cl3PwZu/Qgrm5ZbIE7+Ig3d0B+alvsgTv4iDME/iI/LELw4SzAsuiTzxi4ME81KfRJ5fxEGCealPIs8v4iBth3kiIiI6srTm1XBFnvhFHNSaZ63UF3niF3EQ5kl8RJ74xUGCealPIk/84iDBvNQnkecXcZBgXuqTyPOLOEgwL/VFnvhFHIR51kp9kSd+EQdhnsRH5IlfHCSYF1wSeeIXBwnmpT6JPL+IgwTzUp9Enl/EQdoP85+fn+mN+d+/fw9Lfv361X2NflihuzD8kjvE+z9J/QX68+fP29tbjHCIYfhzn0tOX0qY/GqCQqccwOHCZV+ncKcw7sgOVgahF65ZYez+tz7mOTfbRqYmbdZHeJPW/OPx6J39379/v337FpaEX9LCj4+PiPw1mC/UEm5beP38+TMc/ffv3/HP8Ev4Myzcrbybe0fBxuT5D8uCy1zyZdqCdzNu/VV0y4pZxJ1Bsv9l/DL65n6fW/ObvPzCpa0PcmPMD0mTMP/19ZXWCc3NlekVd6vw6rXjh1D/8eNHWBiqXzB/lqbh3JIO5hl3LgcrI1PZ1q9nfGXNYNm2y+ofyy7h9ZiPDfrUFk99yAk/gffrO+TDHg5727zqxGJMet0kcSQlwB7mz1Jo3qEVeMnW/H2MOwjm5zblF2B+8fWuxHyT5Nl2Cl63lz72z3fL/V//1OvfCOwPtYGI/16nR6goxB2mhZFnhx3ietUp5aIxHDWPMyfCz/SvYFbshulWyEbdCWumDcOaaSwG5huef2UhdclBCsbBfJe4C6C7rL5V00k+q/O/IeaXhXpbzAe0pxl2sR0ZwRCXBFp0O/CjkY/HI+A8tfK77kbGP/870vxakJwa8wHJsWclxj8OfEROxyD/+afwSxoQGboT9xC2Gl0T5ludf65AudI0rkvS7g7G7YP5SaY2xHxNJWzWxV4f84EiYZ04AB+bhhEJcUlvYD43rJUWRq6EikJ3Eh/M5zpRRs8nwbg7KS/UxtI8/BykC3GOLs/dCjbW00JrnnE3ac0vw95czC/j7naYb3ICzx2em49sDs33BJK4JDTue3PEJjEfx/Ijq1I3AMwPFWfb9cbm41SJ7th8DF1s2eeaGmVgx+791MkP8xudf82IL8wzDubXY778nF5jxF4G87HV2H2OLj0u35v1PYn5LlpGu4gVXlFxDkSvFhWHS7pPz8dIhppT94nEQk9Ab3kckYk7hPmtz7+mxDn12wKuSrtrG3cxzC84PZj/PwW6d+fbpyU198OQGfHxvNEx4zibTOHVZXD5ufnejMjuhhH8AeGp9T9cszeKD/Nbn7/n5hl3PQdXzneb9bT9c+Yz6Fs/ULfs0o6I+diODPDotch7T3aNdpIMXwMUcP729hYAk1qlcfp9WNidzafwev7rpU9PIuTeghfiNnxnTiT96Ez73vuOgolhz+lAacOXv+frAm/BK7QCvQWPcVdysLLDY1nTdln/yijm60czh1u1urQjPlB3c4mPyBO/OHjtE9vz2mFe6pPI84s4uN+5HZ/xMK/wEnniF13cwdtOcoR5uSXyxC/i4H3dgXmpL/LEL+IgzJP4iDzxi4ME84JLIk/84iDBvNQnkecXcZBgXuqTyPOLOEgw/6rgEhERvVYwr4Yr8sQv4qDWPGulvsgTv4iDME/iI/LELw4SzEt9EnniFwcJ5qU+iTy/iIME81KfRJ5fxEGCeakv8sQv4iDMs1bqizzxizgI8yQ+Ik/84iDBvOCSyBO/OEgwL/VJ5PlFHCSYl/ok8vwiDhLM3yX1679bcFUTz3tRo5at/DoFvxjHwblmXSlFYf6yqd89+t2cOvv1jp7/sFS6QzHEOA6+0CyYh/nTYP5uZl0A85PtiSsZeiXM38q4s2O+stUeF566jxDmYV7kj3j+d2gFXrI1fx/jLtCar3EH5ulkmE8p28vd3vLR2u5w4Kq7Vfe/rx13vEynfWHk5UqDMtfrtL+JcRfAfI0jME8nwHyP3EOQ55aXb4Yc9V9++VfC3mj8n1MzhtwpjOPgerOuUS2D+StjPjehdFaVdjTvC0UYzO9GC615xnEQ5mFea35i+SzM57r6hzs85rWfNHPqBxHdKYzjYEOznpfofYF5mK/F/KzKL8y3Pf/JXpnnRccOGcdBZsG81N8b84VO+9zdotBZf/6em2ccB19rFszTUeJT6GUanWpXmCQ/+fsx3xh1gbfgFRoW3oLHOA7uadbohjBPt44PzBO/OEgwL/VdtcgTvzhIMC/1z3O9B7lkmelOIQ4SzEt9kSd+EQdhnrVSX+SJX8RBmCfxEXniFwcJ5gWXRJ74xUGCealPIs8v4iDBvNQnkecXcZBgfu/gEhERvVYwr4Yr8sQv4qDWPGulvsgTv4iDME/iI/LELw4SzEt9EnniFwcJ5qU+iTy/iIME81KfRJ5fxEGCeakv8sQv4iDMs1bqizzxizgI8yQ+Ik/84iDBvOCSyBO/OEgwL/VJ5PlFHCSYl/ok8vwiDhLMXzP1ux8n2NmRwybASTNz9DsT5U9QXOMePPtV3Na4JpdT/rZKLsj1X2fpnV7l4YYXVXOgBZGZzJz1ZTvMn7vwWpa+DYs22Njn5HNXBPOMO7WDXWzPIu4Mkv1vIbmMvrnf51b+Ji+/cGnrgwzz5yu8Xt5EgPnd6k8FhFzgNrwM5u9m3EoHJ+Fdv/OabSsPN2pQ/bbL6h/LLgHm74h5pfNlWvM1RQDMMw7mFzTlF2B+8fWuxPzi6gXMX6fwKnQKlccLJ/eTEr2w8nDIYHhTjQ4ybd3hf41O+8laPMwz7vKYLxREc+sHc2sVNUdsVQV5Vg/6LAg1zF+h8MpBurL0GR0f6s12GV25sEKO+jfp52h18jUjds9LTGG72P1+E+P2wfwkUxtivsadWRcL8zC/YSkznIM6q1Oopswq9wrU1DxgAy1gHuYXFFDrOTq5q1lzKrfAfJMTgPmrFV6ziN4W88Oe/FzW7vwAwtnTJhe0+qeJ3CmMg/n6VkrBoMaIhXmYX7D/V2F+VjsG5hfYuqawc6cwDuaf86ezbT79DeZhvmb/NYPfC8bmK1cebcFPVjVgfsHJwzzjLungyvlus562f858Bn3rB+qWXRrM37E1X548v2ymfXlifI7uuan1++fM2d+CV2gFjq5w9k7gy7wF727GNXGwss9jWdN2WRfLKOZzE57KFZRCY2zBpXmgTuElJiIvK4iDu57Yzu8ehXmpLyAiLzGIgzud2/EZD/MKr/1CcYr7gdwpdD0Hb/4KKZiXWyJP/CIO3tEdmJf6Ik/8Ig7CPImPyBO/OEgwL7gk8sQvDhLMS30SeX4RBwnmpT6JPL+Ig7Qd5omIiOjIWo55IiIiOmtDXwiIiIhgnoiIiK6L+eE3SSs/uzT6MdO5Bx39CFvLQOzyCamaLx3l4lY7DJPfyYKYV267YP+zIjP3Ahvuqv6iFm9VH5ALfOWMiA6K+dFPlD5nfiJwAW8KR2le3s39qvEOR6n5NvysnVSeT82xmr9+efHXndd8CXd9rJqkx9YfqSQimJ9XBlVifuWXyPfh7tEwvwztlTtpyJLXYr5wgbP6jdbHau4RYZ6IToD5Ud4Pe3on+5Z7m4/ucNh/MLpm7r+FY5WvJXcyhSMWlleSe3jcQtUq17te3snwJCurcaODCKNXWti8d4a5C1wcpRx0t4vV6BFrkmG0V2xxlIiItsX8gtZPDVwLJXtu5eEEgho25Jg0uv/JMy8crjJiBXLUD5TMqjTkoDh5+blQlF3I7bAmUIUo1Ye6Vawmt6pJhi2iRET0stb8ZCN1sqB8DqYBThaIk7CsP6vcESsbdosxP6s1vxLzk23HuSbmEmOUbZPTDOdavF2snsWJopXJsEWUiIierxqbb4v5ZU29JpWPxe22ynNYPDY/upMFmB/l2YJw1Vdf5k4LqBmn3zNWy5JhiygRET0Xz7RfXIxu0ZpfVnSuac2XS//K/dRUjJYBrKYTey666jvtWwFswQWuxHyrWC1OqrZRIiJ6Ln5uPrekcsNncX7TaOf/5H9z+3lmHo8unOTkTsozsyYnfxXmmpXnW9U/N1+olk1GIzf+ktuwsH5utZoEKLTXJ6NUmZ8NY7UmGXLpPStKRERrMU+bGKCkFiUiIphHL1EiIiKYJyIiIpgnIiKCeSIiIoJ5IiIignkiIiKCeSIiIlqj/we4NW3XlA/KqAAAAABJRU5ErkJggg==</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-11" NO="11" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Weighted relative risk of fracture after risedronate by dose</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-12" NO="12" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Weighted relative risk of fracture after risedronate by dose: Person years</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-13" NO="13" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Weighted relative risk of fracture after risedronate by years of treatment and dose</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-14" NO="14" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Weighted relative risk of fracture after risedronate by dose: Follow-up denominators</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-15" NO="15" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Weighted relative risk of fracture after risedronate by years of treatment and dose: Follow-up denominators</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-16" NO="16" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Weighted relative risk (RR) of fracture after risedronate (5 mg): sensitivity analysis by baseline prevalent vertebral fracture rate</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-17" NO="17" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Summary of adverse drug events reported in randomized placebo-controlled trials of risedronate (part 1)</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-18" NO="18" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Summary of adverse drug events reported in randomized placebo-controlled trials of risedronate (part 2)</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-19" NO="19" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Summary of adverse drug events reported in randomized placebo-controlled trials of risedronate (part 3</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-20" NO="20" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Summary of adverse drug events reported in randomized placebo-controlled trials of risedronate (part 4)</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-21" NO="21" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Adverse drug reactions reported to CADRMP for etidronate, alendronate and risedronate</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiYAAAJYCAIAAADZhLqgAABFpElEQVR42u29Xa4srdKkuYfWQ6vRleqySvouWurB0BcllU6tDBzzHwggHtOro3VyZ0aA4WBAEG7//ut//g/+4z/+4z/+478F//37bwAAAMAS/Pt/AAAAgCX41zbAv39bFAPQLpAGgRA4t3hwBGa0y78Oet98/O03O3wtG8eRGSvqMNhiJJwYikgOkvPR6dJjt/+98mOXXtDPJ12/nLQ8G2eRmRRX8f/eyh6Sg+QgOZErf1xySmboSE5JqZAcJAecJzn/+cd/jqp/RtjfjZHfv38v0vva4x3FT14h7bH8v0wO+XmRzDyTMyQnUOZD2UNykJyvS06vM//+39+u2OvD4teG17T/3lByHosaqPgkMkuYzD+1sleKQyk6mj0kB8lhlfP3UjHJMWavinIMB4h9JMdLUWDQnETmDpLTRs/DlEg4lz0kB8lBctQNkEn9XJ+6luytzZikP268vCI54norw2TJxpq4Oemi9Aj2kBwkB8l5U3LWrGyqRkwXRTYhr5D57sMwXXKMXV9XqGzIHpKD5CA5fy/4n31sk1Hyz/XXkxYQkvb07GcryXlxlWPL9q/qKJQewR6Sg+R8VHLsV0F7R3T+mXi8+OMnw52TZh4DW0yaXR37UJOr4gvIfGtfSOdQPK94KHtIDpLz3VUOpAEIhEAkB9AukAaBEIjkAGIX0iAQApEcgozYBZAGgRCI5ADaBdIgECA5BBmxC2kAAiEQyQH7tEutDYx95HrzGi2+kUGd8cLKTaNByXH2XkA+noRmOEVywJvtUpUbxujk63v+mmCufUtXyb56StUW3MWe69ivfzGcIjngnXYpsczS+/Ok9DZvLQ3LJUcfWO9YWxdKjvJm6GUEIjngSMn53ZHw9kkjEb1RkQskJ0Od8Qr9cFy+RnLyBBpXtnPkIDlIDljdLsaQZ+drGY4dykA5dbK5YOMuQ53hGaO4ap7r1loYe1WZQJEcJAe8KTmBPjl8ivsRydHrNcxIbV/tVslx1c5OkW7TiOQgOWBTyRmucozi2VsZ10uOkRJU3Br6uOQEVjm/qoPkIDngnlWOeFjgm5Jj/9ZOV4zkhFc5SA6SA+6UnKGNo12LL2+s2b/67LOcjOQoj8qQHCQHvNwuir+IPlXXzw60G0+sidQZ46zozH3ribXy2AvsBiM5SA6Ss+N7OZvf94j3cna+LwQiOUgOknNPu5N9gKpBIJKD5HxRctY3PTnWqBcEIjlIznclB9IABCI5cARoF0iDQAhEcsBX20U/kAZph1K3bYMexB6Sg+QgOWXdvr2RJPGOEfMI6rad6BzEHpKD5CA5s3o+k/TLqDtFcnYf05EcJAfJQXKgDslhOEVywKmSo9jkEMxnUXeE5GzOHpKD5CA5lZ2/l8xqn86///GBbanbWbNPYQ/JQXKQnIkFQ3Juom5/AvdnD8lBcpCciaVCcm6i7pSJDpKD5AAkB8lBcmAPyUFykJzJReL4wDXUnTLR2Zk9JAfJQXIgDUAgBCI5gHaBNAiEQCQHELuQBoEAyZnIEQAAgBIgOcxrmC5BGoBACERyAO0CaRAIgUhOksRlOfjE6+eLsT6SSF9464i58/bL5i82HbBzheSsl5yVlkprGviVQN+/89PhmUm8UjBScd8sOX8SuIavOaMlVrYukpMMCTo8iojkIDkRyfmT2LWXiOLPzx+/+RtGv2c/jNW0/U7yn7+N7/Tq9W6UIzn3LQ3b3rtqpxCIZl8rOb0x9/FvO8+r/XN7iO+VcKhDRjGMgtm1+3jsYtGWKdv+PmMM6EjOeZIjjuz2EDaUHEWH7GIoN0JyztrcOCitJyMmqxwk53leJi5BaiVnGGFDpTTuqBTm0RsKydn8rTck51YCeZZzv+SIU/7jJGdYMDbWzi0ekoPkQODNkvP4iL73YWBM1w8OiJJj/2Gs55AcJAfJgT0kZxZHwzNmxmGw9nQoQLmafrTa9S7R8PyboZov7iMhOVeSxom1i9lDcq6aGH4NpB6BNAiEQCSHglF9SINAgORcxNERK2g6P6RBIEBy4uM7AAAA/HKY1zBdApAGgRCI5ADaBdIgECA5VRz1kmMGrv9uYxzXl3YrsJ1EFdJOpw4CkZz3OTLyxOgX36ENTjyMsNtQ7k2CB2lnUQeBSM7LHFV53mzSBkjOmqkJpB1K3UEEIjlfkRxjVWvYz/SymfWyD4jJAnqZC4y/9cITu0jOu10MApXpLwR+QnJcbje6d443vaaYrm34fTaFkZxXSkXU5Qlkc+Irqxx7lG+hrNIx3xrRpa1t5oVzk+SwNLxDrVnlIDn7DiVDO5mMkcHj/pvhhO2VnB28cJAcJAfJCZeKZzlfkRzdeqBEcpR1j1dyNjEmuEZy6PBIDpKD5EzpD/q2WNO8c2KS45KQ37sjOeWbG41nOUgOkoPkVHFknxkzkgsZ3jlNNsj5vf7QyGd491MyI234Xk5vzxPJCVNH1AUIbJz6uVhyAO0CaRAIkByCjNgFkAaBEIjkANoF0iAQApGcHkcAAADwy0GWmS4BSINACERyAO0CaRAIkJxajvJ+OcQ6hEAaBEIgkjPmKOmXo3//RD8bOj+kQSBAcso4yvvluL5PrEMIpEEgBCI51rrkN/2MYWPTfrwMhokrek42xsWNVAW6s84Oqy46P6RBIAQiOX//yUjMbMtP78u2rjQt1bR9fcWkB8mhw0MgQHJ2kZzf9YQ4yvfu4soJbdy9SnKIXTo8BAIkZ7tVjneUH66NXJe1PwkvfXaIGzo/pEEgBH5acsRBXzQpyKxypkrOJqFD54c0CITAD0mOSzOGrmiTJKe3G+a96YZWoVi0XdPhh88pIRACkZxB0/YOhv3+3QS3laElhnH2TLTeaX5nHWL3l6Xhh5A2ZAmHMQhEcgArdFY5L28kQCAEIjmAdkFyZpWKfSEkB8kBxC6Ss4g6JAfJQXIAsYvkMGKyTERykBwkB8lBciAQyUFyAJIDaUjOx2MPyUFykBwkB8m5k8B93p9Dcl7mCAG7ksnhi1OQplPXexENAgMEIjlIDpIDk5AGgRCI5IRW/WKKgWGWgf+8V8+oBtD5IQ0CIfCjkjM0qhG/09tM2CqhGbELaQACkZwtJKcnIcp3FFsdAp3OD2kQCIFfl5zWT6j3qyuikCA5dH5Ig0AIRHLULwwXN0gOnR/SIBACkRw3R70HLY/PYESPHCSHzg9pEAiBSM7z50Mfmt4Rtccv6OfcAJ0f0iAQAr8lOQQlsQtpEAiQnDc5IiKJXUiDQIDkTOeI7S9iF9IgECA5BRwBAAAoAZLDvIbpEqQBCIRAJAfQLpAGgRCI5GQWjKSmpuKQBoEQiOT4OHpMdaNcjaj9ROziyRgq3uYdZPOyHfCwBMmpkhwmSsTu/hOLU0bzbct5RMHQ7Mslp5fZs5cIZ+iOM8xfIF7toLnPfZ0fybl+ZIc9JGe15IiWa3/+MOzajGHr8Ve9q4lZRJEcJIdCXkYgG2sfXeUoQ//wh72TC8Ni/C6b7lvobD6mIznhEiI5t7KH5NRIjvH5DpLTLsWGVdt/TcnGGstEyobkIDn3SM7my0okB8mhbPdIjuF583hAwCU5Q6HSpQ7J+WzxkBwkh7IdKTm9V0ENn5s/SvM4EVbOIzz+3+F9ObFG8ZAcJIeyHbzKAbQLklNbNl4FvZs9JAfJQXIgDUAgBCI5gHaBNAiEQCQHELuQBoEAyZnIEQAAACzakGWmSwDSIBACkRxAu0AaBAIkp5Yj49XOU5rKe+VNgma32H18NXi3nYSdUzZsTt2hBO7fTZAcB0e/72y+xf6yW+8TxLsN5Up2V0ize9DO1B1EYONd2islp5fw5m7JYZUjlgfJCZcNySkkEMm5WXJc2wWPDjeKm07Y2E001xE94ohdcQrCxlpYsNlYCy938KX9luQMM3v+/vGoAUMpGk4MH51Dm2AZp+cVJXaN8jBJF0uV3zOAwCNKi+SUSU5vZmGM1Mo+rKguj3Mc41xDYA8dyWGVs3KezojJpAfJkYaY33G/NxmZJznDeZDL1MdYhBG79tbQbkXlWQ6SA4EXSk5guTBbcmIXYWMNyUFykBwkZxeOYm5pj89LSiSndynx1kgOkoPk3CQ57EzeJjmt/8rV0Dmtjc6nuazYXMZuj7ceGs3tlihpw/dy9n+fccMRnFdBywnkxNrNkgNoF0iDQIDkEGTELoA0CIRAJAfQLpAGgRCI5PQ4AgAAgF8Ossx0CUAaBEIgkgNoF0iDQIDklHC0w8HE2L0Odcc5L3Y5ohoq3uZ7L5uX7YCdKyQnzNHsF6+U94HWBDGxew1vZ+VYg8DL2ENyDpacZY1H548VDMkh6igkkrNOcmw7nBbNF2DkxVEyIAx/ta07DpLDiEnZbhjTkZyM5PTO/9kppQO2NFWJPoeuPPZ1iF29VEhOuIRIzq3sITmzVjm2Y01VnulYbmlxTERykkVCci5ewsIekrOd5IiDkWhLs0xytnXHOUVyNn/rDclBcigbkjNlY631H/C4Cknnv6l4SA6SQ9kulxxlYy1ggeNa5WQKSedHcignkoPkvMyR7nDj/TtmgWOUJ/MrjDeQnJVl41XQu9lDcq6aGNrFvi9RB6lHIA0CIRDJQXJoF0iDQIDkfC/ITllr0/khDQIhEMl5GLgBAADgl8O8hukSgDQIhEAkB9AukAaBAMlJcqSvE8MrSuL7RHI4WX7zkIRfDpLzIkei3ri4RmaOjt3N06yRlfLiic4puojkLJIcVjZM2CkSqxyWYkhOjeTYKQPE9/+93jaPE8OLD0YzekIaxYNAJKd5k0A/itPjNW1tM/KtITmUENI+WDwI/NYqR5EZ+4i6y2/N/hDJoXhIztcIbGysITm9S82QnCNmOoxNlIpmRXKQnEsk5yPLHfoVkkPx6BpIjuNv3SYnoENIzusF41kOkkMhkZwyjryOOL+/Mr7QPGfb7DsiOYtLhRF1nj2iLhN4dNtrVzmAdoE0CARIDkFG7AJIg0AIRHIA7QJpEAiBSI7BEQAAAPxykGWmSwDSIBACkRxAu0AaBAIkp4QjO2PNpPXjpKTU4aK+Gz10fkiDQAj80CrHlpwZxXBd1mUfF4iP17dlt4rdx3nGhpvXe74qpOQbhMAYgbsVGMlJSU7r5LCZROv6VY59BSTntyRiOiJIG7LEu7R5AlnlfEtyfpMF9CYmj//38W/XtDrpyqMkSiB2e6VCcvKjJ5JTJT8QeI/k2F1FSYOWzJ+mWObYOd/yFSF2kRwkZ0P2IPByyfFqg3H9jOQM12F/zsj/rmN+/2k4qhK7SE45dYyYeql6KYN5loPkSDERkJw22r6zlamNHBAeTbWJXWVnA8k5XaoP1Wwk507Jaf1tKMXSplByqr4vBjGSYxdpwzeuj5CcnV9WR3KQnF0kZygSjxtZirr0fhhbYwWe5QxrR+yKcUKHP5c6JAfJeZMj4/hW7/jZ0COnd0hUPz+mGOo0z7G0x3/aZBK651C++UHVnQfxI5xtkRwk5+scfRZb7VY9PuhixIxRh+TECLTnxBCI5ADaBdIgEAKRHIKM2IU0AIFIDhwB2gXSIBACL5ccAAAAWLQhy0yXAKRBIAQiOYB2gTQIBEhOCUeTVosE9AVc7byHcESA7bz9ckTUnZK8FcnxcfTuS3+IE6PSlWGz+5B0QvoGIhDJQXI+2vkpHopICZGcFZKjJKRpo/RlLre0x0s9+hHsf27kaMlhXyhTNvaFkBwk5589uNgGAb1Unob82K6dxoe967dDHAPpWh+XnJ2dcpAcJGeXVc5jbqih15luTzC8qdcIDsn5bAnxUWZAp4THS06TjT51nRg6r3glp21s7kvvgjQkh06B5BRLjrJMiSkKkkMJkRwIpFN8SHKa8HDlVxJiDta/l9X90+44OEDnR3Ig8ES9QXLiHNmmak07Y9ZGHmi/t/tzxKBXnoMMSO4b0zmxdit7SA6SczBHr1CP5HwckAaBEIjk0NhUB9IgEAKRnGkcLd5AuOb1Tzo/pEEgBN4vOQAAAPDLQZaZLgFIg0AIRHIA7QJpEAiQnEKOHlPa9A5VX9UwGxSPzg9pEAiBH5Kc39diWt27lkgOnR/SIBACkZzu54VJcNEbOj+kQSAEIjm+z41tN3sxZKRH6+XLMf62jXxcv0Vy6PAQCAlIzmsc2UllfodyIxu0vX4yhOH3J2LiNeW3SA4dHkAgkrMXR73kabYOuQb0QGJp/Trib3eLGDo/pEEgBH5Rch7XNEdLTutv/SE5dHgIBEjOCxwNRcXlc7Ob5PQKg+TQ4SEQIDnvSE7geYktOV47uN5zo3DZ7KdNW4XLbrErxgmkKaXaNjkKBCI5L69yDKMaO8uQvf/Wix7jCo+n44Yn1h5/e4Tdzm6F2XwfctsOb/cCCIRAJAcQu+pME9ICpWLELCwVBCI54BOSU5uNAsmBQCQHyQG0izVuFiakQHIgEMlBcgDtcti4ieR8SnLY2kVyAJIDaeNSbevoheQgOUgOkoPkMGJC4NltjeS8wxHyhuQwYjJiliwTj+gmSM6bHO1vDE7s2m2nvAIFaUPqdu4IBxHIziSSwyoHriANAiEQyQlxZHvYPE5Ahj95fJnjz4e9fDZHzLLp/JAGgRCI5Lg5CnjYiD951Cc7fafooEPsAkiDQAg8e5Vj/P2YV234E/vDxwKIdyd2AaRBIATeLDmZnxjpnIdLny/0DTo/pEEgBCI5cyUnvzYidunwAAIh8HLJqdpYy/+K2KXDAwiEwMMkx+VhY3/N+EkTDt3rlyJ2AaRBIASeusoBtAukQSBAcggyYhdAGgRCIJIDaBdIg0AIRHJsjgAAAJQAyWFew3QJ0gAEQiCSA2gXSINACERyjLPLU6n3/uoVU/Q1UbV77GL3Eire5nsvm5ftgJ0rJCfMkZ1cQAmONSG4uO2XBf3+nZ8OHy4bfjlXsofkvCY5ry8Fpt7945Lzm2mCDn/lyA57SM4uktPzxTFS1xhuN0YGz+HmnktyhsXu2fmIN0Vy6PBIDpKD5BRLzlBden80zY+g94WY8YGoHD3xezGj6OZjOpKD5FBIJGfpKqdccvQRzf6aWCPd7wfJsVuNDs+ISQmRnAslx96IC0iOMqSKN/2I5Gz+1huSg+RQPCTH94DHqwdTJYeNtbOKx4hJ8SjhqZKjrEVKVjlDyXGN/vqxaeUWSA6SM6N4PMu5kj0kp4Aj8Z3QpClO7Ff2OmlYkeb0+1m8p4Tk3Ddi7p+Ja+eCHZHHDMnZlCNRJ74MOIE0CIRAJAfJIXYhDQIBknMaR6ek+yZ2IQ0CAZIzZegHAACAXw7zGqZLANIgEAKRHEC7QBoEAiSnhCNlwUiY0vkhDQIBkpPlSHzlkzCl80MaBAIkJ8WRnUvmFMckYhfSAARC4NmSo9jM6F8DdH5Ig0AIRHIcq5xhajVewaHzQxoEQiCSU7yx9pjzf2cfSWIX0gAEIjk3SA7RTOeHNAiEQCQHySF2IQ1AIJKzGUeiwYzo+0k00/khDQIhEMmJvAo6tJmx/wmcGLv2iURIK9lIgEClVFihXys5gHb5M8norWIhTeFt+DkEDona+aVAJAfJQXLKCrP/bP2gSTqrnJJSITlIDkByIA3JQXKQHCQHycmVBMkpKdWQTwhEcpAc8NF2Ge6bc3wgzCGSkywVBCI54ELJsU0PkRyv5OxsIonkIDlIDpKzb5EYMRkx3yrVcXuASA6Sg+SkirThMwkk5yMEbvs8DMlBcpCcKUXac3do29dKTpmnH0EgO5PHSw4AAIASIDmscljlQBqAQAhEcgDtAmkQCIFIDqBdIA0CAZJDkBG7ANIgEAKRHEC7QBoEQiCSQ5ARu5AGIBACkRxAu0AaBEIgkgNoF0iDQIDkEGTELoA0CITAgyUH8BozHR5AIJIDAAAAIDkAAACQHAAAAOB4ybEdyB8fRVy2NXxTdbx1Kam7EkJHtN1bkbBtBPIQCMmpjydDRX4dk655Bn5lX/I2jf198VLGRSY5bv2JxrfYO/2+13QNdPHfWa2lRHzPOBLJuXiVo19qsT/mH18vVjlIDpJzySrHlpxfrTKc/oYi93jN3w///NxVktZxHhwW+LFg9k17f//+k13BAL1GeX6n1QaxYlMaS2SjpgrPvTiJBYBeEbHtxErZq8DfPvgYn6J7ptJf7BJO6hor+/IHX0W4cI7wGATG5smfkcj4zjD4hj8RS9K7lNHBjIL1qDNKq/fh4cryd6B3Ncfv15SiGo2rbKx5edZJ1sNMr4jedsbd7dXYLzlKMNhVG/YXbwhVdY1lffmb6547HxIMB1bllMFwgmaHjrfPuC6lfyhuRiks9XqmzY89uLvk0B4KjYIpu1uKmooKlyFZWeWLkeAiwS7GMK68kmMM9MZ6SGy12q6hk+nqy5/dYfuu5BhbB8OYOEhylKl9b9PSFhLvkxVxeqjUbrjfKI77m0iOHcyKbIiiEov2ZZKj131211DKVtKXPyg8SM54Dn665NgysEZyvHsLVRtrR0uOLioByfEqX0By2ugxlavbzpCcjBzm+zIbax+VHO+znCZsyhsbu+EwNTagXfUyKuKaka15lvP4VN9WI/FqKyUnJpZ6RcKClHmWY3+hhY75GCswvd3zXWNBX+ZZzj16Yxy4ch2PaYkDLfa4MPyacUhJrIKeoNO1xZ8/atW7YOxo1uMht5Y4sdacB6XsH/baTj+5ZNRU35hKRnuvIkZNe4W379Ur5LBparvGK30ZyQGOhdTUXwFw337DN0cAgOQgOQAgOfRlJGfvaAusiHGgAV/uLJfpDX0ZyQEAAIDkAAAAAN+UnMxyOL+UHuY7ePyy8vK//jJEzHPaPmz2VlNO3eLIVJCcm6cUjOogOfsGmZ4hf/j5MK1IT4TE/2tLjnK14fjbOye6uM8HTBBczR1+brdziDIul8QGQHJ2iUjlQyWRlOtFevEV8Zjk6BVZ3xYzJIdVDpLDKufTkqO8fel9h0t8S05/i7CN3h5VKqir11aSE34tLpY63sg8ZtzF++6q3QrD1yHDzgLNaS5wpbNAm28uYDgLBIYCcI/kKMnSven3A1kxwgmPmz+HlSg5SgKSBZIzTP4R9oZoddmCw6m6YllH9XJ6U9wPk81c4CzQ5psL6H4cugUGuG2VY0zQ9Hwhdj8M5L1/UXKGY6L9R+AJvD7+imlFht4HilWdHhW6q6w35WWVs0BLW2lc4CzQlpgLDJ+GxoYCcKfkKEOJ1/kjkIRYPMGl56gPSE4TbDmqvKEy3jYBb4jwcOaKk+b0VmgeA4VYmueMlcYdzgJtvrmAnqkWyUFytpCczMaa13nMtR7ypspeIDmZOexsyandWGtFzgKtwuOgHe4s0GaaCyA5SE5EcsJLaVfKd689aFgtmvy4xTWyuEaxWsnJGDC3Oc9yXLcIO8gFwkwpg/Isx/5C295ZoC0xF1BcQprHAgNcIjli/vPh15Sdq/CJNeVNDv1UzPBtTZc5tP6IZTih1s+DiYn9M2ntW/Qk1bAdY8+iSpwFmt9c4D5ngWYeVysxFzAKHBsKwFWrHADAmm2D+2oHkBwAAJKD5CA5AIDPqM6VjyV41oLkAAAAAEgOAAAAJAcAAACSs03Rp+3VlmcODpxFPqJeycLYp8l3jqLywgcyVkwlbYcHIe+W4XU7KCTndiKW5OxTrjypAHm/n9n9eX3axNiN7Bd13/LXKSRtBv9HeA4N0w4BJGdKtL2+fnp3lbNSctY3wbyV3+v+Ojuvco7wHCpZa4J7JMfOulj7cnvzuHcMCzNM0q5n81TsT3o/8b7+7SLZ5UOj5AjwNkELOfR4E0Yob+yH40fJyS+GWTLg9SooN814/zTN/meYTOHx72amSEByPi05mUDx5vUK5AQzCmPITHOmYbZ7jq1wzZ+AMkaysnBRvuy9XTgPWCZ9Zy9EA4UXw2Y4d1GqPLyanqPMe9PmyRfXEl5ZdjvaJR8mhgcfkhwxmsV8aPrgOMy4pRQmls3TO3wPHzbYnFQlAE5KTqAJqjxd8pITjp9Wmso6kG+7NgaG9mjeFK5VkpOhC3xrYy0pOYqkBSIvIzkBx53YdRQ/tM0lxzspiXm6TJIcsfDDbNzJMVS5Wt5dTTQTChCO5CA5b+6wnS45scLHrhPboRreXTwuvFhyMp4uG0pObPSPLUFatWHEbMmJxSGSg+QElaZkVm5bZWR6bzMdRF6RHKXjeW1OqiQn3wTN7+lSKDne52eumYr3cZF+2fDzmIx3ThO8f5rfH8gePYwN5GHkg29JjnFARbROaSMTjub0YlEK82ilY39T9/nQr6PXS6nC4xeUhpvUBEqQNL+jj6sAsYBUbqScE9NdZ5STjVVWNz0TKf3EmmL/o8fh42XFzgs+urEGNlx6Mh98l/mtrkYcAiQH0NWRHCQHIDng/LGPzYe3ON/wasQhQHIAAAAgOQAAAJAcAAAA4KOSMzxD/OfLr5fT+ET/bexD9rIBAEhOwWiu6MqLY24gD4fx25ZLjwgAAEhOmeSUfHN2aWOSkMyqAAAASE6Z5Cjvh7eRY41tudH7if2aulFalyRksigS0AAAJKdGcsRs54Zs2L+y7+VasmS2vEpyxQMAAJJTv8oJ2L2IA7frJ0MV9FazVfgFAAAAkpOSnOHn+fznPZ0Q9cObsB3JAQAgOd+SHGVpokhO5kRZzGsAyQEAIDkvSE7MrMzI5f54O+WVoMCJtYwPEHoDAEByKvUm48iiWG407YVTW29slxpDtHo3FV8FtQ87AAAAkuPAf//33zf5438P5fuUp/cHAAAgOYeTVbF0YP0BAEBywEAneNcSAACQHAAAAEgOAAAAgOQAAABAcgAAACA5AAAAAJIDAAAAyQEAAACQHAAAAEgOAAAAJAcAAABAcgAAACA5AAAAAJIDAAAAyQEAAIDkAAAAAEgOAAAAJAcAAABAcgAAALwsOSsdl113OcgE+pHDf/+B30+8tXuFjZ2b4GiP8Bmd7vFq57L0nxTZtbip4kdHtWOVU6gExr8qfezP6HxclPT+Hv5fpfu90ufpkOXF+88gn3rHSS24oBX+9KPkqLJ5aF0pM1tIjnIjY8g+S36SPLDK+YLkLLjjBZIzozchORtJzv9ZyfaWq487Rcr/FSdlf0ZtY8Pq8Tv2Hpfxd+zK9iqt92Xj81/GfsszLPxv+XtXNlr5V0F7W4W/13xsApvPYQkfK2hHmlHBYWGGsfdIyzAAlG8ahbcDQGxB1329zTRvFO4FXq/Yw26lh+LKsBEvddI+kD5Q2pukjw0s/qt3Qe0aaIYTpWHZXFe2u4q+0fzY+Q0qhoU32FOIsuVKjAeRT6PuvfIb97XDWCmMHnt6LxBD0Z4KuCLE1YK9YVFv6HLVsXuTKD+B0HoxbOwAPnQTyN0HYpIT27xWxjV7Km3PsmdcWVm7eNfR3g7/Wzy7Hb1Eeb8zlF5lPSSGx4zCiNc01DoZ5PYi2FvO2hYU17UzhCdQX5s0V9vNDptkVCM5lvJX9cbAnu/v/+avXCU5omyIoiJ2Xe+wXjXK63VfIDmxG9m0KPHglZwSQsKzmbcGvkBbG2QqoaVsTkwKGyTnzY21gyTHNTkS614oObGpnGvA0jeFlAueLjnhjbWtJOetgU9ZPs6TnHdnKuEudrnk2LvYwz1uXRWGqyilIo97vq4pamDPIbDEsXfqlX1274Z1Gz3LGe4gxV6eyDzLeXwwXiU5xsMAcezQn4ZmJMeYP7laMCw5yrynfD9tWDVvq4kPgdaETX7KfobkiKe5jIHbeOb/iDY6Ede0o1nDw2l6b89c2XtgadjTHonSN6aadgJHP7Fm/NzeNLfvNXxP1j6/J544Ek9YxU5LisWzqRAjx/iy/bmX/97fvc6rTzu8qxwx8Jr8bH/4idLNF4SN3hanrnLeKcc/Uu9chcy7rpvXBdCCO9z00C72jy4N6A/EJ5KD5HxrlQOu7OcnPt7s1YIGPbf5bg0bNtYAAAAAJAcAAACSAwAAAMl5+vbVO9qnZHR+lyIxd+dhqQadmVWHb6e/VfFC2pMXiZ2WviM7+H2FrHzLyhtDt8pJzCftU5Kj5Dr8/Xx/igJ5M5v2st7rDVTOSaC7XXB+5NBCVplZ1LbgV1Y5maxorHKUyq7JKPxWjz1Lcl6/Gkfkb5Kcuasc5RXfsE1LCzm1lN9UN8BonneexRo1IddO2EClCTbYypvt9gZaRnJc7WhXXC+//R54reQoe3S1PajXQIrhk93i4f06JVltr03tjiAWPjwUlNsyuXpZq0hh0Iux35h3ZWGYIjkZV5KWdhBx5XbMe8MMk/e4CPGOtk12AHoM6JKUwDrztascb7o83TUkHBJhyWlCFjWdIr0H6cQqgRfupN7dmGHTFKbs3MGWSY/SqtFMSfItfmHYQYo31mJtb+ec9zq1iP4TLpsKb9Zk12A9nOt5fXoyBfA2VkZyYmlPJ1X8cZ4buFomXbdrOuLqQcZy0zjWEdAtpWm8wqMPEeGs2HZYLrZlcvk3xubZYUVpI6+jWUlaleV5SSc0JhfeJqmdROujgD5UiYOCGEyuAojfD0hvleTo7agYetq7N8ms+16nO3Fo0LMvB/w4YitX0cgy+aRBr2Agh3/gkdICWyaxbN4BNuPMG8iw/s7GWiuyaYnNUAolR/9heTtlHICSe2JJW7bFkhMwma1tR+8yyxV1u0lOeGPAGw+TJCfG3kpbprB5Umbr5XjJSdq05J/ltLQ3jG6Aoe/t5veUXI80ZozUyY21WLB699kzmwyBdnSx4RphdZemkh1LZUZc/ixHb8GY5DwuTbyWNgtsmfJbYWLTGIU03LbsqY/YQSo31np+G8pCtUW9SYb/pN+05zQzNMAYmlKIJ9ZsKxHvwS3FQqaZTjOZszS6xacYpkMPEqPiTTaSsRlT2jETk961SBNMqnQHF91wxcu2bq7oPWolGjspA+IOtkwuuyPvaDYs5PD42fsn1sCV2PMlCXIzA/DF4QgKkBz0BgCA5IDKIX6TpGfYzwCA5AAAAABIDgAAACQHAAAAyEqOfaBWzzCmlkB+K+Jsos2XnO2Dzvq/KueexROceivsb8C+smB3Z1s/ui7e9FQ781xe2nXVj7VWVc72WK6I43pjwNFLf3G6yck/lBwH9g/FFvzuDO60kxFXthreVwtaP/xbdxqGSZJjDKD3tY2SUtCbo1q5Wkxymj8v0cdVh9KeWC8k5zXJUV54DiRiEi1YAnYRj2OrbkAy/JrrvfdA24iS0zyp2EokZ+hi0suKqLeaN/eEeJ3ZLizzPKV0inYwgylsXFdPV3IoNCGpksuGqmnWX23kTpR39hr2NcW5R2993bQpuLGmrz+8CTDERczwLrHklWKu3IDTT0ZyYszEUv27JEe3Cfntb2KreTNQKW2xwIXF/nLGU6o21I1ZSIkZjDjpEb/s6ulNSLQo5ldUfI8UAwgXk64WNNIpDc3Z8q1fnl/c/TwtYBOSlJzYgNv7ZmG2wXclR9/zjDmglLgTNY8ZjEig4ro01YUleVmvIUI41O2QzhCihLQ3VXmtq1NgvuhN6Z3pCMo1M9nNk/mnvVV7TXICk9aw5GSGp4zkNP+TRv24V0ByXIuA2Hjairyh9NSZxnLTmMUrYVDlwjLPUypsKPWKGcyQlsKb2trmyvRcIjn5SpUkh43pd20fXyo5mUIfKjn5jTXXGsXLobLFsY/kBDbWvKVqpS4sazyl8qG+0gymJaxikBw9zjMhXesGMkVyAi57tZITM9dSOp7rMYOyHRwbvl2S462mPWX27hoZS+wSm97aZzltpgvLVE+p8MOM9oYZTOGznPBNjaMfXlaTM4/hSQFvaIkCKT6XyrS+aF0WlByvRUdgn0S5rPfYj/6hcjBG98xoTtMqxZ1i+LamaJNjb9GKqiOeWGuCO0vzHMhpTpufZS4sbaanVDiq7ZpOMoOxaXFZxXg5GUrL0LrGVUH9HG+vv7TOIVjXKGQ/9Xn0XjOGF7H1hw5klRtrV4L3SAAAdw8yO49ySA4AACA5SM6clsCsBQBw8SCze8JDQgQAAACSAwAA4GrJeSsndklC4iN2zNYUctJdUrmVQrkGXqw1oXtNb6qiVzzKe+64sVpyptJnv9Q2dRTbqoe8wnDt9ff06pjH7YzQRWaOaCPjOgtsO+60llhWyRn+SCc2yQWSs+2V10tO5qZIzv5tZFxnQfN9SHIK37IUX++yXQO8F2mh7OvNmVO9CTnDqwoZeMuylgr75T7x3bHh95vHAUFslOY3O8iEbou+FZtsL299jb/1jPclQ0TTXEJK2siOFuVl7V53GLaa93ZTI2QvyfHmhxim0davlkysksm+rvxK6UiZrBuBtP9tQiL65syqpBRPTNEfcEAIRO/U0H2lvbzN0fy5+LzmBS1qHaL/NnY1RYNbKJmeroKF5gKBCNl3Y602+1ssG3/MqSycCjczzjZ/Pq6SkpdfMECFMSjkI6flkksqCS5nhG4rSsjo3c8JJ71Xcti4bprMyOdKoR/IjprMfOjNPlx1u3yEnCo5LZdKL2bKZOv5pyQnkIp8ARXG5+HIKZecBaHrjd7ZkqPfXV9Hzpac8LRgOFDomuFyqUhKzrIIOVhyAvtvLZo619Wol0nOcGN3Q8lx5e3PUJGJ3nmh643eqZJTQot+C6/kiE9fStpIb6Dkxpo3HlZGyPEba4q/dzOf/rn2kVs/gfb63aT1qxzlocLr6utt4ljJw5IzO3QD0TtJcvTnBKJBe+GWZuDB6pB81znmUySnPEI2khzv8TDXeS0jrbqCZibfbhXZ15vzfE4bnfZpzkT6oi+AsdldlYi+RY0Gmt/R4LHkLiq80Ts1dIe1qGqvmFGIYbiQSafv/bnSpoGgstsoWTCXwUHYDmBNhGy0ykld60vvGaysrOge+EHaN3+h56YgJLyJECQHyUFyvis592RAIby/FCH/Cqv3HV+A9ZV1uXl+hPxCvYHYy9oU7NvWUAAAAADJAQAAgOQAAAAA+0iOd0928R7u7kfX/cUbvuu+rMyuO4ZzydwXFcm7Kz83XhkJhMq7XsuHjbNLuD0iqflEI6+PBMeGdSwnX3n9MMab1+bkC4+Xp9rrJaOllxrnU/qx53jobZEZTbnFKgfJuWDMcg1GhVdGchZcObwqRXJ2Gw9fb8qI5IiOL8ZLv7/XURJkDR01jBI+Xnn4+q5RHZexiusFfmPyPiyeYbzR+vlLhgkjApY/j3MrxdhD9PlQDDJiORSGreCKsSZ7uoiXitVxSLtNbNgRJ2YZ5U1rokSIy1TJ1Tf3Hw9b3/PF1QrLljtSN/hTLEO3Y1n2FGGwh2ZXrl/Ru6VFUwgrvxXDS/TGsOVn2JTNY9hjr81t2pUSirYoLZQpbjgGtYRrUcy+IVlHo6F7A5mSRVuP6uGQ2tv5Cfe4pKmS3jf3Hw/Fzh42G1u3yhlOsYcLNG++uXzGScVdQ1nnKiuMgOS0UF7efCpZb0LMwnTa4eaOTQi8xasiYSgw3oAJSE5JBcXFgYveoYVrssdVZa3VDTgOHQ+rwmyF5NhTqubP6B7rb95xxL6v17slMIrpYe2dABZKTsCiw8WGkVwyLzmu8WKS5Ijjo3e6qtdRCenMcOM1jBkOILoJTcmioVxyzh0PA94/u0hOeCEZntfnJUf//iuSo8z7XAN9YD03Q3ICW0wHSY64V5lZ5cQkJxzkAWcEl+SU2+4FTJXKJWf/8TBsxPCy5Az3Lh+ne0PLhwDFgX127x+BEUSnblj3gM9HQJO8GmC3mnGOoFxylBn9VMmxH4aV1Fqso2t0i/m+9PQvMNjprjDejtw8p8JKJGef8dC4XZj2RZITcHz5Uyvbs2H4mE45oqOcJsoYxnhNO+zVcdKZxmUeMzzmNLRRCVuztNGBK2OL2fYBMmxRxCcc3uNYSQLt7UQ9Jl2bZmLHCfi+GM1tx+GwCYZ0Nc29xmWqFGNs5/GwOU+s2WY8C14hJ2f7SZUlz+7m8TDvLU7CALouaR2GGDoPerNzeYgBGENy3gymr5lqYCVySiSUF4l2p9cgOQAAAACSAwAAAMkBAAAALMnxpvg9qc7//h135fXFONGzJ1zgEjuTDavJk4xaMsWXwECx5Jz4UG6BzOi0kK19hxYMh3HYHOi4UN9/rvBuPL9lOXP0eDIwCLhm0FyzskFypirEPoVEcj4rOcm+j+T4JEd/1TxgM6OnG9BfAHaZ5fRuJ96laXYp4Wr2+P+dZxW6+/z5p908e2weRBrDJbQnwmFXmMJuFQt1bw9tsvFEIEdGJoa93XlYca+vT/P7AxmFeYxz72AY7jhVm+TB/OSubFRGjw2k54s5cOgWMrqbjl0eV1ZHrzOH4rwi5gNVhkuFpfWePY9dIhAJ3hIOZ2MuExe7g7SoKVQ41F1DgT02ifGcqaNd2oChTqF7UOALSo28o6hCS6DkSyVH3Nk0XCWGaYWML3utIAKFVy4YiFFXNtmAVY+YKV0huR3i2SNOj2L+K2IJY+ToHSRclzYhyX9scHQVvtChqiXsZEr4sbPPtVE6uIzkBGhxlbxYcvSZV3OaUw0XKMpYbBR4kuQ0wdmiFdmlFFYhkAFzveRkPHvKLRsCJSwZ312ODzMmUgskR9nAr7ULmTqDDIdfwHbvFcmxS14mOeGE594eFQuC5reCqO2H4pVbwi7lLclRZuUz4nj2KicpOUnDGyQHyYmNe7tJzqyNNUVydI/3Yfx5d1eTz3Lsh8aZIanWXyfwLMd2rPE+y2mHePZk7jhkrMRjLeAKE+tWuiOLV3JEYQi0VEkda6eV89yDap/luM7y5LvqrGc5yqkM77OZJh/SCH+o+5G0qJWOaFYhuneE625bMAXMS4aUto09e5J3bObTVLGExnfs8uvWUN4ql7hG9aZ04ok1V1/O1DEQxkpd9MO0rvBzdUl9EPCeWAt0nMInOrwxeyRWnsQnFTzYKiDB2aECBfRwJAcgOQDJAU1cay+7IyML2CEgAZIDAAAAIDkAAACQHAAAAEhO6Q02tpDZIa/+bH5e5984XpzxDjjdsWl9FQ5lbGW27+EVlIeasSzjr4wDr5ii/VvQtXbu9pOuo7sYXP/QVclvnbnaBYRcIzP7NEq+Zw07da1xzlTqAqWaNzT9+04Urlzl6Ff+zjmfDEs30fXiAfdPdfa85HjtKnaO6n1KpWbRT/pVGP8aePM24IchvsMfsDxpo1zuzWk0EiO5l/1CySXRPO+Zl0tOIEWC4SASsBdqad8jMaeDsTMjOt+4uoOdun+YQMHbGcXeahsC9QLY2JsVe2VsCFIkJ2yc07Q0Cq6UKLqzVAt5YhVLztBZofnTE4nJu2KJu0V7GyMpmU29Uhgx67hRzVjGOSX/ptfZaOrOT77urrCssnfy5oILx4BuqCN2h9Y3B5pt3KL332GPdt3O2yv1UHetcsRO6s3pqfMvJsHT3bXnmhfYpRdNFMI5er192Js/OGzwo9h4xIYbpTzKgKV7CIXz7M7bWFPq7grLKnsne8pcEgOx6ihtNy+Bujjy1lYhcAu7zMkN8LD9jFfkMkZc3sll1W6he2Mt47ky3NGaLTktkVdVrPVsyQnvMuclp815eFhV90wDhQ0O7Fzuycz/seq8Ljmi0dGMKsR6Za/MLlOPsOQEnpQYWfCbaY99jOQEJh2BEaTWmcar/xdITmxWWD63RXJukpwmPHFMdsY2esI6W3Jcl9pccmYMnq4lwTuS8/qznMxNXRsponGFEStVXVd3KfcSNbTbWS85ro0117Mc74aP3SJTJae38673Vq93jlKXQk8gsWVdzSSaTMcmefbVAk5Ryn6GyyOxygx39caa13Olyd4nyqWa85CM7o0xPM2Vca/pxYerms1zCKrJ53mM39rdteStOt0wRjyxVmIvpAeS7mqjB7D+ofcQ3W9lXb5HrroonkDN42vV+0nhiTXxmfRwX67HcyuynxnOdbwnJ+1I8LqFFUgOAPdh9nt2p1ehLbGowAXjlA4yt79AN0ByNtcbJAcgOQAc050mHcBblq9ozb0WuCJhvLR/N5keZnANAABgkbZBAQAAgF0kZ/E+uJ6DOX+vzDftFzWambT/zxfaSxsO8zjsLdhj6WyrXhFP1oi9oH1GCVekud43AretcvJZvsOjXuE3xQj2ZjtfrDfeATfvNRAb4ic5QbiSOfL44RW5cvXcYfDMcNABx0hO2zWLe2aVo7/O8hYPi1c5mWouSLceznMFlsVhYdQhOZtKTjjnufdDPZ+2Mn32ehzorw3qL5qJ83T7hdnh3ZMZ9XtTeOXNSrtdjPf4xC2RR4rsqg3TrXtNCrxftgug76kOW7NFPUQMWrxOJTbzLeQToRtJeAO7OZNZ6C3VZCMVcST8zjJabQNXznM9KY7oMtBbTATyzCt5X3rfDKQCVF5Z9969JTLq/5ahytQgnyyupTPXeTO0D3c1Y0npleq4snJlrjwcwZvTqcT2trG9MzKWB97AVohyeaAoJATqe4HRbY3keIchYxYf62mxfOktlIAvnNM+tsppoTyAtloEdhK8WdCVBJevS44rolypz5Qg0Z0+5l25ZFbhEoPmSXApiqud8U8/EhIrgxIwmbEoc6bm2o21pOSExxcxhf4ayUnu7Ffx0Ju0BtIb2xtr4t3fkpwmpHNfLznieJepS8t5iJRLTvM/rheDLZPVu1xyxE3a8FikDHSfkJzYltS8obZqZnG65JRk1A9MgQONjuS8KDklKdgnrXJKzFVXSk54MHRJDhtrKZaVnuN66JKRHK95gZjTPuyXHjPYKMyoX7XrMsP4p8mGK706eh/jBRTOtSh3eZCLTz1d6w+vEXve4S0sObqNiOtFq5KNNfHEU0xieZYzSB7ePCnxxSf/utmBWKqweUGrO7EmZlz3HonR05XbvXSYuD5wFi58Dif8+t7QgCDGvBiurocuLrlNXtnoILYauc5W2c4CukuC7mrRQieqXV4Yw7sPjRWa0wllhlfIkRtr4Ox2JWvvzq3z3/6V/x0YiC8IbIDkAPQGqKpT+7/XSw6RjOSA7fokqVlY6wxD4rg4IbCRHAAAAADJAQAAgOQAAABAcgAAAAAkBwAAAJIDAAAAIDkAAACQHAAAAEgOAAAAgOQAAABAcgAAAAAkBwAAAJIDAAAAyQEAAACQHAAAAEgOAAAAgOQAAABAcgAAACA5AAAAwFrJCXuM72xLLlYqU4Xdqn+iS/yfMv/7D+Tr9Qoh27bCieFRNQLYdX/810Pp2rPYWX7/Tyvu37uGoZYZzsqrn1H9nZtD5/C3CuF6vULIbq2weUjMK96fKYtxo5Ime5fn/Tt+jeTcMaHbapWTXGieJTm/089e+VnlIDn51fPUYiA5KcmxFzG/y9XHuary88wnxjUfN2eMKxvXMWr3K72PZTAu1Su2WGtvgXtN9niXPz95/Dt2ZVtyeq0mMvDYQLHyx4LwT71+Q7F3zd6Czw4qV0QNu5jd6wMRPryRN+CTo3CvIXrdUydWrIhNY4bD31YeXm3livzfcH/GXscYzWbPWx9Z632iXLD3r8PN2eFd7IYcjk3DSw2LLS5fehsIroFGbKyqK7taSlz9GA0UKH84CHv92dXcYlAp60WRDbvXxyLce6PyvZPh9EWUnyHzYkUC812FQ2VQEsP45VWOKDl6rxOXt8bSxBVD3r3B37tkYsu1fTSUPV1yhs2hT3nWXzmzYehSl2H580GoVFmfS4nrIa8qFxYmf6NJI2BY+8U4D08QxQiMDTixVj5YcgKrXXvzwfswY7gFZ+t/piF1yTEKoweEqzvF9rh//zd55do+LHIYKH8mCGdIjl33xZIz40bztnpiMxI9sMWK6F0GyZklOcoQUCU5rsCaLTlVAXGi5IQ3zcINFCh/Mgj1JWPV8HSB5BQOhcpgMk9yYjQukJxW+sDsEf/f//u/ZkmOayV43LMcfbldLjn6US7lJ/ZpUWU3SfxtYPdswbMc5RGaEsyBZzn2F5rzGFXmWU6vZ5VIjvHwQ7yRUbzy/bRhQyhPQwM8i20a4DDcyithneMyjvfYO7niUSXjdIfyYMDeXdHv3jvsoR/Tav2neeKlejTa9ep1LaU5YtzqTzhcVxbnX2LTGw0UKH+4JLbq/A4KLursZjU6V/OcuRLPX8VOrBkhrRxc8q5yxIZo/mf7PZ6VYdMYKAIc9mJPHHNe21gDR+BrL5B/qjWPbtz7IvOV94hvDTmGLfoAQHIITiQHyQHgY6qzfpdjXi1uapRbOWRjDQAAwNVTKygAAACwo+Tc/QjhMsuGxUt+4/DhuU2vJ/3bJDBmpyaLlWRNat09h4g7Cll4zX/eGLpVTgK1u2nP2sWhMsIexIye9UB5dexdvakqQDK2db+Ab47gawpZ5RBW24JfWeW4cnOxyvEuBU6nJZBoZ2fJef1qHMC7SXLmrnIKM8A3LYm9+K5o4U31dOLN8waZWKMmvMk/ZKxpjhK/H5a8pRsjzW7TQMX18uveE3nJUfboantQr4EUOwm7xcP7dWGXDfH15xKDgLbE9MHVy1rUhaT3E6PdXZvGsyRnRgb4cO6QWC4yPfP8MKeLixBlnLK70HBHQswtP6QowLw9k3JtuDV/Mh49B3s4JMKSM2TARazeg5onS+Ew8DIJfly7McOmqU2A9rrpQzJtY2A009PaNjkJ4aKNtXwG+ObPMmL/U+Cm+iS0RW0FXHM9rwtApgAlvhKuxIuBhIYzKm6sRVo0p6Q3n6NrOuLqQbpvgsuwZzjUxg4mDG3oCnNuKvt7i00fMhkFxdANK0obOaRM2iuWludeRoYa4xoxxREkPInWRwHXxD886IRbxPX9jO9OUnL0dlTswuzdm2Subpfbk74C03O2hk2UM45Heqh499n0CgYyIgceKS0wfRDL5h1gM75/mSzJSzfWSiQnPEMplBz9h+XtlPEXSO6JxcT+LcmJJQUvbEfvuO+Kut0kJ7wx4GVskuTE2Ftp+hDec85svRwvOd4M8Eo8xQadcP/RHzx4PQtmSE6JJURy1ygpOcPHyK4ZXHiTIdCOsTFRXLP25r9hrx3XIiAjObFjtfrWk9eds+UMAlxDR2ZjLbwVJjaNUchezvLh1EfsIJUba5kM8C2a+Xz4T/pNH89sKOnEhym+xRNrRvUDB7eUBPXNzGOfOUtT9WWxHZvHXWLYBKL3hD1u2kwOf6vLhti+eisE7DP0g1v2IzTvUSvRNkIZEHcwfXA5rXhHs2Ehh8fP3j+xBq7Eni9JkAwbgC8OR1CA5KA3AAAkB1QO8ZtkPLssuT0AAMkBAACA5AAAAEByAAAAgBckZ3ja8j8//P2tuwSetyLO4NQ8bOq9VBUPF2R39h6y35CQbVvh9KdrJc8Iwz/n2WRccsR3tapytsdyRezfIUsOifXO18foPatXiO/YhsPvRU97ZKa8hIUzs02a9WINC2alLJec4eBytOTk75uUnHaLh01h+LHKuU9yrmESyRlLjmi7qaRn99pFPC7CdAOS4ddc773btNjFGNo9DF9NF2vk+lphGoWmWb/YEeVKijzP/CmQoMFoUMMVRrQp0l/dH7pgeC2a3u13yjeNuzfNracJL+eLfWfY8WPpPC6XnOaxCWm5tF360kq0mVJcalxOP8ZwL2bOaM5kSjHaMxX3/p20fmlaEppwurmk+VMsW6AtV7+jknHBkgx1GScYb3mm9rshk0pGHG/7DmcGXk+d5snIeaHkBNJCN7/bVezLotdL87vpNE+2wfwqJ7mazCt92KBltvVL7cZaufmT1/lJD4wWzTDtchsKsOGaHyzudwFPEL176jXKP30UnWyQnH+x4M5IjljskgSuoqzGuGp+zxI90V7Mnsc17k/Kw18iOVPNn5JmEOWS46r7AslZ2e/KJUdp30LJCZhy3SY5GU+h6yXHO+0Sx0pvAnkkp+V8HErMn8KWd2JpY+Zj5VaSO0jOjBFDv908yak9inmk5OTjrERyYu2hTB4DA7pit7NMcpp8LjPApG7QMtX6ZbbkJM2fMs9yhjtIAeuHzLOcmBOMqzyz+928jTXvs5xayZlqCL2L5OiOIM1vEyIewwichtI/VE7O6E/+m3xQqnn8S2zzEl2BvEwGDI1EHvJWSUbHHl6k3PwpVpImGMk089SWK84V25uwE8zr/U4fWFzHB1zVfOy5gVv0hoUeS3c+y7kVlxw0rMj7AA5q4guyA9CmAMlBbwCSQ78DSM60uD/6oCFmM98MVxKgASQHAAAAQHIAAAAgOQAAAJCc//sj+UCe93WKrYmYWey7d7GPSOH8Lj/Dw9PDDw9qev248CaBUfuoKXOd2GHow3xJjNIriYqPHo7X3PrcB6fi26b7G9XswGHgRfojpNQeQOxRZYeXHGu9djLh7c2qdckqx3U0E8m5e14/ya3km5Jz5Q6Bnmdkf8l5/YKXHYsPSs5jlAxNX4wVq/6e82+p8m4czfQpES+lvMn8h6v11izlZjbDHARecxHX7lMT8uvEHFOUvSCXx08vBYDCmL3V5s0UIMaS2FmMwNYlp5dcR+FzhjOTkqDBjj3RuCGpVcPxwY5AseTvSI53vWy3TS/UmsftrcqNo/WdP4a+Vd6csu1ta5bmSa2m31Gct4rWLMo45TI1scdxb0pN8UP9OvZMP5/12RXww+srURFoSqWyygWrnJlcA0vM48q1YaC4lClMih9uITlGBHsrYzum6JWvcuMIRLA3el63ZhGZcREYGxSGnTO5V+PyT6py1rFXurrkVOlZVcWTMezaWHM9wJjtzGQ70wSkS4wWXXiUCmYGtF0kJ1+ZWOLxqanR50nOhtYs4Tsqk2jXaBgjMDbP9TaH6/sB6a2SHL0dh0u64S5WeV9Q+vJw3JhkkxFeA7l2WTKPdvQKeke8V4SnvjL5IzoxQ6qpktP8CZVft2aplRzXAJqpb15yMoYX+jb9hpITK8CkFX+hndq2klO7ZxXzgilclb4mObrRSMZVTHwIpD+xEPdSbdeQGdPbV6xZWsd7o7xpvJKjO4tkdvPzkhMza5gqOU04qhPeV8nsnOt6o0wU7BeVyp2ZYlPDGc9yvEZHmfba6FmO7uehzASVo1bDszRVbhxN8AvRDS2U5ysvWrOE7/ho2pE5IPd4NZHAljiz1DMc0p+BDcszJD/QTMOX4cQ7Zo7bDUmzT6wp233N77YV6z52xWPxpnhcGcOU3bjD8gcO/T4qzS4bawVXfKUak2/6kSPzYPMWJ/DA8T0LyUFywBEtTtQBJEddF8/uigtufY15CTiuxQk8gOQAAAAASA4AAAAkBwAAAJIz+R4n7EHPKKRu/TDJTWR4KJYOAAC4QXLOlZlhyTMZ+h6vMMlNREkXdqvYAwCQnG9JTuz6MyTHkDckBwDwpuTEfFP0d25FT47ka9tKMgLjJ4ZJhjefwpBeRXIUFTSyz2ZY8sZG03JAtJAbDQDgKslRstfo+zbKtN3OPxZOeOx1f9EzQDc57dLQ1l63I9NXCa7U8S5noCrXIuM6O2RWBwC8sMp5HCP0NHwtl5g2lim5d4WSVIbKGFqbMnko+SWS81i7YYu76h5LSggA+Kjk9PZw5klOk41zXJLTEr5zrciiKiw5XuHMSI6o92EJ95p0AQA+Kjkz0rOLWeVLJCdTntmSU+Jhc7rksNwBAMkZLBGGHi3hjbWSQW34LOfxpkaub9sqKmYMM1zN1EqO171bnH+ID4cer+N6fAUAuEFyXKfR7INGAXeHnufE76CpH0WzjTRsk5jf7/SkVz+x1kany0SjKv2avYuUOPTkDwq20WlAuigAN69yAIgHEwoBAEByAJIDAEBywFV6w3kzAIAqOYwXAAAAkBwAAABIDgAAAIDkAAAAQHIAAAAgOUgOAAAAJAcAAACSAwAAACA5AAAAdpOc//qf/4P/+I//+I//+G/Bf/8/mP5Xs5k8YMQAAAAASUVORK5CYII=</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-22" NO="22" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Summary of Findings for Primary Prevention</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.png" FILE_TYPE="PNG" ID="FIG-23" NO="23" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Summary of Findings for Secondary Prevention</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>